Classification, Diagnosis and Risk Assessment Methods in Diseases with Visual Impairment by Paiva, Bárbara Cecília Bessa dos Santos Oliveiros
  
Bárbara Cecília Bessa dos Santos Oliveiros Paiva 
Técnicas de Classificação, Diagnóstico e Avaliação de Risco  
em Doenças com Compromisso da Visão 
 
Classification, Diagnosis and Risk Assessment Methods in Diseases with Visual Impairment 
 
Tese de doutoramento em Ciências da Saúde, Ramo de Ciências Biomédicas, orientada por Prof. Doutor Miguel Castelo-Branco, 
Professor Doutor Joaquim Murta e Prof. Doutor Alexandre Silva e apresentada à Faculdade de Medicina da Universidade de Coimbra 
 
Agosto 2014 

 Bárbara Cecília Bessa dos Santos Oliveiros Paiva 
 
 
 
 
 
 
 
Técnicas de Classificação, Diagnóstico e Avaliação de Risco 
em Doenças com Compromisso da Visão 
 
Classification, Diagnosis and Risk Assessment Methods  
in Diseases with Visual Impairment 
 
 
 
 
 
Agosto 2014 
 
 
  
 
 
  
  
 
 
 
 
 
 
 
 
 
Tese de Doutoramento em Ciências da Saúde, Ramo de 
Ciências Biomédicas, orientada por Prof. Doutor Miguel 
Castelo-Branco, Professor Doutor Joaquim Murta e Prof. 
Doutor Alexandre Silva e apresentada à Faculdade de 
Medicina da Universidade de Coimbra. 
 
 
 
 
 
 
 
 
 
A Faculdade de Medicina da Universidade de Coimbra não 
aceita qualquer responsabilidade em relação à doutrina e à 
forma desta dissertação. 
(Regimento da Faculdade de Medicina Da Universidade de Coimbra, 1931, Artº 108, § único) 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
To my children, Marta, Filipa e Bernardo 
 
To my husband, Nuno 
 
 
 
 
 
 
  
 
 A C K N O L E G M E N T S  
 
 
In such a work, it is not possible to thank all who have contributed. Over time there were 
many people who helped in several ways to its achievement. It would be a long list to name 
all of them. However, I cannot fail to mention the people who, by their direct intervention, 
played a leading role in the implementation of this thesis. 
 
To Professor Miguel Castelo-Branco, whom I greatly admire given his intellectual and human 
qualities, I would like to thank for the encouragement, motivation, guidance and friendship 
that were crucial to this work. My questions and suggestions, as well as the work I 
developed, always received his attention, with his usual jovial competence. His scientific 
example was and continues to be fundamental for my training. 
 
To Professor Doctor Joaquim Murta that, from the outset, has always been receptive to 
collaborate with the established objectives, and for the demonstrated availability. 
 
To Professor Alexandre Silva, I would like to express my gratitude for his indefatigable 
attention, and for always being available as a co-tutor; his ability to encourage, to read and 
to motivate the search for new paths and solutions, and for his safe and timely advice. I wish 
to express my deep gratitude for his encouragement since the beginning of my Master’s 
Thesis, in which he also played a strong role in co-orientation.  
 
To the Faculty of Medicine, University of Coimbra, Portugal, I would like to thank for the 
support to elaborate the practical work. 
 
To the Institute of Biomedical Imaging and Life Sciences, to the Institute of Nuclear Sciences 
Applied to Health, to the Ophthalmology, Endocrinology, Cardiology and Imaging Services of 
the Coimbra Hospital and University Centre, I would like to thank the cooperation provided 
for obtaining data. 
VIII 
There were also three key people to the realization of this thesis, with a very strong and 
active contribution. To each one I would like to show my most sincere appreciation. 
To my great friend since my youth, Mrs. Catarina Viegas, and to my husband, companion 
since the days of High School, Engineer Nuno Paiva, thank you for your precious help with 
the Platform DeGóis. Both were tireless inserting the data of my Curriculum Vitæ. 
To my friend and colleague, Researcher Ana Cristina Santos, for the exhaustive reading of all 
the chapters of the thesis, prior to any tutor, having given me valuable suggestions and 
recommended insightful changes. 
 
A very special word to my colleagues in the Laboratory of Biostatistics and Medical 
Informatics, who accompanied me daily, for the good working environment they provided 
me, being always helpful and available. In particular, I thank Professor Francisco Caramelo 
who always listen to my doubts and answered to my questions with particular interest, 
giving critical responses, as it is his feature. 
 
To Professors Maria Filomena Botelho and Emanuel Ponciano, without whom I would never 
have started this journey. My sincere thanks for their support. 
 
My great esteem and gratitude goes also go to my Mother who will always be connected to 
any work developed by me, for having instilled in me her fondness for the Theory of 
Probability and her experience and practice of Statistical Analysis. 
 
I am also grateful to my husband, Nuno, and my three children Marta, Filipa and Bernardo, 
for their patience and tireless support. Their complaints were more than fair, always! 
Marta e Filipa, I would like to thank you for never have charged me for the lack of support in 
your studies, especially in mathematics and physics, in the last months. Bernardo, I am sorry 
I have not accompanied you in your wills, proper of your age. It would be fair from you three 
to do it! 
Nuno, I thank you for replacing me, with our children, in an extraordinary way. 
 
To my family and friends, thank you for everything! 
 I N D E X  
 
 
AKNOLEDGEMENTS VII 
INDEX  IX 
FIGURE INDEX XIII 
TABLES INDEX XIX 
GLOSSARY XXV 
RESUMO  XXIX 
ABSTRACT XXXIII 
PART I CONTEXTUALIZATION 1 
 CHAPTER 1 INTRODUCTION 3 
 CHAPTER 2 OBJECTIVES 9 
PART II THERORETICAL FRAMEWORK 11 
 CHAPTER 3 VISUAL IMPAIRMENT AND SYSTEMIC DISEASES 
  WITH OCULAR MANIFESTATIONS 13 
  SECTION A VISUAL IMPAIRMENT 13 
1. Definition of Visual Impairment 13 
2. Wold wide epidemiological estimates 14 
3. Main causes of Visual Impairment 17 
4. Risk factors for visual impairment 20 
  SECTION B SYSTEMIC DISEASES WITH OCULAR MANIFESTATIONS 21 
1. Chronic Systemic diseases 21 
2. The case of diabetes 22 
2.1 The Insulin mechanism and consequences of its failure 23 
2.2 Estimates on diabetes 24 
3. Impact on the eye - Diabetic retinopathy 26 
3.1 Major earlier studies on Diabetic Retinopathy 27 
X 
3.2 Classification of Diabetic Retinopathy 28 
3.3 Prevention of diabetic retinopathy 31 
 CHAPTER 4 ROADMAP TO STATISTICAL CLASSIFICATION 33 
  SECTION A THE PROBLEM OF WORKING WITH CORRELATED DATA 33 
1. Introduction 33 
2. Mathematical Issues on dependent or correlated data 34 
3. Revision of Literature 35 
  SECTION B STATISTICAL CLASSIFIERS 41 
1. Introduction 41 
2. Classification Methods 43 
2.1 Discriminant Function Analysis 43 
2.2 Regression procedures 46 
2.3 Bayesian Classifiers 49 
2.4 Decision trees 50 
2.4.1 Evolution of Decision Trees Algorithms 51 
2.4.2 Actual Decision Trees Algorithms 52 
2.4.3 Growing the tree – splitting, stopping and pruning 54 
PART III MODEL DEVELOPEMENT, APPLICATION AND ASSESSMENT 59 
 CHAPTER 5 MATERIAL AND METHODS 61 
1. Collecting data – general procedures 61 
2. Selection of patients and data management 63 
3. Sample: train sample and test sample 64 
4. Variables measured in the training sample 
and measurement instruments 64 
5. Statistical methods 70 
5.1 Handling correlated data from both eyes – measures 
and graphics of agreement 70 
5.2 Computing a global measure for data obtained from 
each meridian in psychophysical tests 78 
5.3 Data reduction for classification 79 
5.4 Statistical classification 83 
5.4.1 Development of the statistical classifiers 85 
5.4.1.1 Discriminant analysis 85 
XI 
5.4.1.2 Logistic regression analysis 87 
5.4.1.3 Decision Tree analysis 88 
5.4.2 Testing developed statistical classifiers 89 
 CHAPTER 6 RESULTS 91 
  SECTION A CORRELATION BETWEEN EYES 91 
1. Evaluation of  recommendations found in the Literature 91 
2. Correlation among measurements 91 
3. Concordance among measurements 92 
4. Graphical evaluation of random errors between controls 
and type 2 diabetics as a measure of concordance and 
accuracy of data for analysis 95 
  SECTION B STATISTICAL CLASSIFIERS FOR TYPE 2 DIABETES 99 
1. Training sample description 99 
2. Variable reduction 101 
2.1 Phase 1: Factors of differentiation in diabetes 101 
2.1.1 Clinical and demographic assessment 101 
2.1.2 Blood Tests 104 
2.1.2.1 Biochemistry 104 
2.1.2.2 Cell Blood Count Cytometry 106 
2.1.2.3 Hormonology 108 
2.1.3 Ophthalmological tests 109 
2.1.3.1 Optical Coherence Tomography 109 
2.1.3.1.1 Volume Scan density 109 
2.1.3.1.2 Retinal Nerve Fiber Layer 110 
2.1.3.2 Psychophysical tests 111 
2.1.3.2.1 Speed 111 
2.1.3.2.2 Achromatic contrast 112 
2.1.3.2.3 Chromatic Contrast 113 
2.2 Phase 2: Univariate classifiers of Diabetes 116 
3. Multivariate Models for Diabetes Classification 124 
3.1 Discriminant Function Analysis 124 
3.2 Regression procedures 128 
3.3 Decision trees 131 
XII 
4. Model Comparison – applying obtained models on a test sample 134 
  SECTION C STATISTICAL CLASSIFIERS FOR DIABETIC RETINOPATHY 
   IN TYPE 2 DIABETICS 139 
1. Training sample description 139 
2. Variable reduction 141 
2.1 Phase 1: Factors DIFFERENTIATING Diabetic Retinopathy 141 
2.1.1 Clinical and demographic assessment 141 
2.1.2 Blood Tests 142 
2.1.2.1 Biochemistry 142 
2.1.2.2 Cell Blood Count Cytometry 144 
2.1.2.3 Hormonology 145 
2.1.3 Ophthalmological tests 145 
2.1.3.1 Optical Coherence Tomography 145 
2.1.3.1.1 Volume Scan density 145 
2.1.3.1.2 Retinal Nerve Fiber Layer 146 
2.1.3.2 Psychophysical tests 147 
2.1.3.2.1 Speed 147 
2.1.3.2.2 Achromatic contrast 147 
2.1.3.2.3 Chromatic Contrast 148 
2.2 Phase 2: Univariate classifiers of Diabetes 149 
3. Multivariate Models for Diabetic Retinopathy Classification 155 
3.1 Discriminant Function Analysis 155 
3.2 Regression procedures 158 
3.3 Decision trees 161 
4. Model Comparison  161 
 CHAPTER 7 DISCUSSION 165 
 CHAPTER 8 CONCLUSIONS 183 
 CHAPTER 9 FINAL CONSIDERATIONS 191 
1. Study Limitations 191 
2. Further Work 192 
REFERENCES  195 
 
 
 F I G U R E  I N D E X  
 
 
Figure 1 Visual Impairment prevalence, per region (lines) and in the world 
(circles), in the year of 2002. Data obtained at WHO’s public 
domain
1
. 15 
Figure 2 Blindness prevalence, per region (lines) and in the world (circles), in 
the year of 2002, according to age group. Data obtained at WHO’s 
public domain
1
. 16 
Figure 3 Percentage of increase in the number of blindness, low vision, and 
visual impaired people between 2002 and 2010 per region (bars). 
Population growth is represented by a line. Data obtained at WHO’s 
public domain
7
. 17 
Figure 4 Main causes of visual impairment in the years of 2002, 2004 and 
2010. Data obtained at WHO’s public domain
7
. 19 
Figure 5 Prevalence of visual impairment around the world. Figure obtained 
at WHO’s public domain
7
. 19 
Figure 6 Pro-Insulin and Human Insulin molecule. Figure obtained at a public 
domain. 23 
Figure 7 Distribution of chosen eye to analyse within papers which used data 
from one eye only, per journal (Adapted from data available at 
reference 32). 37 
Figure 8 Distribution of methodologies on number of eyes to analyse, per 
journal (Adapted from data available at reference 32). 37 
Figure 9 Overall distribution of eye chosen for analysis, when only one eye 
was used (A) or when both eye information was used (B) (Adapted 
from data available at reference 32). 38 
Figure 10 Distribution of methodology for analysis, when only one eye 
information or both eye information were used. (Adapted from data 
available at reference 32). Values between brackets indicate 95% 
confidence interval for the p-values, if Monte Carlo simulation was 
applied 39 
Figure 11 Flow chart for planning statistical analysis suggested by Armstrong
32
, 
and adapted. 40 
 
XIV 
 
Figure 12 Modified 7-standard Fields Colour Photographs. Figure obtained 
from the Study Protocol. Field 1M (Disc), Field 2 (macula), Field 3M 
(temporal to macula), Field 4 (Superior Temporal), Field 5 (Inferior 
Temporal), Field 6 (Superior Nasal), Field 7 (Inferior Nasal). Font: 
Diamarker Study Protocol. 66 
Figure 13 Fields of volume scan density for Frequency Domain Spectralis OCT 
(Heidelber Engineering, Heidelber, Germany). 67 
Figure 14 RNFL quadrants for Frequency Domain Spectralis OCT (Heidelber 
Engineering, Heidelber, Germany).  68 
Figure 15 Representation of normal and colour defects on chromatic vision. 69 
Figure 16 Construction of a Youden plot for measurements performed in both 
eyes of the same subjects (A) and determination of the Total error of 
measurement between eyes (B). 75 
Figure 17 Determination of the Random (A) and systematic (B) components of 
the error. 76 
Figure 18 Determination of the Random and systematic errors. 76 
Figure 19 Youden plot for measurements performed in both eyes of the same 
subjects. 77 
Figure 20 Values measured for the Speed test (º/s) for each one of the 
meridians, plotted in a polar referential. 78 
Figure 21 5-sided polygon obtained by joining the measure obtained for each 
meridian of the speed test (º/s), which represents the vertices, and 
the origin. 78 
Figure 22 Nonparametric Spearman Rank-Order Correlation Coefficient. 92 
Figure 23 Intra-class correlation coefficient. concordance correlation 
coefficient and pseudo-concordance correlation coefficient between 
left and right eyes on Volume Scan and RNFL. *Difference between 
eyes (p < 0.05) by Wilcoxon Matched-Pairs Test. 93 
Figure 24 Mountain plot for concordance correlation coefficient based on 
Pearson correlation coefficient (CCC) and on Spearman correlation 
coefficient (pCCC). compared to Intraclass correlation coefficient 
separately for volume scan (A) and RNFL (B). 93 
Figure 25 Global random error and comparison of the group random errors on 
Volume Scan OCT quadrants. 96 
Figure 26 Global random error and comparison of the group random errors on 
RNFL OCT quadrants. 97 
Figure 27 Distribution of sociodemographic charateristics (Binomial Test or 
Adjustement Chi-square test). 100 
 
XV 
Figure 28 Descriptive statistics and comparison of clinical and demographic 
measures assessed between controls and type 2 diabetics 
(Independence Chi-square; * Fisher exact test). 101 
Figure 29 Age distribuion by group. 102 
Figure 30 Correlation between clinical and demographic variables measured in 
controls and in type 2 diabetics. 103 
Figure 31 Speed test on meridians 0º, 45º, 90º, 135º and global area 
generated by these meridians in controls and type 2 diabetics. 112 
Figure 32 Achromatic contrast test on meridians 0º, 45º, 90º, 135º and global 
area generated by these meridians in controls and type 2 diabetics. 113 
Figure 33 Chromatic contrast test (Protan) on meridians 0º, 45º, 90º, 135º and 
global area generated by these meridians in controls and type 2 
diabetics (meridian values should be read x10
-6
; area values should 
be read x10
-6
). 114 
Figure 34 Chromatic contrast test (Deutan) on meridians 0º, 45º, 90º, 135º 
and global area generated by these meridians in controls and type 2 
diabetics (meridian values should be read x10
-6
; area values should 
be read x10
-6
). 115 
Figure 35 Chromatic contrast test (Tritan) on meridians 0º, 45º, 90º, 135º and 
global area generated by these meridians in controls and type 2 
diabetics (meridian values should be read x10
-6
; area values should 
be read x10
-6
). 116 
Figure 36 ROC curve for Speed test. 121 
Figure 37 ROC curve for Achromatic contrast sensitivity test. 122 
Figure 38 ROC curve for chromatic contrast sensitivity test (Protan). 123 
Figure 39 ROC curve for chromatic contrast sensitivity test (Deutan). 123 
Figure 40 ROC curve for chromatic contrast sensitivity test (Tritan). 123 
Figure 41 p-values obtained from the Kolmogorov-Smirnov or the Shapiro-Wilk 
test to variables in analysis presented as |log |, in logarithmic 
scale. The horizontal lines reflect the values of 0.01 (|log 0.01| =
2.00) and 0.05 (|log 0.05| = 1.30) for type I errors. All bars below 
horizontal lines represent variables with normal distribution in the 
group. 125 
 
 
 
 
 
XVI 
Figure 42 Scaterplott of the probability for group (y) control (blue) or diabetic 
(red), based on the value of the discriminant funcion (d). Horizontal 
lines mark the cut-offs defined by discriminant analysis (50%) and 
ROC analysis (62,16%) for group classification while vertical lines 
mark the cut-offs defined by the definition frontier line (-0,12) or 
obtained by ROC analysis (-0,28), used for classification in the 
discriminant function; big circles mark the centroid for the 
discriminant function (at 50% probabilituy) for each group. 128 
Figure 43 Decision trees obtained with CART, CHAID / Exhaustive CHAID and 
QUST algorithms. 133 
Figure 44 Predictive values (positive – PPV and negative – NPV) according to 
disease prevalence (prevalence data published by the National 
Observatory for Diabetes, in 2013). 137 
Figure 45 Distribution of ETDRS grading and duration of the disease, in years 140 
Figure 46 ROC curve for duration of disease since diagnosis. 150 
Figure 47 ROC curves for biochemistry, cell blood counts citometry and 
immunology parameters presenting statistical differences between 
groups. Curves plotted with blue present significant area under the 
ROC curve. 152 
Figure 48 ROC curves for OCT Volume Scan and Visual psychophysical tests 
that presented statistical differences between groups. Curves 
plotted in blue, green and orange present significant area under the 
ROC curve. 154 
Figure 49 p-values obtained from the Kolmogorov-Smirnov or the Spapiro-Wilk 
test to variables in analysis presented as |log |, in logarithmic 
scale. The horizontal lines reflect the values of 0.01 (|log 0.01| =
2.00) and 0.05 (|log 0.05| = 1.30) for type I errors. All bars below 
horizontal lines represent variables with normal distribution in the 
group. 155 
Figure 50 Scaterplott of the probability for group (y) control (blue) or diabetic 
(red), based on the value of the discriminant funcion (d). Horizontal 
lines mark the cut-offs defined by discriminant analysis (50%) and 
ROC analysis (58.46%) for group classification while vertical lines 
mark the cut-offs defined by the definition frontier line (-0.12) or 
obtained by ROC analysis (-0.28), used for classification with the 
discriminant function; big circles mark the centroid for the 
discriminant function (at 50% probability) for each group. 158 
Figure 51 Chromatic contrast test (Tritan) on meridians 0º, 45º, 90º, 135º and 
global area generated by these meridians in type 2 diabetes without 
and with diabetic retinopathy (meridian and area values should be 
read x10
-6
; area values should be read x10
-6
). 160 
XVII 
Figure 52 Decision tree for classification of diabetic retinopathy. 161 
Figure 53 Predictive values and 95% confidence interval relative to the three 
classifiers developed, assuming a prevalence of 34.6%. 163 
Figure 54 Expected proportion of papers using right, random or dominant eye 
for analysis, in OVO, OVS, CBO and global measure of the total 
expected proportion. 166 
Figure 55 Expected proportion of papers using Right, random or dominant eye 
for analysis, in OVO, OVS, CBO and global measure of the total 
expected proportion, when data from both eyes were available. 167 
Figure 56 12 years prevision for predictive values of T2 classifier. 178 
Figure 57 Final classification model for type 2 diabetes and non-proliferative 
diabetic retinopathy in subjects aged between 40 and 75 years old. 189 
 
XVIII 
 
 T A B L E S  I N D E X  
 
 
Table 1 The International Clinical Diabetic Retinopathy Severity Scales 
(Adapted from WHO’s public domain
18
). 29 
Table 2 The International Clinical Macular Oedema Disease Severity Scales. 
(Adapted from WHO’s public domain
18
). 29 
Table 3 Conversion table for classification of diabetic retinopathy (Adapted 
from the Royal College of Ophthalmologists
29
) 30 
Table 4 Association between eye methods selection and journals. 38 
Table 5 Statistical methodology to apply when both eye data is collected, 
suggested by Armstrong. 39 
Table 6 Main earlier and actual tree growing algorithms. 58 
Table 7 General 2x2 contingency table used for ROC analysis. 81 
Table 8 Comparison of measures of concordance. 94 
Table 9 Descriptive statistics on age and medical preliminary procedures 
measured in global sample. 99 
Table 10 Descriptive statistics and group comparison between clinical and 
demographic variables measured between controls and type 2 
diabetics. 102 
Table 11 Descriptive statistics and group comparison of blood glucose between 
controls and type 2 diabetics. 104 
Table 12 Descriptive statistics and comparison of creatinine values between 
controls and type 2 diabetics. 104 
Table 13 Descriptive statistics and group comparison of liver function 
parameters between controls and type 2 diabetics. 105 
Table 14 Descriptive statistics and group comparison of lipid related 
parameters between controls and type 2 diabetics. 106 
Table 15 Descriptive statistics and group comparison of leucocytes between 
controls and type 2 diabetics. 107 
XX 
Table 16 Descriptive statistics and group comparison of red cell counts between 
controls and type 2 diabetics. 107 
Table 17 Descriptive statistics and group comparison of platelet between 
controls and type 2 diabetics. 108 
Table 18 Descriptive statistics and group comparison of TSH (3
rd
 generation) 
and Peptide C between controls and type 2 diabetics. 109 
Table 19 Descriptive statistics and group comparison of Volume Scan measured 
by OCT between controls and type 2 diabetics. 110 
Table 20 Descriptive statistics and group comparison of Retinal Nerve Fibre 
Layer measured with OCT between controls and type 2 diabetics. 110 
Table 21 Descriptive statistics and group comparison of Speed test measured in 
meridians 0º, 45º, 90º, 135º and global area generated by these 
meridians between controls and type 2 diabetics. 111 
Table 22 Descriptive statistics and group comparison of the achromatic contrast 
test measured in meridians 0º, 45º, 90º, 135º and global area 
generated by these meridians between controls and type 2 diabetics. 112 
Table 23 Descriptive statistics and group comparison of Chromatic contrast test 
on Protan, measured in meridians 0º, 45º, 90º, 135º and global area 
generated by these meridians between controls and type 2 diabetics. 113 
Table 24 Descriptive statistics and group comparison of Chromatic contrast test 
on Deutan, measured in meridians 0º, 45º, 90º, 135º and global area 
generated by these meridians between controls and type 2 diabetics. 114 
Table 25 Descriptive statistics and group comparison of Chromatic contrast test 
on Tritan, measured in meridians 0º, 45º, 90º, 135º and global area 
generated by these meridians between controls and type 2 diabetics. 115 
Table 26 Accuracy of medical clinical outcome measures for univariate 
classification of type 2 diabetes. 117 
Table 27 Accuracy of blood glucose and glycosylated haemoglobin for 
univariate classification of type 2 diabetes. 118 
Table 28 Accuracy of liver function parameters for univariate classification of 
type 2 diabetes. 118 
Table 29 Accuracy of lipid related parameters for univariate classification of 
type 2 diabetes. 118 
Table 30 Accuracy of Blood cell counts for univariate classification of type 2 
diabetes. 119 
 
XXI 
Table 31 Accuracy of Hormonology for univariate classification of type 2 
diabetes. 119 
Table 32 Accuracy of OCT tests for univariate classification of type 2 diabetes. 120 
Table 33 Accuracy of Speed test for univariate classification of type 2 diabetes. 120 
Table 34 Accuracy of Achromatic contrast sensitivity test for univariate 
classification of type 2 diabetes. 121 
Table 35 Accuracy of Chromatic contrast vision test for univariate classification 
of type 2 diabetes. 122 
Table 36 Variables included in the discriminant model (Wilks’ Lambda method). 125 
Table 37 Discriminant classifier accuracy using two different cut-offs for 
posterior probability: classical (50%) and obtained by ROC analysis 
(61.04%). 127 
Table 38 Significance of models and improvement, step by step, on forward 
stepwise logistic regression model (Conditional, Likelihood Ratio and 
Wald’s methods). 129 
Table 39 Adjustment of the model, step by step, to observed data, and overall 
correlation. 129 
Table 40 Evaluation of the accuracy of developed logistic regression models. 130 
Table 41 Odds ratio and confidence intervals for variables identified on logistic 
regression model (step 5). 130 
Table 42 Evaluation of the accuracy of developed decision tree models. 132 
Table 43 Descriptive statistics on the test sample. 134 
Table 44 Evaluation of developed models on the test sample – concordance and 
disagreement. 135 
Table 45 Evaluation of the accuracy of the developed models on the test 
sample. 135 
Table 46 Expected predictive values for the final classifier of Diabetes (T2) and 
other indicators or accuracy. 138 
Table 47 Descriptive statistics of clinical and demographic variables. 140 
Table 48 Distribution of diabetic retinopathy for factor, and association with 
each factor (p-values for the independence Chi-square test). 141 
Table 49 Descriptive statistics and group comparison of medical preliminary 
procedures measured between type 2 diabetics without and with 
diabetic retinopathy. 142 
XXII 
Table 50 Descriptive statistics and group comparison of Blood glucose and 
glycosylated haemoglobin values between type 2 diabetics without 
and with diabetic retinopathy. 142 
Table 51 Descriptive statistics and group comparison of creatinine values 
between type 2 diabetics without and with diabetic retinopathy. 143 
Table 52 Descriptive statistics and group comparison of liver function 
parameters between type 2 diabetics without and with diabetic 
retinopathy. 143 
Table 53 Descriptive statistics and group comparison of lipid related 
parameters between type 2 diabetics without and with diabetic 
retinopathy. 143 
Table 54 Descriptive statistics and group comparison of leucocytes between 
type 2 diabetics without and with diabetic retinopathy. 144 
Table 55 Descriptive statistics and group comparison of red cell counts between 
type 2 diabetics without and with diabetic retinopathy. 144 
Table 56 Descriptive statistics and group comparison of platelet between type 2 
diabetics without and with diabetic retinopathy. 145 
Table 57 Descriptive statistics and group comparison of TSH and C-Peptide 
between type 2 diabetics without and with diabetic retinopathy. 145 
Table 58 Descriptive statistics and group comparison of Volume Scan measured 
by OCT between type 2 diabetics without and with diabetic 
retinopathy. 146 
Table 59 Descriptive statistics and group comparison of Retinal Nerve Fibre 
Layer measured with OCT between type 2 diabetics without and with 
diabetic retinopathy. 146 
Table 60 Descriptive statistics and group comparison for the speed test, 
measured in meridians 0º, 45º, 90º, 135º and global area generated 
by these meridians between type 2 diabetics without and with 
diabetic retinopathy. 147 
Table 61 Descriptive statistics and group comparison for the achromatic vision 
test, measured in meridians 0º, 45º, 90º, 135º and global area 
generated by these meridians between type 2 diabetics without and 
with diabetic retinopathy. 148 
Table 62 Descriptive statistics and group comparison for the chromatic contrast 
test for Protan, measured in meridians 0º, 45º, 90º, 135º and global 
area generated by these meridians between type 2 diabetics without 
and with diabetic retinopathy.  148 
XXIII 
Table 63 Descriptive statistics and group comparison of Chromatic contrast test 
for Deutan, measured in meridians 0º, 45º, 90º, 135º and global area 
generated by these meridians between type 2 diabetics without and 
with diabetic retinopathy. 149 
Table 64 Descriptive statistics and group comparison of chromatic contrast test 
for Tritan, measured in meridians 0º, 45º, 90º, 135º and global area 
generated by these meridians between type 2 diabetics without and 
with diabetic retinopathy. 149 
Table 65 Accuracy of medical preliminary procedures measured for univariate 
classification of diabetic retinopathy in type 2 diabetics. 150 
Table 66 Accuracy of glycaemia and glycosylated haemoglobin for univariate 
classification of diabetic retinopathy in type 2 diabetics. 150 
Table 67 Accuracy of creatinine for univariate classification of diabetic 
retinopathy in type 2 diabetics. 151 
Table 68 Accuracy of hepatic function parameters for univariate classification of 
diabetic retinopathy in type 2 diabetics. 151 
Table 69 Accuracy of lipid related parameters for univariate classification of 
diabetic retinopathy in type 2 diabetics. 151 
Table 70 Accuracy of Blood cell counts for univariate classification of diabetic 
retinopathy in type 2 diabetics. 151 
Table 71 Accuracy of Blood cell counts for univariate classification of diabetic 
retinopathy in type 2 diabetics. 152 
Table 72 Accuracy of OCT tests for univariate classification of diabetic 
retinopathy in type 2 diabetics. 153 
Table 73 Accuracy of the speed test for univariate classification of diabetic 
retinopathy in type 2 diabetics. 153 
Table 74 Accuracy of the achromatic test for univariate classification of diabetic 
retinopathy in type 2 diabetics. 153 
Table 75 Accuracy of the chromatic vision test for univariate classification of 
diabetic retinopathy in type 2 diabetics. 154 
Table 76 Variables included in the discriminant model (Wilks’ Lambda method). 156 
Table 77 Discriminant classifier accuracy using two different cut-offs for 
posterior probability: classical (50%) and obtained by ROC analysis 
(58.46%). 157 
 
XXIV 
Table 78 Significance of models and improvement, step by step, on forward 
stepwise logistic regression model (Conditional, Likelihood Ratio and 
Wald’s methods). 159 
Table 79 Adjustment of the model, step by step, to observed data, and overall 
correlation. 159 
Table 80 Odds ratio and confidence intervals for variables identified on logistic 
regression model (models Conditional and Likelihood ratio). 159 
Table 81 Logistic regression classifier accuracy using two different cut-offs for 
posterior probability: classical (50%) and obtained by ROC analysis 
(37.88%). 160 
Table 82 Decision tree classifier accuracy. 161 
Table 83 Comparison of diabetic retinopathy classifiers on the training sample. 163 
Table 84 Expected values of sensitivity, specificity, positive likelihood ratio and 
predictive values. 163 
Table 85 Data information from one eye – only one eye data collected. 166 
Table 86 Data information from both eyes – two eye data collected. 167 
Table 87 Accuracy of developed models measured in the training sample. 176 
 
 
 G L O S S A R Y  
 
 
General abbreviations 
AAO American Academy of Ophthalmology 
BDR Background Diabetic retinopathy 
CEO Clinical and Experimental Optometry 
DCCT Diabetes Control and Complications Trial 
DRS Diabetic Retinopathy Study 
DRVS Diabetic Retinopathy Vitrectomy Study 
EDICT Epidemiology of Diabetes Interventions and Complications Trial 
ETDRS Early Treatment Diabetic Retinopathy Study 
HRC High Risk Characteristics 
ICD International Classification of Diseases  
ICO International Council of Ophthalmology 
NPDR Non-proliferative diabetic retinopathy 
NSC National Screening Committee 
OPO Ophthalmic and Physiological Optics 
OVS Optometry and Vision Science;  
PDR Proliferative Diabetic Retinopathy 
SDRGS Scottish Diabetic Retinopathy Grading Scheme 
SQL Structured Query Language 
UKPDS United Kingdom Prospective Diabetes Study 
WHO World Health Organization 
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Clinical and demographic assessment 
ALT alanine transaminase 
AST aspartate transaminase 
BMI Body mass index 
C-peptide Connecting peptide 
DBP Diastolic blood pressure 
EVC Erythrocyte variation coefficient 
Gama GT Gamma-glutamyl transferase 
HDL Hight density Lipoprotein 
IFCC International Federation of Clinical Chemistry 
IFCC International Federation of Clinical Chemistry Working Group 
LDL Low density Lipoprotein 
MCH Mean corpuscular haemoglobin 
MCHC Mean corpuscular haemoglobin concentration 
MCV Mean corpuscular volume 
MPV Mean platelet volume 
NGSP National Glycohemoglobin Standardization Program 
NGSP National Glycohemoglobin Standardization Programme 
PVC Platelet variation coefficient 
SBP Systolic blood pressure 
TSH Hormonology measured Thyroid stimulating hormone 
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Optical Coherence Tomography abbreviations 
CS Central Subfield from Volume Scan 
G Global measure from RNFL 
II Inner Inferior quadrant Volume Scan 
IN Inner Nasal quadrant from Volume Scan 
IS Inner Superior quadrant Volume Scan 
IT Inner Temporal quadrant Volume Scan 
N Nasal quadrant from RNFL 
NI Nasal-Inferior quadrant from RNFL 
NS Nasal-Superior quadrant from RNFL 
OCT Optical Coherence Tomography 
OI Outer Inferior quadrant Volume Scan 
ON Outer Nasal quadrant from Volume Scan 
OS Outer Superior quadrant Volume Scan 
OT Outer Temporal quadrant Volume Scan 
RNFL Retinal Nerve Fibre Layer from OCT 
T Temporal quadrant from RNFL 
TI Temporal-Inferior quadrant from RNFL 
TS Temporal-Superior quadrant from RNFL 
VS Volume Scan from OCT 
 
Decision Tree Algorithms abbreviations 
AID Automatic Interaction Detector 
CART Classification And Regression Tree 
CHAID Chi-squared Automatic Interaction Detection 
CLS Concept Learning Systems 
ELISEE Exploration of Links and Interactions through Segmentation of an 
Experimental Ensemble 
IDEA Interactive Data Exploration and Analysis 
MAID Multivariate Automatic Interaction Detector 
QUEST Quick, unbiased, efficient, statistical tree
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Statistical abbreviations 
95% CI 95% Confidence Interval 
AUC Area under the ROC curve 
CCC Concordance correlation coefficient 
DF Degrees of Freedom 
DFA Discriminant Function Analysis 
GLM General Linear Model 
GRM General Regression Model 
ICC Intra-class correlation coefficient 
LBCI Lower bound of the 95% Confidence Interval 
NLR Negative Likelihood Ratio 
NPV Negative Predictive Value 
P25 Percentile 25 or 1
st
 quartile 
P50 Percentile 50 or 2
nd
 quartile or Median 
P75 Percentile 75 or 3
rd
 quartile 
pCCC Pseudo-Concordance correlation coefficient 
PLR Positive Likelihood Ratio 
PPV Positive Predictive Value 
ROC Receiver Operating Characteristic curve 
SD Standard Deviation 
SEM Standard Error of the mean 
Sens Sensitivity 
Spec Specificity 
UBCI Upper bound of the 95% Confidence Interval 
 
 
 R E S U M O  
 
 
As doenças da visão incluem a cegueira e a baixa visão, e afetam cerca de 4,25% da 
população mundial. Cerca de 80% destas podem ser prevenidas ou curadas. Estas 
estimativas, da Organização Mundial de Saúde, referem que 82% das pessoas com cegueira 
têm 50 ou mais anos. A sua prevalência está relacionada com o envelhecimento da 
população, emergindo neste contexto as doenças do segmento posterior. Nestas, inclui-se a 
retinopatia diabética, uma manifestação clínica da diabetes mellitus. Esta doença sistémica é 
a principal causa de novos casos de cegueira em todo o mundo, entre os 20 e os 74 anos de 
idade, sendo a complicação referida causada por danos acumulados ao longo do tempo 
sobretudo nos pequenos vasos sanguíneos na retina.  
A diabetes, especialmente do tipo 2, está entre as principais causas de morte e de invalidez, 
apresentando um elevado peso económico em todo o mundo. Teme-se que esta doença se 
torne epidémica, dado o aumento da sua incidência e prevalência devido ao crescimento e 
ao envelhecimento das populações, e ainda a alterações no estilo de vida tais como a 
redução da atividade física e o aumento da obesidade. Assim, a retinopatia diabética foi 
adicionada à lista de prioridades no que diz respeito a doenças da visão evitáveis. As últimas 
estimativas de prevalência de diabetes na população portuguesa entre os 20 e os 79 anos 
datam de 2012, e referem uma prevalência de 12,9%, representando um aumento de 1,2% 
desde 2009. Neste ano, a retinopatia diabética foi referida como a principal causa de 
cegueira na população portuguesa em idade ativa. A necessidade de diagnosticar 
precocemente ambas as doenças é fundamental em todos os contextos socioeconómicos, a 
fim de reduzir os seus custos diretos e, principalmente, os custos indiretos e intangíveis, 
quer para os diabéticos e seus familiares, quer para os Serviços Nacionais de Saúde. Apesar 
de os métodos para diagnóstico destas doenças estarem claramente definidos, a 
necessidade de encontrar novos marcadores e classificadores não invasivos, utilizados para 
rastreio noutros contextos médicos, tornou-se de extrema importância. 
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Para construir um modelo que identificasse marcadores da diabetes tipo 2, utilizou-se uma 
amostra de treino constituída por 96 casos, dos quais 49 eram diabéticos tipo 2, com idade 
compreendida entre os 40 e os 75 anos. O grupo de diabéticos foi usado para o 
desenvolvimento de um classificador de retinopatia diabética em diabéticos tipo 2, na 
mesma faixa etária, sendo a amostra constituída por 40 sujeitos, dos quais 20 tinham 
retinopatia diabética não-proliferativa. 
Foi avaliada a correlação e concordância entre as medidas obtidas para os olhos direito e 
esquerdo, obtidas por Tomografia de Coerência Óptica, concluindo-se que um olho era 
suficiente para a análise. Foi seleccionado o olho dominante, já que os testes visuais 
psicofísicos foram realizados apenas neste olho. Foi construída uma medida global do 
desempenho para cada teste psicofísico (velocidade, visão acromática e visão cromática nos 
eixos Protan, Deutan e Tritan) com base nos valores obtidos para os meridianos 0º, 45º, 90º 
e 135º, em cada sujeito. 
Posteriormente, foi necessário proceder a uma redução de variáveis, tendo-se comparado os 
grupos através do teste t-Student para amostras independentes ou do teste de Mann-
Whitney, de acordo com a distribuição amostral. Apenas prosseguiram em análise as 
variáveis que apresentaram diferença estatisticamente significativa entre os grupos, ao nível 
de significância de 5%. Subsequentemente, foi usada a análise Receiver Operating 
Characteristic (ROC), com o mesmo nível de significância, e identificou-se o conjunto das 
variáveis que, individualmente, podiam separar os grupos. 
Tornou-se assim possível a aplicação de métodos de classificação estatística, tais como a 
análise discriminante, a regressão logística e a utilização de algoritmos de árvore de decisão, 
ao conjunto de variáveis remanescentes. O desempenho dos classificadores estatísticos 
obtidos para a diabetes tipo 2 foi comparado, quer na amostra de treino, quer num conjunto 
de novos indivíduos participantes. O desempenho dos classificadores para a retinopatia 
diabética não proliferativa foi avaliado apenas na amostra de treino, mas tenciona-se 
também testá-lo, futuramente, num conjunto de novos sujeitos. O desempenho dos 
classificadores foi avaliado através da avaliação da sua acuidade, determinada pela área sob 
a curva ROC obtida para as probabilidades a posteriori de cada um dos modelos, e pela 
sensibilidade e razão de verossimilhança positiva determinada para as classificações nos 
grupos. 
Um classificador final é apresentado, quer para diabéticos tipo 2 com idades entre 40 e 75 
anos de idade, quer para a retinopatia diabética não-proliferativa em diabéticos tipo 2, na 
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mesma faixa etária, assim como os seus valores preditivos positivos ajustados para os dados 
mais recentes da prevalência de cada doença na população portuguesa. 
A visão cromática relativa ao eixo dos cones Tritan parece desempenhar um papel 
dominante para a classificação de ambas as doenças. 
 
 
Palavras-chave: Classificadores estatísticos; Diabetes tipo 2; Retinopatia Diabética; Análise 
Discriminante; Regressão Logística; Árvores de Decisão 
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 A B S T R A C T  
 
 
Visual impairment, which includes blindness and low vision, affects about 4.25% of the world 
population, and about 80% is avoidable, since it can be prevented or cured. Those estimates, 
from the World Health Organization, refer that 82% of blind people are aged 50 or more. 
The largest proportion of visual impairment is necessarily related to the increase of the 
ageing of populations, and where posterior segment (retinal) diseases dominate. Among 
these diseases, there is diabetic retinopathy, an ocular manifestation of diabetes mellitus. 
This systemic disease, is the leading cause of new cases of blindness around the world in 
persons aged between 20 and 74 years old, and occurs as a result of long-term accumulated 
damage to the small blood vessels in the retina. Furthermore, the eye is considered to play 
an important role in the diagnostic of systemic diseases due to its composition. Every part of 
the eye is able to give important clues for diagnosis.  
Diabetes mellitus, especially type 2, is among the leading causes of death, disability and 
economic loss throughout the world. It is feared to become an epidemic disease, since its 
incidence and prevalence are increasing, mainly due to population growth and ageing, as 
well as a result of alterations in lifestyle, which are leading to the reduction of physical 
activity and to the increase of obesity. With its increase, diabetic retinopathy was gained a 
prominent role in the list of preventable visual impairment. The latest prevalence estimates 
for diabetes in the Portuguese population aged between 20 and 79 years date from 2012, 
and referred a value of 12.9%, which represents an increment of 1.2% since 2009. In fact, in 
2009, diabetic retinopathy was referred as the leading cause of blindness for the Portuguese 
population in active age.  
The need for early diagnosis of both the diseases and its ocular complications is crucial in all 
socioeconomic contexts, in order to reduce its burden due to its direct costs, and mainly due 
to its indirect and intangible costs, either for diabetics and their families, or for the National 
Health Services. In spite of the fact that methods for diagnosing those diseases are clearly 
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defined, the need to find new markers and non-invasive classifiers used for screening in 
other medical contexts has become of extreme importance. 
A training sample for determination of markers for type 2 diabetes was used, comprising 96 
cases, of which 49 were type 2 diabetics, aged between 40 and 75 years old. The group of 
diabetics was used to build a classifier for diabetic retinopathy in type 2 diabetics in the 
same age group, and the sample comprised 40 subjects from which 20 had non-proliferative 
diabetic retinopathy. 
Correlation and concordance between measures obtained by Optical Coherence 
Tomography in the left and right eyes of the same subjects was evaluated, leading to the 
conclusion that only one eye was needed for the analysis. Hence, the dominant eye was 
selected for analysis since visual psychophysics tests were performed only in that eye. A 
global measure of the performance, for each subject, in each one of the visual psychophysics 
tests (speed, achromatic vision and chromatic vision over the Protan, Deutan and Tritan 
axes) was build, based upon values obtained for the 0º, 45º, 90º and 135º meridians. 
Afterwards, a variable reduction was performed applying an independent samples t test or a 
Mann-Whitney test, according to data distribution, and only the variables that showed 
statistical significances, at 5% significance level, were selected to remain in the analysis. 
Subsequently, a Receiver Operating Characteristic curve was applied to each one of the 
remaining variables, using the same significance level, and the set of variables which were 
able to separate groups, individually, was identified.   
By then, it was possible to apply different statistical classifying methods, such as discriminant 
analysis, logistic regression and decision tree algorithms. The performance of the classifiers 
obtained for type 2 diabetes was compared either in the training set, or in a test set of new 
subjects. Non-proliferative diabetic retinopathy classifiers were only tested on the training 
sample, at the moment. Hereafter, we intend to test their performance in a set of new 
cases. The performance of those classifiers was assessed using accuracy measures, 
determined by the area under the ROC curve for the posterior probabilities of models, and 
according to its sensitivity and positive likelihood ratio for group classification. 
A final classifier is presented, either for type 2 diabetics aged between 40 and 75 years, or 
for non-proliferative diabetic retinopathy in type 2 diabetics for the same age group, as well 
as its positive predictive values adjusted for the latest data on the Portuguese prevalence for 
each disease. 
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Whichever the clinical category (presence of disease or complications), chromatic vision over 
the Tritan cone seems to play a main role for the classification of both diseases. 
 
 
Keywords: Statistical Classifiers; Type 2 Diabetes; Diabetic Retinopathy; Discriminant 
Analysis; Logistic Regression; Decision Trees 
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I N T R O D U C T I O N  
 
 
Visual impairment, which includes low vision and blindness, affects about 4.25% of the world 
population, and estimates from the World Health Organization, dated from 2010, refer that 
low vision corresponds to 86% of visual impaired people around the world. Moreover, those 
estimates refer that about 80% of vision impairment is avoidable since it can be either 
prevented, or cured. On the other hand, blindness prevalence is almost constant since 2002, 
according to the World Health Organization, but visual impairment prevalence is rising since 
2002, from 2.59%, due to the increase on low vision prevalence. Higher differences are 
observed in the South-Eastern and Western Pacific regions, mainly due to the increase of 
incidence in India and China, where the prevalence of visual impaired people was, in 2010, 
respectively 21.9 and 26.5%. It is also known, according to the World Health Organization, 
that about 90% of visual impaired people live in developing countries, and that 82% of blind 
people are aged 50 or more. 
 
The main causes of visual impairment around the world are uncorrected refractive errors, 
cataract, glaucoma, age related macular degeneration, diabetic retinopathy, trachoma and 
corneal opacities. The largest proportion of blindness, as well as low vision, is necessarily 
related to the ageing of populations, which is increasing, and where posterior segment 
(retinal) diseases emerge most. Therefore, age related macular degeneration, glaucoma and 
diabetic retinopathy are becoming a dominant cause of visual impairment.  Furthermore, 
there are many diseases, namely systemic diseases, with relevant ocular manifestations. The 
case of diabetes, which is the leading cause of new cases of blindness around the world in 
persons aged between twenty and seventy four years old according to the World Health 
organization, is one example. The ocular manifestations of diabetes are diabetic retinopathy 
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and macular oedema, which affects up to 80% of those who have had the disease for 15 
years or more, and occurs as a result of long-term accumulated damage to the small blood 
vessels in the retina.  
Moreover, diabetes is related to nephropathy, being the leading cause of kidney failure, 
cardiac diseases (about half of diabetics die from cardiovascular disease), and other systems 
failures which are also known to be related with the eye. Whenever diabetes is combined 
with reduced blood flow, neuropathy on the feet increases the chance of foot ulcers, 
infection and eventual need for limb amputation. 
Furthermore, the eye is considered to play an important role in the diagnostic of systemic 
diseases, since it is composed by many different types of tissues and every part of the eye is 
able to give important clues for diagnosing systemic diseases, which signs may be evident on 
the outer surface of the eye (such as eyelids, conjunctiva and cornea), on the middle of the 
eye, or at the back on the retina.  
 
In fact, diabetes mellitus is among the leading causes of death, disability and economic loss 
throughout the world, and feared to become an epidemic disease. Systemic diseases are a 
major cause of mortality and, according to the World Health Organization, chronic non-
communicable diseases are, by far, the leading cause of mortality in the world.  
According to that organization, simple lifestyle measures, such as maintaining a normal body 
weight, being physically active, eating a healthy diet and reducing sugar and saturated fats 
intake, and also avoiding alcohol and tobacco use are measures that have shown to be 
effective in preventing or delaying the onset of type 2 diabetes. Adequate treatment of 
diabetes, as well as the control of blood pressure and some lifestyle factors such as tobacco 
use, regular exercise and food habits are, thus, important.  
 
Diabetes mellitus is one of the most common chronic diseases in nearly all countries, 
especially type 2 diabetes, and its incidence is becoming higher, mainly due to population 
growth and ageing, but also as a result of alterations in lifestyles, which are leading to the 
reduction of physical activity and to the increase of obesity. 
With the increase of diabetes in the population, diabetic retinopathy was added to the 
priority list of avoidable visual impairment.
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In Portugal, the prevalence of diabetes in the population between 20 and 79 years of age 
was, in 2009, 11.7% and estimates were that one in each three Portuguese (34.9%) was 
already diabetic without having its knowledge, or that he/she was at risk of becoming 
diabetic. Likewise, half of diabetics do not know that they have the disease. Data from 2012 
refer that diabetes prevalence is 12.9%, which represents an increment of 1.2% in only three 
years. The diabetes prevalence is higher in men, increasing with age and with body mass 
index. Gestational diabetes prevalence, which is related to later onset of type 2 diabetes, 
also has increased from 3.4% in 2005 and 2006 to values of 4.9% in 2011 and 4.8% in 2012, 
especially in older pregnant. 
According to data from 2009 published by the Portuguese Study Group on Vitreo and Retina 
(PSGVR), diabetic retinopathy is the leading cause of blindness in the active age group. The 
PSGVR refers that It develops nearly in all persons with type 1 diabetes, and in more than 
77% of people that survived for 20 or more years with type 2 diabetes. The threat to sight 
can be due to the growth of new vessels leading to intraocular haemorrhage and possible 
retinal detachment with profound global vision loss, and also to localised damage to the 
macula or fovea of the eye with loss of central visual acuity. However, the World Health 
Organization referred in 2005 that evidence-based treatment could reduce the risk for 
severe vision loss and blindness from proliferative diabetic retinopathy by more than 90%.  
 
Therefore, the need to early diagnose diabetes is crucial in all the socioeconomic contexts, 
since treatment, hospitalization and complications of diabetes represent a burden both for 
diabetics and for National Health Services. On the other hand, intangible costs either for a 
diabetic person or for his/her family are considerably high and, in a certain way, higher than 
direct and indirect costs. Methods for diagnosing diabetes are clearly defined, but the need 
to find new markers of the disease, as well as simpler non-invasive classifiers that may be 
used for screening in other medical contexts (which may raise the suspicion of the presence 
of diabetes) are emerging. On the other hand, simple markers of the presence of diabetic 
retinopathy are also useful in order to try to delay the progression of the disease. 
 
Particular care has to be taken when considering the use of applied statistics to 
ophthalmology, among other medical areas that use data obtained from two similar organs. 
Often, correlated information from both eyes was used in the past as if two independent 
measures were being analysed, artificially duplicating the sample size in some cases, 
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whenever the unit of analysis was the subject and not the eye. Other times, eyes were 
analysed separately, in spite of the fact that the relevant unit of analysis was the subject, or 
some other criteria was used, such as choosing only one eye for analysis, or the mean of 
both eyes. These options prevent the problem of statistical dependence but information is 
lost. In any case, different results may be achieved according to the chosen eye, and perhaps 
the best choice is to randomly select one eye for analysis, instead of selecting the right or 
the left eye, or the best or the worse eye, or even to use the mean or median of both eyes. 
Decision must take into account the context of the problem. However, as we had tests 
performed in the dominant eye, and tests performed in both eyes, with strong correlation 
and concordance between eyes, then the chosen eye for analysis should be the dominant 
eye for all tests, and results and conclusions must report always to measures obtained for 
the dominant eye. We will also propose a measure for evaluating concordance between eyes 
whenever data is not normally distributed, and to evaluate the random error between eye 
measurements, according to the nature of the case in order to evaluate and compare 
random error between controls and type 2 diabetics. 
Having defined procedures for handling, in a given way that we found appropriate for the 
present context, with duplicate data, then we were able to establish statistical classifiers and 
to identify possible markers of either type 2 diabetes or diabetic retinopathy. 
 
In statistics, classification problems are the ones that allow the assignment of individuals to a 
given group, according to the set of characteristics of the subject that must be quantifiable. 
Any mathematical function or algorithm that implements that procedure is called a classifier. 
This situation, in machine learning, is considered to be an instance of supervised learning, 
while for statistics, it is a problem that may be related either to supervised or to 
unsupervised learning, since involves grouping data into categories according to measures of 
similarity or measures of dissimilarity. In fact, classification may be included in a more 
general problem of pattern recognition and profile detection, and then the classical 
probability theory is necessarily involved in the process. Other forms of classifying are 
related to artificial intelligence, which often involve machine learning procedures, but that 
are more distant from the previous methods, and data mining algorithms. Data mining is 
procedure that reflects a mixture of machine learning and statistical theory, with a goal in 
mind. It is often applied when massive data are available, namely whenever we have more 
variables than cases to analyse, which is of course problematic. We applied data mining 
Introduction 
7 
techniques to reduce the number of variables since, initially, we had more than 100 
variables available measures in less than 100 cases. This reduction of variables was achieved 
using classical statistical techniques, such as comparison between groups that were being 
studied, and more recent techniques such as Receiver Operating Characteristic curves 
applied to the remaining set of variables, which have showed differences between groups, in 
order to use only variables that were able to discriminate between groups in the exploratory 
analysis. Hence, both univariate statistical techniques were used just as exploratory statistics 
in order to conduct a variable reduction for the use of multivariate classification methods. 
Classification was, then, performed using classical statistical techniques such as discriminant 
analysis (which has strong assumption related to data distribution) and regression 
procedures, namely logistic regression (without assumption on data distribution, which is 
usually binary, but with assumptions on multicolinearity), and using algorithms that are 
related to data mining procedures, such as decision tree (without assumptions). These 
methods were applied to a subset of all available data, named the training sample, which 
was formed with the available data on the 31th of December of 2013. Data available after 
this date were used to test developed classifiers, and to evaluate their performance and 
accuracy in previsions, so that the best model would ideally be used for classification of new 
subjects, determining its predictive values according to the most up to date prevalence data. 
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O B J E C T I V E S  
 
 
The main purpose of this work is to develop approaches toward a non-invasive simple 
classifier for type 2 diabetes based upon measures obtained just in the dominant eye, for 
volume scan density, retinal nerve fibre layer thickness (obtained with Optical Coherence 
Tomography) and visual psychophysics tests on speed, achromatic and chromatic vision, 
according to sociodemographic factors, daily habits, and parameters from collected blood 
samples, which may be used for screening purpose in subjects aged between 40 and 75 
years old. 
We also intend to build a non-invasive simple classifier for the presence of non-proliferative 
diabetic retinopathy on type 2 diabetics aged between 40 and 75 years old, based upon the 
same factors. 
For each one of the proposed classifiers, either for type 2 diabetes or for diabetic 
retinopathy, the posterior probability for the presence of the condition will be defined. 
 
Along with the defined outcome measures, we want to give an emphasis on statistical and 
probability methods concerning several points, enumerated below. 
 
Concerning measures obtained for the left and the right eye, we intend to evaluate the need 
to use both eye information based upon correlation and concordance between eyes. In spite 
of the existence of recent guidelines for this subject, we propose other alternative methods 
which may be more useful according to data distribution. 
Still regarding this subject, we intend to use graphical methods for the evaluation of 
statistical correlation between both eyes, enabling the evaluation of error in measurement 
between eyes, namely the random error, in order to ascertain about sample size. 
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Concerning multiple measurements in some tests, such as psychophysics tests, which are 
performed at four different meridians (meridians 0º, 45º, 90º and 135º), we intend to build a 
global measure based on a simple mathematic algorithm, and to evaluate its discriminatory 
ability compared to individual measures for each test. 
 
We intend to compare classification methods using three different approaches. On one 
hand, we intend to compare classical statistical classifiers, such as discriminant analysis and 
logistic regression methods, with decision tree algorithms. On the other hand, we intend to 
compare models that have strong assumptions on data distribution, such as discriminant 
analysis, with methods without assumptions, such as logistic regression and decision trees, 
as well as methods that use quantitative information (discriminant analysis and decision 
trees) against logistic regression performed in the same variables after being dichotomized. 
 
For each one of the developed classifiers, we will hopefully be able to identify markers of the 
disease. 
For the best classifier obtained, either for type 2 diabetes, or for diabetic retinopathy, a 
posterior probability function will be defined in order to allow classification of new cases.  
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V I S U A L  I M P A I R M E N T  
A N D  S Y S T E M I C  D I S E A S E S  
W I T H  O C U L A R  M A N I F E S T A T I O N S  
 
 
S E C T I O N  A  
 
V I S U A L  I M P A I R M E N T  
 
 
1. Definition of Visual Impairment 
The definition of visual impairment, low vision and blindness used by the International 
Statistical Classification of Diseases (ICD), injuries and causes of death
1 
states that visual 
impairment includes low vision as well as blindness. According to those norms, low vision is 
defined as visual acuity within 3/60 inclusive and 6/18 exclusive, or a corresponding visual 
field loss to less than 20 degrees in the better eye with best possible correction (ICD-10 
visual impairment categories 1 and 2); blindness is defined as visual acuity of less than 3/60, 
or a corresponding visual field loss to less than 10 degrees in the better eye with best 
possible correction (ICD-10 visual impairment categories 3, 4 and 5). 
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2. Wold wide epidemiological estimates 
Estimates on global blindness and visual impairment are recent. The first known estimate, 
according to Resnikoff
2
 was published in 1995 based on data from the year of 1990. 
Previsions were made to the year of 1996 and projected onto the year of 2020. These data 
provided a base for the Global Initiative for Elimination of Avoidable Blindness, known as 
“VISION 2020: the Right to Sight”
3
. Since the first estimates on blindness and visual 
impairment were published, almost all regions belonging to the World Health organization 
have carried out population-based studies. In fact, several countries conducted studies 
mostly in cataract surgery, which provided general information on the status of visual 
impairment in adults aged 50 or older. Recently, many studies have specifically targeted 
older adults as a mean of updating global and regional estimates on visual impairment.  
The availability of new data is crucial for the constant update on the estimates, especially on 
other target populations such as younger adults or children, in order to prevent visual 
impairment, as well as the identification of its major causes.  
The latest estimates refer 285 million people worldwide affected by visual impairment, 
which corresponds to 4.25% of the world population. From these 285 millions, 39 millions 
are blind (14%) and the other 86% have low vision, but 80% of the vision impairment is 
avoidable since it can be prevented or cured. Cataract and uncorrected refractive errors 
were identified as the main causes of avoidable vision impairment, and un-operated cataract 
and glaucoma as the main causes of avoidable blindness.   
The World Health Organisation (WHO) owns data from its member states, which are divided 
into six regions (African Region, Regions of Americas, European Region, South-East Asia 
Region, Eastern Mediterranean Region and Western Pacific Region).  
The last published prevalence data on age-specific blindness by the World Health 
Organisation dates from 2010, but there were previous estimates published related to the 
years of 1995, as mentioned above, and on 2002 and 2004.  Besides this, data published is 
not comparable since data was published in different subgroups, either according to gender, 
or to different age groups, or even on different sub-region divisions. 
The report on 2002 data was related to population-based studies on seventeen sub-regions 
of those six regions (Afr D: Bebin, Cameroon, Cape Verde, Equatorial Guinea, Gambia, 
Ghana, Mali, Mauritania, Niger, Nigeria, Sierra Leone, Sudan, Togo; Afr E: Central African 
Republic, Congo, Ethiopia, Kenya, South Africa, United Republic of Tanzania; Amr A: United 
States of America; Amr B: Barbados, Brazil, Paraguay; Amr D: Peru; Emr B: Lebanon, Oman, 
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Saudi Arabia, Tunisia; Emr D: Morocco; Eur A: Denmark, Finland, Iceland, Ireland, Italy, 
Netherlands, United Kingdom; Eur B1: Bulgaria, Turkey; Eur B2: Turkmenistan; Eur C: no 
population-based studies identified; South-East Asia Region: Sear B: Indonesia, Malaysia, 
Philippines, Thailand; Sear D: Bangladesh, India, Nepal, Pakistan; Wpr A: Australia; Wpr B1: 
China, Mongolia; Wpr B2: Cambodia, Myanmar, Viet Nam; Wpr B3: Tonga, Vanuatu). It used 
estimates of population size and structure based on the 2002 demographic assessment of 
the United Nations Population Division
4
, as used by the World health report 2003
1
. 
For the 2002 estimates, they have considered 55 countries grouped into 17 regions 
according to the Global Burden of Disease 2000 Project
5,6
, and used estimations of 
population size and structure from the 2002 demographic assessment of the United Nations 
Populations Division
4
 as published on the World Health Report on 2003
1
. 
 
Prevalence of visual impairment using the ICD-10 definition of best corrected visual acuity 
and the 2002 world population, estimated that the number of people with visual impairment 
exceeded 161 million of people, from which 37 million were blind and 124 million had low 
vision, which represented a global prevalence of 2.59% on visual impairment (0.57% on 
blindness and 2.00% on low vision). Median ratio on low vision to blindness was 3.7, but 
ranged between 2.4 to 5.8 by region considered, which shows big variability by regions, as 
observed in Figure 1.  
 
Figure 1 – Visual Impairment prevalence, per region (lines) and in the world (circles), in the year of 2002. Data 
obtained at WHO’s public domain
1
. 
 
Childhood blindness (under 15 years of age) is a significant problem, with a global 
prevalence of 0.07%, but prevalence of blindness more than duplicate on ages between 15 
and 49 years (0.16%), and increases significantly in the elderly population (1.68%). Variability 
between WHO regions, by age group, may be observed in Figure 2. 
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Figure 2 – Blindness prevalence, per region (lines) and in the world (circles), in the year of 2002, according to 
age group. Data obtained at WHO’s public domain
1
. 
 
It is also known that the prevalence of visual impairment in females, adjusted for age, is 1.50 
to 2.20 times higher than in males. Between the years of 1990 and 2002, the increase 
number of blind people was estimated in 8.57%, although there was an increase on world 
population of 18.50%. However, the increase of low vision people between those twelve 
years was 80%. 
The 2010 report used 53 surveys from 39 countries and estimated a number of 285 million 
of visually impaired people in the world. Methods were not the same but world estimates 
were precise so they could be compared. It represents an increase of 77% on visual 
impairment, although the distribution of these increases is much heterogeneous. The actual 
prevalence of visual impairment is 4.24% (against 2.59% in 2002), with the maintenance of 
the blindness prevalence since 2002, but an increase from 2.00% in 2002 to 3.65% in 2010 in 
low vision, which represents an increase of almost 98% in the number of visually impaired 
people in the world, in spite of an 8.43% of population growth. Higher differences appear in 
the South-Eastern and Western Pacific regions, mainly due to India and China, where 
prevalence of visual impairment was, in 2010, of 21.9% and 26.5%, respectively, whereas the 
prevalence in those regions excluding these countries was of 9.8% and 5.2%, respectively
7
. In 
the world, the percentage of increase in low vision was almost 100% (Figure 3), with a 
population growth of 6.80%. 
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Figure 3 – Percentage of increase in the number of blindness, low vision, and visual impaired people between 
2002 and 2010 per region (bars). Population growth is represented by a line. Data obtained at WHO’s 
public domain
7
. 
 
The latest update on these statistics refer that about 90% of the world’s visually impaired 
live in developing countries, and that 82% of blind people are aged 50 or more.  
 
 
3. Main causes of Visual Impairment 
According to data published by the World Health Organization relative to the year of 20107, 
the principal causes of visual impairment around the world are uncorrected refractive errors 
(43%) and cataracts (33%). Other important causes are glaucoma (2%), age related macular 
degeneration (AMD), diabetic retinopathy, trachoma and corneal opacities, all about 1%, 
while a large proportion (18%) of causes remain undetermined. 
Despite advanced in surgical procedures, cataract remains as the leading cause of blindness 
in visual impaired populations (51%), followed by glaucoma (8%), an eye disease known for 
centuries, but which remains on the public health agenda due to difficulties in its early 
diagnosis and frequent necessity of life-long treatment. Age-related macular degeneration 
(AMD) ranks third among the global causes of visual impairment with a blindness prevalence 
of 5%; in fact, it is the primary cause of visual deficiency in industrialized countries. An 
emerging important cause of visual impairment is uncorrected refractive errors, related to 
avoidable vision impairment. The increase of diabetes among many population groups has 
caused diabetic retinopathy to be added to the priority list. 
Cataract, onchocerciasis, and trachoma are the principal diseases for which world 
strategies and programmes have been developed. For glaucoma, diabetic retinopathy, 
uncorrected refractive errors, and childhood blindness (except for xerophthalmia), the 
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development of screening and management strategies for use at the primary care level is 
ongoing at WHO. 
The largest proportion of blindness is necessarily related to ageing. Although cataract is not 
a major cause of blindness in developed countries, globally it is still the leading cause. 
Cataract is even more significant as a cause of low vision; it is the leading cause of low vision 
in all sub-regions of WHO. 
 
Estimates published 1995
8
, relative to the year of 1990, identified the main causes of 
blindness and low vision identified as cataract, trachoma, glaucoma, onchocerciasis, and 
xerophthalmia. However, there was insufficient data on blindness from causes such as 
diabetic retinopathy and age-related macular degeneration as there were no specific 
estimative of the global prevalence of diabetes and older populations. 
  
In 2002
9
, uncorrected refractive errors such as myopia, hyperopic or astigmatism were 
identified as the main causes of visual impairment (43%), so they begun to be considered on 
prevalence and population based studies; cataracts were once more identified, in 2002, as 
they were in 1995, as the leading cause of blindness (33%) followed by glaucoma (2%). In 
fact, among blind people, cataract represented (in 2002) almost half of the causes of 
blindness (47.8%), followed by glaucoma (12.3%), age-related macular degeneration (8.7%) 
and Corneal opacities and diabetic retinopathy (approximately 5% each). 
Estimates from 2004
2
 refer once more cataract and uncorrected refractive errors as the 
main causes of blindness among all causes of blindness. Note that uncorrected refractive 
errors are an avoidable cause of vision impairment in most of the cases. Oschocerciasis was 
still considered, at that date.  
 
According to the 2010 update on these statistics, the number of people visually impaired 
from infectious diseases has greatly reduced in the last 20 years, suggesting progressively 
reduced incidence. An example is onchocerciasis (Figure 4), which remains endemic in some 
African regions and few isolated regions of South-America, but was no longer considered in 
2010 as a major cause of blindness. 
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Figure 4 – Main causes of visual impairment in the years of 2002, 2004 and 2010. Data obtained at WHO’s 
public domain
7
. 
 
However, posterior segment (retinal) diseases are a major cause of visual impairment 
worldwide, and are likely to become more important due to the rapid growth of the aging 
population, and the proportion of the total visual impairment and blindness from age-
related macular degeneration, glaucoma and diabetic retinopathy is currently greater than 
from infective causes such as trachoma and corneal opacities. 
 
On Figure 5, we may observe the world’s distribution of visual impairment, in percentage, on 
the year of 2010. 
 
Figure 5 – Prevalence of visual impairment around the world. Figure obtained at WHO’s public domain
7
. 
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4. Risk factors for visual impairment 
Approximately 65% of visually impaired people are aged 50 or older and about 20% of world 
population are in these age group. On the other hand, in most of the countries, especially on 
developed and developing countries, the elder population is increasing so, the number of 
people at risk of aged-related visual impairment, around the world, is also increasing. 
Overall, visual impairment worldwide decreased since 1990, as a result of a reduction in 
visual impairment due to infectious diseases, despite the aging of populations. Globally, 80% 
of all visual impairment can be prevented or cured. In 2013, the World Health Assembly 
approved the “2014-19 Action Plan” for the universal access to eye health, with the aim of 
achieving a measurable reduction of 25% of avoidable visual impairment by 2019. One of the 
aims is to eliminate trachoma from the world by the year of 2020 and as a response to the 
increasing burden of chronic eye disease; the World Health Organization has coordinated 
the development of research projects and policies for diabetic retinopathy, glaucoma, age-
related macular degeneration and refractive errors. These last ones are responsible for 
about 12 millions of visual impaired children below age 15, on the overall estimated 19 
million of visually impaired children below 15, a condition that could easily be diagnosed and 
corrected. 
 S E C T I O N  B  
 
S Y S T E M I C  D I S E A S E S  
W I T H  O C U L A R  M A N I F E S T A T I O N S  
 
 
1. Chronic Systemic diseases 
A systemic disease is a disease that affects a number of organs and tissues, or affects 
the body as a whole. Although most medical conditions will eventually involve multiple 
organs in advanced stage, such as multiple organ dysfunction syndrome, diseases where 
multiple organ involvement appears in early stages are considered to be systemic diseases. 
The eye and nails are considered to play an important role in the diagnostic of systemic 
diseases. The eye is composed by many different types of tissues and its unique feature 
makes the eye susceptible to a wide variety of diseases and provides insights into many body 
systems. Every part of the eye gives important clues for diagnosing systemic diseases, whose 
signs may be evident on the outer surface of the eye such as eyelids, conjunctiva and cornea, 
on the middle of the eye, or at the back on the retina. 
Fingernails and toenails may also indicate some systemic diseases, since they can cause 
disruption in the nail growth process. For instance, pitting looks like depressions in the hard 
part of the nail, and it is usually associated to psoriasis, affecting 10 to 50 per cent of 
patients with that disorder
10
; it can also be caused by some systemic diseases, including 
Reiter’s syndrome and other connective tissue disorders such as sarcoidosis, pemphigus, 
alopecia areata and incontinentia pigmenti
11
. 
 
A chronic disease is a health condition or disease that is persistent or long-lasting in its 
effects, and usually lasts for more than three months. The most common chronic diseases 
generally known by individuals are arthritis, asthma, diabetes, chronic obstructive 
pulmonary disease (COPD), cancer or acquired immunodeficiency syndrome (AIDS). 
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Chronic diseases are a major cause of mortality. The World health Organization (WHO) 
reports that chronic non-communicable diseases are, by far, the leading cause of mortality in 
the world. In fact, in 2005 chronic non-communicable diseases represented 35 million 
deaths and exceeded 60% of all deaths.  
 
 
2. The case of diabetes 
There are many diseases known to cause ocular or visual changes. An eye condition that 
results, directly or indirectly, from a disease process in another part of the body is said to be 
an ocular manifestation of that disease. It is known that Diabetes is the leading cause of new 
cases of blindness around the world in persons aged between twenty and seventy four years 
old, being its ocular manifestations diabetic retinopathy and macular oedema. These ocular 
manifestations affects up to 80% of those who have had the disease for 15 years or more. 
Moreover, diabetes is related to nephropathy, cardiac diseases and other systems which are 
also known to be related to the eye. In fact, diabetes mellitus is among the leading causes of 
death, disability and economic loss throughout the world. 
Diabetes mellitus is a group of metabolic diseases caused either because the pancreas does 
not produce enough insulin or because cells do not respond to the insulin that is produced 
(insulin resistance), causing the person to have high levels of blood sugar or glycaemia. In 
fact, it is considered to be a metabolic disorder of multiple aetiologies characterised by 
chronic hyperglycaemia with disturbances of carbohydrate, protein and fat metabolism 
resulting from defects in insulin secretion and/or insulin action. 
There are three main types of diabetes mellitus: 
- Type 1, which results from the failure insulin production, so it is needed to be daily 
injected. Therefore, many times it is called insulin-dependent diabetes (IDDM) and usually 
appears in early or juvenile ages. This type of diabetes involves β-cell destruction. 
- Type 2, which results from insulin resistance and/or insulin secretion, where there is a 
failure on the insulin usage from the cells, sometimes combined with an insulin 
deficiency. Usually, it is called non-insulin dependent diabetes (NIDDM) or adult-onset 
diabetes, since it is a disease that is usually diagnosed after thirty years-old. 
- Gestational diabetes occurs in pregnant women without a previous diagnose of diabetes, 
and may precede the development of type 2 diabetes 
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Other forms of diabetes are less prevalent, and may include congenital diabetes, genetic 
defects of insulin secretion or steroid diabetes induced by high doses of glucocorticoids, 
among other causes. 
 
2.1 The Insulin mechanism and consequences of its failure 
All forms of diabetes have been treatable since insulin became available..  
Human insulin protein is composed by 51 amino acids, has a molecular weight of 5808 
Dalton, and is an A-chain and B-chains linked together by disulfide bonds. 
 
Figure 6 – Pro-Insulin and Human Insulin molecule. Figure obtained at a public domain. 
 
Insulin is a peptide hormone produced by beta cells of the pancreas, and it is released by the 
same cells whenever glucose levels arise. It is necessary to regulate the carbohydrate and fat 
metabolism in the body as it induces cells in the liver, skeletal muscles and fat tissue to 
absorb and consume glucose from the blood, the main source of cell energy, in a process 
known as glycolysis, where glycogen is synthesised and converted into fatty acids. On the 
other hand, it inhibits gluconeogenesis and glycogen degradation. Insulin causes cells in the 
liver, skeletal muscles and fat tissue to absorb glucose from the blood, which is stored by the 
liver as glycogen, and by the adipocytes (fat cells) as triglycerides. Insulin stops the use of fat 
as a source of energy as it inhibits the release of glucagon, and it is provided in a constant 
proportion to remove the excess of glucose from the blood, which would be toxic to the 
organism. If blood glucose falls below a critical level, body begins to use stored sugar as an 
energy source through glycogenolysis, which breaks down the glycogen stored in liver and 
muscles into glucose to be used as an energy source. As it is also a central metabolic control 
mechanism, its status is also used as a signal control to other body systems, causing anabolic 
effects throughout the body.  
If control of insulin fails, the result is diabetes mellitus, and insulin must be medically 
taken
12
. 
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Over time, diabetes can damage the heart, blood vessels, eyes, kidneys, and nerves, as 
diabetes mellitus increases the risk of heart disease and stroke. Half of people with 
diabetes die of cardiovascular disease. To join this, whenever diabetes is combined with 
reduced blood flow, neuropathy in the feet increases the chance of foot ulcers, infection 
and eventual need for limb amputation. 
On the other hand, diabetic retinopathy is an important cause of blindness, and occurs as 
a result of long-term accumulated damage to the small blood vessels in the retina. 
Diabetes is also among the leading causes of kidney failure
13
. 
The overall risk of dying among people with diabetes is, at least, the double than the risk 
of their peers without diabetes
14
. 
Simple lifestyle measures have been shown to be effective in preventing or delaying the 
onset of type 2 diabetes. To help prevent type 2 diabetes and its complications, people 
should achieve and maintain healthy body weight, while being physically active, eat a 
healthy diet and simultaneously reduce sugar and saturated fats intake, and avoid tobacco 
use as smoking increases the risk of cardiovascular diseases
13,14
.  
Untreated diabetes can cause many serious long-term complications, as mentioned before, 
such as cardiovascular disease, nerve damage, chronic renal failure known as nephropathy, 
and diabetic retinopathy. Adequate treatment of diabetes is thus important, as well as the 
control of blood pressure and some lifestyle factors such as tobacco use, regular exercise 
and food habits. Diabetes mellitus is one of the most common chronic diseases in nearly all 
countries, and continues to increase in number and significance as changing in lifestyles is 
leading to the reduction of physical activity and to the increase of obesity
14
. 
With the increase of diabetes on population, diabetic retinopathy was added to the priority 
list of avoidable visual impairment
7
. 
 
2.2 Estimates on diabetes 
The incidence of diabetes is increasing, mainly due to population growth, aging, 
urbanization and increasing prevalence of obesity and physical inactivity. 
According to the world health organization, diabetes prevalence by age and sex 
extrapolated to all 191 World Health Organization member states, and applied to United 
Nations’ population estimates for 2000 for all age-groups worldwide, was estimated to be 
2.8% in 2000 and previsions for 2030 are of 4.4%. The total number of people with 
diabetes is projected to rise from 171 million existed in 2000 to 366 million in 2030. The 
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prevalence of diabetes is higher in men than women, but there are more women with 
diabetes than men. The urban population in developing countries is projected to double 
between 2000 and 2030. The most important demographic change to diabetes prevalence 
across the world appears to be the increase in the proportion of people 65 years of age. 
These findings indicate that the “diabetes epidemic” will continue even if levels of obesity 
remain constant. Given the increasing prevalence of obesity, it is likely that these values 
provide an underestimate of future diabetes prevalence. 
 
Based on the Prevalence Study on Diabetes in Portugal
15
, 11.7% of the Portuguese 
population between 20 and 79 years of age had diabetes mellitus, in 2009. Besides this fact, 
one in each three Portuguese (34.9%) is already diabetic or is in risk of becoming diabetic 
and half of diabetics do not know that they are. This study found that gender as a risk factor 
since prevalence is expected to be between 12.5 and 15.5% in man and between 8.5 and 
10.6% in women, with 95% confidence interval. Age is also correlated to diabetes, in 
Portuguese people, since prevalence increases as people grow older. In addition to that, pre-
diabetes prevalence, which is related to impaired fasting glucose and/or impaired glucose 
tolerance, is estimated to be of 23.3% in the Portuguese Population. 
More recent data, from the report published in 2013, relative to 2012, by the National 
Observatory for Diabetes in Portugal, the prevalence of diabetes in Portugal within the ages 
of 20 to 79 is 12.9%. The impact of the ageing of the Portuguese population has increased 
diabetes prevalence in 1.2% since 2009. Notice that 44% of the population with diabetes did 
not yet been diagnosed. According to that report, prevalence between 40 and 59 years old is 
of 12.7%, and between 60 and 79 years old more than duplicates (27,0%), although 10,3% of 
those 27,0% have not yet been diagnosed. 
It is also known that prevalence is higher in man (15.4%) than in women (10.6%), and this 
latest report estimates diabetes prevalence for men in 17.6% or 30.3% if they are in the age 
group of 40-59 or of 60-79 years, respectively, being the data in women of 8.2% and 24.3%, 
respectively. 
Prevalence data was reported also according to Body mass index, which is known to be 
related to diabetes, as 5.8% if BMI is below 25 kg/m
2
, as 12,7% if BMI is between 25 kg/m
2
 
inclusive and 30 kg/m
2 
exclusively, and as 20.3% if BMI is, at least, 30 kg/m
2
. 
On the other hand, alterations on fasting blood glucose (AFBG) and low tolerance to glucose 
(LTG) reach 26.8% of the Portuguese population aged between 20 and 79 years old, 
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distributed as 10.1% of population with AFBG, 14.0% of population with LTG, and 2.6% with 
both, a condition that may lead to the development of type 2 diabetes so the global 
prevalence of diabetes and hyperglycemias is of 39.6%. 
Every year, diabetes incidence is estimated to increase between 0.5 to 0.9%. Gestational 
diabetes prevalence, a condition that is related to type 2 diabetes development after the age 
of 50, has increased from 3.4% in 2005 and 2006 to 4.9% in 2011 and 4.8% in 2012, being 
this prevalence related to the age of the mother during pregnancy (13.5% if mother is aged 
40 or more, 5.9% between 30 and 39 years, 2.9% between 20.29 years and 1.4% below 20). 
The total number of diabetic medical consultations in the National Health Service grew from 
1 877 259 in 2011 to 2 202 224 in 2012, and the mean number of diabetes medical 
consultations per patient remained the same between those years. 
On the other hand, almost half of the diabetic patients have or will have diabetic 
retinopathy. The prevalence of diabetic retinopathy among all types of diabetes, in Portugal, 
is 44.1%, and in 25.1% of the diabetic subjects, it is classified as proliferative. 
By all this reasons, and the chance in lifestyles that leads to less activity, the increase of 
obesity and the ageing of the population, there is some consensus that so diabetes my 
become epidemic.  
 
 
3. Impact on the eye - Diabetic retinopathy 
Diabetic retinopathy is a chronic progressive disease of the retinal microvasculature 
associated with the prolonged hyperglycaemia and other conditions linked to diabetes 
mellitus such as hypertension. This potentially sight-threatening disease is a micro vascular 
complication that may occur either on type 1 or type 2 diabetes. It is a disease of the retinal 
microvasculature associated with prolonged hyperglycaemia and other conditions linked to 
diabetes mellitus, such as hypertension, hypercholesterolemia or dyslipidaemia. In fact, it 
develops nearly in all persons with type 1 diabetes, and in more than 77% of people that 
survived to 20 or more years of type 2 diabetes
16
.  
According to the Portuguese Study Group on Vitreo and Retina
17
, Diabetic Retinopathy is the 
leading cause of blindness in active age.  
The threat to sight can be due to the growth of new vessels leading to intraocular 
haemorrhage and possible retinal detachment with profound global sight loss, and also to 
localised damage to the macula or fovea of the eye with loss of central visual acuity.  
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However, evidence-based treatment can reduce the risk for severe vision loss and blindness 
from proliferative diabetic retinopathy by more than 90%, as shown by five large multicentre 
clinical trials conducted in the United Kingdom and United States
18
.  
 
3.1 Major earlier studies on Diabetic Retinopathy 
The Diabetic Retinopathy Study (DRS), conducted between 1971 and 1975, demonstrated 
that scatter pan-retinal laser photocoagulation reduces the risk for severe vision loss due to 
proliferative diabetic retinopathy by 60%
19,20
, and provided the first and still most widely 
used classification system for grading the severity of diabetic retinopathy. 
 
Later, between 1979 and 1990, the Early Treatment Diabetic Retinopathy Study (ETDRS) 
confirmed previously DRS results on scatter (pan-retinal) photocoagulation, demonstrating 
that it can reduce the risk for severe vision loss to less than 2% and that focal laser 
photocoagulation can reduce the risk for moderate vision loss due to diabetic macular 
oedema by 50%, without having adverse events on the progression of diabetic retinopathy 
or increasing risk for vitreous haemorrhage
21,22
. 
 
The Diabetic Retinopathy Victrectomy Study (DRVS, 1977 – 1987) provided useful 
information about the timing of vitrectomy surgery to restore useful vision in eyes with non-
resolving vitreous haemorrhage, drawing attention to the poor prognosis of eyes which have 
experienced vitreous haemorrhage, a late complication of diabetic retinopathy
23,24
. 
 
During 1983 and 1993, the Diabetes Control and Complications Trial (DCCT) compared 
conventional blood glucose control with intensive blood glucose control in patients with type 
1 diabetes mellitus without or with little diabetic retinopathy. For these patients, it was 
demonstrated that intensive blood glucose control as reflect of measurements in 
glycosylated haemoglobin reduced the risk for progression of diabetic retinopathy. Seven 
years after DCCT was finished, the Epidemiology of Diabetes Interventions and 
Complications Trial (EDICT) showed that diabetics in intensive control group continued to 
have a substantial lower risk for progression of diabetic retinopathy than the conventional 
control group, despite the convergence of glycosylated haemoglobin levels
25
. 
These two studies became notable for the following findings, which were not the primary 
outcome measures: They have shown that 
Chapter 3 
28 
- There is no threshold on glycosylated haemoglobin for diabetic retinopathy to occur, that 
is, there is not a cut point on glycosylated haemoglobin below of which there is no 
retinopathy; however, there is a linear relationship between achieved glycosylated 
haemoglobin level and the risk for visual complications of diabetes.  
- People receiving intensive blood glucose control had a significant rate of hypoglycaemic 
reactions so such aggressive control is not benefice. 
 
The United Kingdom Prospective Diabetes Study (UKPDS), performed during 1977 to 1999, 
had similar findings to the DCCT study, but it was performed on type 2 diabetes
26,27
. 
Furthermore, it highlighted the role of systemic hypertension as a potential risk factor for 
the development and progression of diabetic retinopathy, and has also demonstrated the 
negative effects of high cholesterol and serum lipid concentrations, increasing the risk of 
retinal complications in patients with diabetes mellitus. 
 
3.2 Classification of Diabetic Retinopathy 
The classification and severity grading of diabetic retinopathy have been based, since ever, 
on ophthalmoscopic visible signs of increasing severity, from no retinopathy through various 
stages of non-proliferative or pre-proliferative disease, to proliferative disease, but this 
grading scale may not reflect with accuracy the severity of the disease as maculopathy with 
severe visual loss may occur in the present of none or moderate ophthalmoscopic signs. Due 
to this, two different approaches have emerged, depending on the population to be applied: 
one designed to cover the full range of retinopathy based on the original Airlie House / 
ETDRS classification, used by most of the ophthalmologists, and another that intends to be 
applied on population screening. 
Modified and simplified versions have been developed from the original Airlie House 
classification, modified by the DRS developed for the ETDRS, to use in the context of overall 
severity of ophthalmoscopic signs.  
A simplified version was developed for the first version of the guidelines for diabetic 
retinopathy, in 1977
28
. Later, in 2003, the American Academy of Ophthalmology Guidelines 
Committee endorsed a reduced version of the ETDRS classification to be used in countries 
without systematic screening programmes. However, it was updated in order to have a 
clinical grading system that reflects the vision threatening risk of diabetic retinopathy, and 
considers five main stages of diabetic retinopathy. The first three stages consider low risk 
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non-proliferative retinopathy, a fourth stage of severe non-proliferative retinopathy and the 
fifth grade as proliferative retinopathy; additionally, macular oedema is determined as 
present or absent and is sub classified based on the involvement of the centre of the macula.  
There is a considerable overlap between classification systems. All of them recognize two 
mechanisms that conduce to the loss of vision: retinopathy (risk of new vessels) and 
maculopathy (risk of damage to the central fovea). Differences between classifications are 
mainly due to terminology or levels of retinopathy 
The World Health Organization
18
 suggests the use of the following rating scale for Diabetic 
Retinopathy (Table 1) and Macular Oedema (Table 2): 
 
Table 1 - The International Clinical Diabetic Retinopathy Severity Scales (Adapted from WHO’s public domain
18
). 
Proposed disease severity level Findings observable (Dilated Ophthalmoscopy) 
No apparent retinopathy No abnormalities 
N
o
n
p
ro
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v
e
 
D
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b
e
ti
c 
R
e
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n
o
p
a
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y
 
Mild Micro aneurysms only 
Moderate 
More than the presence of micro aneurysms but less than severe 
non-proliferative diabetic retinopathy 
Severe 
Any of the following: 
- More than 20 intra-retinal haemorrhage in each of the four 
quadrants 
- Define venous beading in two or more quadrants 
- Prominent intra-retinal microvascular abnormalities in one or 
more quadrants 
Proliferative diabetic retinopathy 
One or more of the following: 
- Neovascularization 
- Vitreous or pre-retinal haemorrhage 
 
Table 2 - The International Clinical Macular Oedema Disease Severity Scales (Adapted from WHO’s public 
domain
18
). 
Proposed disease severity level Findings observable (Dilated Ophthalmoscopy) 
Apparently absent No apparent retinal thickening or hard exudates in posterior pole 
Apparently present Some apparent retinal thickening or hard exudates in posterior pole 
D
ia
b
e
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c 
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p
re
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n
t 
Mild 
Some retinal thickening or hard exudates in posterior pole but distant 
from the centre of the macula 
Moderate 
Retinal thickening or hard exudates approaching the centre of the macula 
without involving the centre 
Severe Retinal thickening or hard exudates involving the centre of the macula 
 
The Royal College of Ophthalmologists
29
 proposed, in 2012, the following conversion table 
for classification of diabetic retinopathy on their Guidelines for Diabetic Retinopathy (Table 
3). 
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Table 3 - Conversion table for classification of diabetic retinopathy (Adapted from the Royal College of 
Ophthalmologists
29
). 
ETDRS NSC SDRGS AAO RCOpht 
None (10) None (R0) None (R0) 
No apparent 
retinopathy 
None 
Micro aneurisms only 
(20) 
Background (R1) 
Mild Background 
(R1) 
Mild NPDR Low Risk 
Mild NPDR (35)   Moderate NPDR  
Moderate NPDR (43) 
Pre-proliferative 
(R2) 
Moderate BDR (R2)  High Risk 
Moderately severe 
NPDR (47) 
    
A-D Severe NPDR 
(53) 
 Severe BDR (R3)  High Risk 
E very severe NPDR 
(53) 
 Severe BDR (R3) Severe NPDR  
Mild PDR (61) Proliferative (R3) PDR (R4) PDR PDR 
Moderate PDR (65)     
High Risk PDR 
(71, 75) 
    
Advanced PDR 
(81, 85) 
    
ETDRS – early treatment Diabetic Retinopathy Study; AAO – American Academy of Ophthalmology; NSC – 
National Screening Commitee; SDRGS – Scottish Diabetic Retinopathy Grading Scheme; NPDR – 
Non.proliferative diabetic retinopathy; BDR – Background Diabetic retinopathy; PDR – Proliferative Diabetic 
Retinopathy; HRC – High Risk Characteristics 
 
Before this, in 2009, the Portuguese Group on Vitreo and Retina Studies
17
 had proposed the 
Guidelines for evaluating diabetic retinopathy, based on the orientations made by the 
International Council of Ophthalmology (ICO) and by the American Academy of 
Ophthalmology (AAO) and their “Preferred Practice Patterns”. This group proposed an 
international classification for Diabetic Retinopathy and Macular Oedema based on the 
ETDRS classification (Table 3), in an effort to facilitate communication between the 
ophthalmic community and the internists and endocrinologists, based on the ocular fundus 
observation and on the retinography. 
The presence of hard exudates are a sign of a recent macular Oedema or in phase of 
reabsorption, being the Diabetic Macular Oedema defined as a retinal thickening, which may 
be observed by the Optical Coherence Tomography (OCT) or Fluorescein Angiography. 
Although this last method is useful in several situations, it has become less applied since the 
emergence of the Optical Coherence Tomography as this offers a lower cost, greater safety 
and likelihood of obtaining useable information. The OCT is an effective mean of evaluation 
of the retina, either qualitatively or quantitatively, especially in the early detection of retinal 
thickening and in the follow-up of the macular Oedema
30
.  
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3.3 Prevention of diabetic retinopathy 
Despite clinical standards for evaluating and treating diabetic retinopathy cost-effectively, 
are clearly defined, some treatments that have shown to be effective, such as laser surgery, 
are still underused. On the other hand, it has been reported that, in patients with type 1 
diabetes mellitus, about 26% of patients have never had their eyes examined, being the 
correspondent proportion of 36% in type 2 diabetes mellitus patients. The pattern for the 
patients is that they are older, less educated, have a more recent diagnosis than the ones 
that receive eye care regularly, live in rural areas and receive health care from a family or 
general practitioner. When these patients are examined, almost 61% are found to have 
diabetic retinopathy, cataract, glaucoma or another ocular manifestation of diabetes 
mellitus
18
. 
It is known that population prevalence of diabetes mellitus is over 6% in most of the high 
and middle income countries. 
According to the Guidelines for Diabetic Retinopathy published by the Portuguese Study 
Group on Retina
17
, it is generally accepted that there are some factors that should be 
controlled on diabetic, and that could help prevent diabetes complications, such as the 
metabolic control concerning the reduction as much as possible of the glycosylate 
haemoglobin to values below 7% and/or fasting blood glucose below 110 mg/dl. In addition, 
systolic and diastolic pressure should be controlled, with maximum values of 130 mmHg and 
80 mmHg, respectively, as also cholesterol and triglyceride levels. Furthermore, obesity 
should be controlled with an adequate diet and daily physical activity is required, with the 
maintenance of the renal function. 
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1. Introduction 
In biomedical research, namely in clinical research, whenever we have a pair of identical 
organs, there is a challenging problem: data usually involves examining both organs, and 
measures are often correlated. Ophthalmic research is one of those cases, where we have a 
pair of eyes to analyse. So, it is extremely important to define who the subjects for analysis 
are, that is, we should define if we use all the data or if we look at individuals. It depends 
mostly on the question that is being asked, on the data collected and on the nature of the 
condition that is being studied. So, a question of major importance is the definition of the 
Unit of the Analysis. 
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2. Mathematical Issues on dependent or correlated data 
Improper analysis of repeated measurements on the same person not taking in account for 
correlation between observations, or even the analysis of dependant measurements on the 
same person as if they were independent is a common error in medical studies. Correlated 
data arise when pairs or clusters of observations are related and thus are more similar to 
each other than to other observations in the dataset. There are two different types of 
dependency: 
1) Observations may be related because they come from the same subject, either due to 
subjects that are measured at multiple time points (repeated measures), or when 
subjects contribute data on multiple body parts, such as both eyes, hands, arms, legs, or 
any pair of organs. 
2) Observations from different subjects also may be related, such as in the case of the 
dataset containing siblings, twin pairs, husband-wife pairs, control subjects who have 
been matched to individual cases, or patients from the same physician practice, clinic, or 
hospital. 
Other type of dependency are cluster randomized trials, which are performed to assign 
interventions to groups of people rather than to individual subjects (for example, schools, 
classrooms, cities, clinics, or communities), also are a source of correlated data because 
subjects within a cluster will likely have more similar outcomes than subjects in other 
clusters. 
Many statistical tests assume that observations are independent and its application to 
correlated observations will lead to the overestimation of the p-values when we consider 
within-subject or within-cluster effects and underestimation of the type I error if we intend 
to analyse between subjects or between cluster effects. 
We can state that there is a within-subject comparison when subjects are compared with 
themselves under multiple treatments, or at different time points; when they are compared 
with related subjects, such as twins, these are called within-pair or within cluster 
comparisons. Certainly, there is an advantage on doing these, because we can reduce 
variability. However, analysis that ignores correlation between data will overestimate the 
variability and artificially increases the p-values, decreasing the chance of observing a 
significant effect and the correspondent power of the test. 
When comparisons are made between unrelated subjects or clusters that have each 
received just one treatment, these are called between-subjects or between-cluster 
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comparisons. In these situations, ignoring correlations in the data will lead to an 
underestimation of p-values because we cannot assume that results will be independent. For 
example, if a treatment works in a person’s left eye, it is more likely to work in his or her 
right eye, so we cannot assume that we have two good outcomes from that treatment. If we 
assume that, we would be artificially increasing the sample size and, by doing that, 
decreasing the p-values which would lead to significant differences that, in fact, do not exist 
(type I error). 
Correlated data need to be handled by special statistical techniques, which may be 
challenging to implement and interpret; one solution could be removing correlations by 
changing the unit of analysis, but it always leads to loss of information. 
 
 
3. Revision of Literature 
Concerning the problem to handle, if it is purely at the ocular level, both eyes should be 
used; on the other hand, if the problem that is being investigated is related to the individual, 
then the method of analysis depends on the nature of the condition that is being studied. 
If we collect data from just one eye, then we have no problem since each eye represents one 
individual, but if we collected both eyes information, then we must look at the condition 
that is being studied before analysis. A major problem is when data has information from 
one eye only for some individual, and both eyes on others. In this case, it is generally safer to 
analyse data of only one eye per person.   
So, the nature of the condition that is being studied is crucial to define if we use one or both 
eyes data. However, if sometimes it is obvious that both eyes data should be used, such as in 
cases of visual disabilities such as squint where the two eye information are needed in order 
to reflect the disability level of individuals. 
Some conditions affect usually only one eye, such as choroidal melanoma (99% of cases) or 
corneal herpes, or severe ocular trauma (98% of cases)
31
; in these situations we should use 
the disabled eye information at the level of the individual. Eventually, the “good” eye could 
be used as a matched control for age and gender, or for other socio-demographic and 
clinical information. Other extreme conditions such as blepharitis almost always are bilateral 
(95% of cases)
31
. Due to this, whatever is found in one eye is found in the other, and 
correlation between eyes is very strong, almost perfect, so there is no use for both eye 
information and we should use only one eye. 
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In the middle situation lies the majority of cases, those where we find correlation between 
both eyes, but not perfect correlation. The simplest and safest statistical way to analyse data 
is to use only one eye information per subject, but it can lead to a waste of important data. 
For instance, if we have a sample of 100 individuals, therefore we have 200 eyes; if we use 
one eye per subject, then there is a waste of information, but if we use the 200 sample we 
have a bigger sample and then we can have a falsely degree of precision. 
In sequence of this, there are some Statistical Guidelines for the analysis of ophthalmological 
data, published by Richard Armstrong
32
. 
There are a number of issues raised by the decision of collecting data from one or both eyes. 
When only one eye is chosen, it must be decided which one should be chosen.  On the other 
hand, if both eyes are chosen, it must be defined how to analyse both eye information. 
Measurements are usually correlated
33,34
,
 
and typical statistical procedures such as t-tests, 
ANOVA, confidence intervals or other basic nonparametric methods assume that 
observations are independent when, in fact, they are not. As the variance between eyes 
(within subject) is usually less than the variance between subjects, the overall variance is 
likely to be and underestimate of the true variance and the risk of finding falsely significant 
differences (type I error) increases. It is essential to combine in some way data from both 
eyes in order to take its correlation into account
35,36
. 
Armstrong suggests that investigators should consider whether it is advantageous to collect 
data from both eyes or not, and if one eye is studied and both are eligible, it should be 
randomly chosen; otherwise, two-eye data can be analysed using eyes as a within subjects if 
they are not used as case-control. 
Armstrong reviewed referenced articles in three optometry journals (OPO – Ophthalmic and 
Physiological Optics; OVS – Optometry and Vision Science; CEO – Clinical and Experimental 
Optometry) between 2009 and 2013, eliminating those that involved animal or laboratory 
studies. 
Of the 230 articles remaining and reviewed, 148 (64%) used data from one eye only, and 82 
(36%) used data from both eyes. Whenever one eye only was used (148 papers) for analysis, 
different approaches were used, such as choosing either the right eye or the left eye, or 
even randomly selected eye, dominant eye, eye with best visual acuity, and the worst or 
diseased eye, as presented on Figure 7. 
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Figure 7 – Distribution of chosen eye to analyse within papers which used data from one eye only, per journal 
(Adapted from data available at reference 32). 
 
Papers with two-eye information (82) analysed it in several different ways, also (Figure 8): 
some of them rejected data from the adjacent eye, other used both eyes separately, some 
used both eye taking into account correlation between eyes or, in other cases, using one eye 
as a control and the other as a disease or treated eye. 
 
Figure 8 – Distribution of methodologies on number of eyes to analyse, per journal (Adapted from data 
available reference 32). 
 
On that revision, Armstrong did not find any association between different methods of 
selecting the eye intended to study when methodology involved only one eye in articles 
published in those three journals (independence chi-square(12) = 14.48; p = 0.310), or 
between different methods of analysis of data from both eyes and those three journals 
(independence chi-square(8) = 7.44; p = 0.510).  However, as the number of expected cells in 
those contingency tables is too high, it is useful to correct those statistics applying a Monte 
Carlo simulation. By doing this, we can perform the independence chi-square test in a 
random sample of 10000 cases, for instance, generated by that method. Conclusion is similar 
to the one that Armstrong
32
 stated, but more reliable (Table 4). 
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Table 4 – Association between eye methods selection and journals. 
Data collected Chi-square (df) p-value Monte Carlo simulation 
p-value 95% CI 
One eye only 14.48 (12) 0.271 0.272 0.263 – 0.280 
Both Eyes 7.44 (8) 0.490 0.510 0.501 – 0.520 
 
This means that methodologies applied were identically distributed between journals, but 
apparently there is as predominance of the choice of the right eye when only one eye is 
chosen for analysis in all the journals (Figure 9.A), and the use of both eyes information 
uncorrected for correlation when data from both eyes is used in all the journals considered 
together (Figure 9.B). The left eye is rarely used (in fact, it is only considered at OVS). This 
shows great heterogeneity in the methodology chosen between studies.  
 
Figure 9 – Overall distribution of eye chosen for analysis, when only one eye was used (A) or when both eye 
information was used (B) (Adapted from data available reference 32). 
 
Actually, an adjustment chi-square test performed within each journal in papers that 
considered just one eye shows that there is a prevalence of studies using the Right Eye at 
OVO (chi-square(6) = 45.35; p = 1.23E-08), of the Right, Random or Dominant Eye in OVS 
(chi-square(6) = 25.61; p = 2.63E-4), while in CEO there is a only a tendency for the use of the 
Right Eye or Dominant Eye, although all journals have larger observed papers relative to 
expected without a given criteria for the choice of the eye (Figure 10.A). When both eye data 
were collected, the prevalence of two eyes used separately or both used uncorrected for 
correlation is significantly higher than other methodologies. This pattern is present at OVS 
papers (Figure 10.B). Analysis of both eyes uncorrected for correlation appear to be the 
method most frequently used in these journal, but no differences were found in 
methodologies used in the two other journals. 
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Figure 10 – Distribution of methodology for analysis, when only one eye information or both eye information 
were used. (Adapted from data available at reference 32). Values between brackets indicate 95% 
confidence interval for the p-values, if Monte Carlo simulation was applied 
 
Armstrong
32
 suggests the use of the following statistical methodology whenever data from both eyes 
is collected: 
 
Table 5 – Statistical methodology to apply when both eye data is collected, suggested by Armstrong
32
. 
Objective Procedure References 
Mean, SD of a sample of right 
and left eyes 
ANOVA nested design (variance 
components determination) 
Armstrong, Eperjesi, Gilmartin
37
 
Comparing two groups 
(correlated data) 
Modified Wilcoxon test Rosner, Glynn, Lee
36 
Rosner, Glynn, Lee
39
 
Comparing a proportion of eyes 
with a feature (two samples) 
Adjust variance of the difference 
proportions by calculating 
asymptotic normal distribution 
Fleiss, Levin, Paik
40
 
Measure correlation between 
eyes (no systematic differences 
between eyes) 
Intra-class correlation coefficient Bland, Altman
41
 
Measure correlation between 
eyes (systematic differences 
between eyes) 
Intra-class correlation coefficient Rosner, Glynn, Lee
36
 
 
Linear regression Regression models Glynn, Rosner
42
 
Glyyn, Rosner
43
 
Level of agreement between 
eyes 
Bland and Altman test of agreement Bland, Altman
44
 
 McAlinden
45
 
Treated eye, other as control 
(two-way) 
Paired t-test Armstrong
46
 
Treated eye, other as control 
(factorial design) 
ANOVA split-plot Armstrong, Eperjesi, Gilmartin
37
 
 
He also recommends the use of the following flow chart, presented on Figure 11, to plan the 
statistical analysis: 
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One eye, 
conventional 
analysis
Randomly select  
eye 
Self-selected eye, 
random selection 
of subjects 
Better or dominant 
eye
Worse or disease 
eye 
Figure 11 – Flow chart for planning statistical analysis suggested by Armstrong
 
One eye or 
two? 
Both eyes, 
modified analysis 
Any correlation
Measure 
agreement 
between eyes44 
Calculate SD, SE, CI 
for ICC or Nested 
ANOVA38,39,40,42,43 
Univariate analysis 
for correlated data 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
32
, and adapted.
Exploit eyes as 
“within subjetcs”: 
Nested ANOVA, 
Randomized Blocks 
ANOVA, Split plot 
ANOVA37
Correlation close 
to 1
 
 S E C T I O N  B  
 
S T A T I S T I C A L  C L A S S I F I E R S  
 
 
1. Introduction 
As seen above, there is a concurrent problem in defining or classifying diabetic retinopathy 
and, moreover, in identifying risk factors for the development of a characteristic that, in no 
doubt, classifies the individual to a group or traces the profile of a determined group of 
individuals. 
In statistics, classification is the problem of identifying to which groups a new individual 
belongs, given a set of characteristics. This usually involves having a training set of data 
containing observations whose group membership is known, given this explanatory variables 
or features. However, measurement levels of variables must be taken into account since all 
variables must be quantifiable. Any algorithm that implements classification or any 
mathematical function that maps input data into a category is known to be a classifier. 
In the terminology of machine learning, the term classification is considered to be an 
instance of supervised learning (while in statistics it is related to unsupervised learning) 
which means that it is necessary to have available a set of correctly identified observations, 
while the corresponding unsupervised procedure is known as clustering or cluster analysis, 
which involves grouping data into categories based on some measure of inherent similarity 
or, in other cases, dissimilarities
47
. 
Terminology is quite varied across fields and a class of methods which are often used for 
classification is regression. Here, independent variables, or regressors, are the explanatory 
variables and the categories to be predicted are the outcomes, which represent the set of 
possible values for the dependent variable. Conversely, in machine learning, the 
observations are called instances while the explanatory variables are the features, grouped 
into a feature vector, and the possible categories to be predicted are called classes.  
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Classification and clustering are included in a more general problem related to pattern 
recognition or profile detection, which often includes probabilistic models. Algorithms of this 
nature apply statistical inference to find out the bets class for a given instance, which is 
chosen as the one with the highest probability membership. This kind of algorithms have 
some advantages on clustering and non-probabilistic algorithms since they offer a 
confidence interval for the probability of group membership and often they can abstain for 
classifying if that probability is too low, avoiding the problem of error propagation. 
There is a considerable overlap among concepts related to classifiers, related to statistical 
classifiers, machine learning, data mining and Artificial Intelligence algorithms. In a certain 
way, these four fields intend to solve the same kinds of problems but with different 
approaches. 
Artificial Intelligence is fairly distinct from the others since it is related to programming a 
computer or electronic device in order for it to behave as if it had intelligence. However, 
most experiences to induce intelligence require machine learning algorithms, since it is 
intended to induce new knowledge from previous learned experiences so a large area of 
artificial intelligence is machine learning. 
This area involves the study of algorithms developed for the automatic extraction of 
information, without human involvement, with some ideas inspired or directly derived from 
classical statistics. 
Data mining can be said to have born from machine learning, in some aspects and though, 
from statistics but it is carried out by a person and not by a computer, in a specific situation 
or data set, with a goal in mind. We can say that this person wants the influence of different 
pattern recognition techniques developed in machine learning and, quite often, the data set 
is massive, complex, and frequently with more variables than observations. Data mining 
problems can be unsupervised, that is, when we do not know the answer (discovery) or 
supervised when they are used as predictions since we know the answer. Data mining 
techniques often involves cluster analysis, classification and/or regression trees, or neural 
networks. 
Classical statistics are often related to frequentist or Bayesian methods, and clearly there is 
an intersection between this topic and optimization theory in order to achieve fields above 
mentioned. The election prediction statistical procedure for classification is regression, but 
others are available. 
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2. Classification Methods 
Classification methods were born with the work of Sir Ronald Fisher
49,49
, and his work as a 
co-founder of the actual population genetics. He worked in the context of two group 
problems, leading to Fisher’s Linear Discriminant Function, which is very similar to a multiple 
regression function, since the intention is to assign a group to a new observation when the 
dependent variable is qualitative and independent variables are quantitative or binary 
qualitative. 
For the effect, discriminant functions are created as linear combinations of the initial 
variables in order to maximize the differences between group averages and, at the same 
time, minimize the probability of incorrect classification of the cases within groups. If we 
code the two groups for analysis as 0 and 1 and use them as the dependent variable, in 
general, groups can fit a linear equation
50
 of type
  
 (, , … ) = 
 + ∑ 
 ×    
 
Where b0 is constant and 
 ,  = 1,  are regression coefficients so interpretation is straight 
forward and closely follows the logic of multiple regressions, where variables with largest 
standardized regression coefficients (Equation 1.2) are the ones that most contribute to the 
prediction of group membership. 
 ∗(, , … ) = ∑  ×    
 
 
2.1 Discriminant Function Analysis 
Discriminant function analysis is an extension of Fisher’s Liner Discriminant Function as it can 
be applied to discriminate two or more than two groups. When there are more than two 
groups, then more than one discriminant function as the one presented above can be 
estimated. For instance, if there are three groups, two discriminant functions will be 
estimated: one that discriminated between group 1 and groups 2 and 3 combined, and 
another one which discriminates between groups 2 and 3. These functions are created in 
order to optimize the combination of variables that provide the best overall discrimination 
between groups, sequentially, that is, the first function provides the most overall 
discrimination between groups, and the second one provides the second most, and so on. 
Moreover, these functions will be independent and orthogonal so that their contributions to 
discrimination between groups do not overlap. This can be obtained after a canonical 
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correlation analysis is performed, so that successive functions and canonical roots (canonical 
eigenvalues that generate functions) are determined, in a maximum number of the number 
of group minus one (k-1), as long as the number of variables is at least k-1; otherwise, the 
number of discriminant functions determined equals the number of variables. This is done 
thought the Wilk’s Lambda Test which represents a generalization of the F distribution, and 
is performed in a stepwise method that includes, in each step, the variable with the higher 
Wilk’s Lambda, in spite of the importance of eigenvalues, eta-squared and canonical 
correlation. Moreover, it permits the identification of new cases or the choice of an 
alternative data set of variables with a similar dimension of the initial model which can 
discriminate groups. It is also possible to identify similar groups using similarities of 
centroids, that is, vectors of group means. 
Discriminant analysis is often used as a confirmatory analysis for clustering or factorial 
analysis, a method of reducing variables, but it can also be used as a classification method as 
a predictive classification of subjects: once discriminant functions are derived, they can be 
tested in a new set of data to cross-validate the utility of discriminant functions, using 
classification functions, which cannot be confused with discriminant functions. Classification 
functions are in the same number as the number of groups, and are used to determine to 
which group each case most likely belongs, after computing a classification score (Si)
 
for a 
new observation
50
, defined as: 
  =  + ∑  ×  ,  = 1,   
 
Where k is the number of groups, m is the number of variables, ci is constant for group i, wij 
is the weight for the j’th variable in the computation of the classification score for the i’th 
group and xi is is the observed value in variable j for the new case. 
By doing this, we can classify the new case to the group where it has the higher classification 
score, unless prior probability membership are quite disperse. If here are much more 
observations in one group than in others, a priori probability that the case belongs to that 
group is much higher. So, a priori probabilities should be adjusted to represent the 
proportion observed in the sample if only that represents the true distribution proportion in 
the population; otherwise, if proportions observed in the sample reflect only the random 
result of sampling, then a priori probabilities should be set to be equal, since a priori 
probabilities have a great impact on the accuracy of the prediction, that is, on posterior 
probabilities. These posterior probabilities are almost proportional to the Mahalanobis 
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distance, that is, the distance between the point and each group centroid, so classification is 
performed by choosing the smallest Mahalanobis distance. 
The Mahalanobis distance
51 
between a multivariate vector  = (, , … , ) and its mean 
= ( ,  , … ,  ) , with a covariance matrix  is given by 
 !() = "( −  )$( −  )  
 
Note that if the covariance matrix is the identity, than the Mahalanobis distance is the 
Euclidian distance
51
. This is highly improbable with real data, but if we have a diagonal 
matrix, the Mahalanobis distance is the usually called normalized Euclidian distance, and the 
distance from a given point in multidimensional space each group centroid is given by
  
 
!(,  ) = %∑ (&'$('))*')   
 
In the two group problem, this formula may be used to estimate the probability of a given 
point in space belongs to a data set, or a group, and classify it according to the higher 
posterior probability. 
For each subject i, the distance between the score obtained in the discriminant function (+) 
and the centroid for each group j (!), considering the variance for scores obtained for the 
discriminant function in group j (,-. ) defined51 as  
 
! = !/+, !012 = 3/-'$452)*6.)   
 
Another way to classify subjects is to use these distances, and classify the subject according 
to its closeness to each group centroid, after determining the frontier line that separates 
groups, which is given by
50 
 + = 7478)4)78)   
 
where 	and  are the number of cases in each group and ! and ! are the centroids for 
each group. 
Based on the distances to the frontier line, or to each group centroid, it is possible to 
determine posterior probabilities for a given subject belongs to a specified group. 
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The distribution of the squared distances, D
2
, follows a chi-square distribution with one 
degree of freedom (since there is only one discriminant function) and the right probability of 
significance for the chi-square obtained is the conditional probability of obtaining that 
distance, given the group, :/;|=2, for each one of the groups. Applying the Bayes theorem, 
it is possible to determine posterior probabilities, given by
50
 
 
:/=>;2 = ?/@.2×?/A|@.2∑ ?/@.2×?/A|@.2).B7 , C = 1,2  
 
The subject is classified according to the group for he has higher probability of belonging. 
 
However some assumptions should be evaluated, such as: 
- Each group is a random sample of a multivariate normal population. The violation of this 
assumption can lead to incorrect decisions, especially in present of small samples. 
However, incorrect decisions are in terms of the type II error and rates of classifications, 
but not in the type I error, that is, violation of multivariate normal distribution will not 
increase type I error, but it can reduce the power of the test and lead to a higher rate of 
misclassifications, unless the lack of normality is only due to the lack of symmetry and not 
due to a non-mesokurtic distribution, according to Sharma
51
. In the presence of 
leptokurtic or platikurtic distributions, it is common to use logistic, ordinal or multinomial 
regression as an alternative to discriminant function analysis. 
- Homogeneity of covariance matrices which means identical variance within groups, which 
can be tested using the Box M Tests. The violation of this procedure increases the number 
of cases classified in the group with higher dispersion and affects almost only the type I 
error, especially if groups have different dimension. In case of identical dimensions, 
Sharma
51
 considers that the violation of this assumption is no problematic in terms of 
increase of type I error, even because classification rates are not influenced by this. 
 
2.2 Regression procedures 
Also based on multiple regression, some methods have become very popular in classification 
problems, such as logistic, probit, multinomial or ordinal regression. Perhaps logistic 
regression is the most popular of those, since it is the simplest to interpret but other may be 
useful. 
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Logistic regression is a type of probabilistic statistical classification model used to predict a 
binary response from a binary predictor or set of predictors; however, it is possible to use 
ordinal or scale predictors. 
Logistic regression is an extension of linear regression and measures the relationship 
between a binary categorical dependent variable E ∈ G0; 1J and one or more independent 
variables (K,  = 1, ) by using probability scores as the predictive value on the dependent 
variable. 
In multiple linear regression, the estimated model is obtained by
52 
 LM = 
 + ∑ 
 × N   
 
Since LM can assume only to possible values, let’s say, 0 and 1, it would be unrealistic to use 
that condition. On the other hand, theoretically, the right-hand side of the previous equation 
can take any value between minus infinity (−∞) and plus infinity (+∞) unless we restrict the 
values of the regression coefficients (
 ,  = 0, ) and LM is assumed to be the expected value 
of a normal distribution. Well, we are dealing with binary variables so that model does not 
apply to these variables. 
Thus, it is more reasonable to consider a regression model which involves the probability of 
E being 1 (probability that the event occurs) instead of using E by itself since P = 	:(E =
1|) ∈ Q0; 1R . However, it is still too narrow since 
 + ∑ 
 × N ∈ (−∞;	+∞)  but $ ∈ (0;	+∞) and, if we take the logarithm of this expression, we have a real number  
S T $U belonging to the interval (−∞;	+∞). So, it is possible to write the following 
condition
52
: 
 S T ?(V|&)$?(V|&)U = 
 + ∑ 
 × N   
 
Which is equivalent to 
 ?(V|&)$?(V|&) = WXY8∑ X'×&'Z'B7   
 
And to 
 
:(E = 1|) = [\Y]∑ \'×^'Z'B78[\Y]∑ \'×^'Z'B7   
 
Or 
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 :(E = 1| = [\Y×∏ /[\'2^'Z'B78[\Y×∏ /[\'2^'Z'B7   
 
Which reveals that the model links the linear expression 
 + ∑ 
 × N  to the probability :E = 1|, where 
 denote regression coefficients and if a 
 = 0 then the correspondent K as no association with the dependent variable E; each one of the WX' can be interpreted 
as an odds ratio. 
 
Multinomial logistic regression is a classification method that generalizes logistic regression 
to a multiclass problem
53
, with more than two possible discrete nominal outcomes, used to 
predict the probabilities of a nominal distributed dependent variable, given a set of 
independent variables. 
 
Ordinal regression is a classification method applied to predict ordinal dependent variables. 
The two most common types of ordinal regression models are ordered logit and ordered 
probit. 
In ordered logit, the model applies to data that meets the proportional odds assumption, 
that is: suppose that the dependent variable Y is ordinal, and has m ordered categories 
( ` ,  = 1,a) so that the proportion of a statistical population who would answer ` is 
denoted by P,  = 1,a.  
The logarithms of the odds
53
 (not the probabilities) of answering in a certain way are given, 
to the fist m-1 categories, by: 
 
bc
cc
d
ccc
e `	f!W!	g,	0:	S 7∑ 'i'B)`	f!W!	g,	1:	S 78)∑ 'i'Bj…`N	f!W!	g,	 − 1: S ∑ 'Z'B7∑ 'i'BZk7 	…`$	f!W!	g,	a − 3:	S ∑ 'ik)'B7ik78i`$	f!W!	g,	a − 2:	S ∑ 'ik7'B7i
  
 
The proportional odds assumption is that the number added to each one of these logarithms 
to get the next is the same in every case so that we obtain an arithmetic sequence and  
The probit function (probability unit function) is the quantile function associated with the 
standard normal distribution, and it has applications in exploratory statistical graphics and 
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also in specialized regression models, especially with binary response or ordinal response 
variable, leading to probit regression models and ordered probit regression, respectively. 
Generally, the probit function is the inverse of Φn, the cumulative distribution function of 
the standardized normal distribution Z, and can be expressed as Pof
p/Φn2 =n	g!	Φ/Pof
pP2 = P	 
 
2.3 Bayesian Classifiers 
A Bayes classifier is a simple probabilistic classifier based on the Bayes’ Theorem and due to 
that often called Naïve Bayes Classifier, as it uses strong independence assumptions
54
. 
Bayes’ Theorem shows a very simple relation between a conditional probability and its 
inverse, and is itself a corollary of the Total probability Theorem, and shows how we can 
change prior probabilities having in account new evidences into posterior probabilities. 
Total Probability Theorem states that if we have n independent events 	q,  = 	 1,  in the total sample space, Ω, that satisfy simultaneously the following conditions 
 
r ⋃ q = Ω:q > 0, ∀ = 1, q ∩ q = ∅, ∀, C = 1, :  ≠ C  
 
Then 
 :z = ∑ :z ∩ q = ∑ :q × :z|q)   
 
So, from this, and with the same assumptions, the following corollary can be stated, and it is 
known as the Bayes Theorem: 
 :(q|z) = ?({||')×?(|')∑ ?({||')×?(|')}'B7   
 
The Naïve Bayes Classifier assumes that the presence or absence of a feature of a group or of 
a class is unrelated to another feature, either it is present or absent. For instance, a naïve 
Bayes classifier may predict the gender of a given subject just because the height is above 
1,80 meters, the weight is above 75 kg and the hair is short, considering that this features 
contribute independently, regardless the presence or absence of other features. In spite of 
this, it can be trained very efficiently in a supervised learning setting, and they have a good 
behaviour in many complex real-world situations.  
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An advantage of this classifier is that it needs a small amount of training data to estimate 
parameters necessary for classification and, as it assumes independence of variables, it is 
only necessary to estimate variances and not the entire covariance matrix. 
Nowadays, naïve Bayesian classifiers are outperformed by other approaches, such as 
boosted trees or random forests, methods that are included in decision trees. 
 
2.4 Decision trees 
Decision trees are nowadays widely used either as prediction or simply exploratory tools. A 
decision tree is a predictive model which maps observations about an item into conclusions 
about its outcome value, and it is used either in statistics, machine learning and data mining 
and often decision trees are called classification trees or regression trees, depending on the 
problem that is being solved, although is common the use of the acronym CART standing for 
Classification And Regression Tree: 
- Classification tree analysis is used whenever the predicted outcome is qualitative (the 
class to which the data belongs) 
- Regression tree analysis is used whenever the predictive outcome is quantitative 
The tree structure is composed by leaves that represent class labels and branches represent 
conjunction of features that lead to those class labels, starting from a root with no incoming 
edges. This kind of models are useful since they put conclusions into a visually space that 
explicitly represents decisions. The goal is to find the optimal decision tree by minimizing the 
generalization error. The classical CART algorithm was popularized by Breiman
55
, but there 
are numerous algorithms for predicting continuous or categorical variables from a set of 
continuous predictors and/or categorical factor effects, and General Linear Models (GLM) or 
General Regression Models (GRM) are a an example of it, since the design is constructed in a 
linear combination of those predictors and factors, with or without interactions, being the 
predicted value continuous. This is the main difference between these algorithms and 
Discriminant Function Analysis (DFA). 
Algorithms for constructing decision trees usually work top-down, choosing a variable that, 
at each step, best splits the set of items, depending on the metric that is being used. Most 
popular algorithms are the CART, the CHAID (Chi-squared Automatic Interaction Detection
56
) 
and the QUEST (Quick, unbiased, efficient, statistical tree
57
) algorithms. The Quest is 
generally faster than CHAID and CART algorithms, but can only be applied to classification 
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problems and, in very large data sets, the amount of memory required to compute this 
algorithm may be impractical. 
Perhaps the first published proposal of tree algorithms was done in 1959 by Belson
58
, where 
he addressed a matching issue which was, in fact, a predictive model where the prediction of 
the second group depend on the outcome observed for a first group. Predictors and 
outcome are dichotomized, and the tree grows using the difference between the observed 
count and the number expected under no association assumption, for each one of the two 
outcome categories. 
 
2.4.1 Evolution of Decision Trees Algorithms 
The first algorithms for inducing trees begun to appear from survey data and were mainly 
developed by statisticians. Perhaps the first tree algorithm proposed was published by 
Belson
58
, in 1959, as a predictive model for the outcome of a second group given the 
outcome observed for the first group which, in fact, uses a Bayesian procedure. All 
predictors and outcomes needed to be dichotomized and the growing criteria computed the 
differences between observed counts and expected counts under the no association 
assumption which is something similar to a Chi-square test. 
In few years, other proposals were made, such as the AID (Automatic Interaction Detector) 
algorithm for growing a binary regression tree for a dependent quantitative outcome, 
proposed by Morgan and Sonquist
59
 in 1963, or the ELISEE (Exploration of Links and 
Interactions through Segmentation of an Experimental Ensemble) algorithm, proposed by 
Cellard, Labbé and Savisky
60
 in 1967, a binary model for categorical dependent variables. 
Meanwhile, with the computer development and the use of routines or programmes, the 
AID tree method became popularized in 1971, by Sonquist, Baker and Morgan
61
, and ELISEE 
somewhere between 1970 and 1972, by Bouroche and Tenenhauss
62,63
. However, AID was 
always more popular, especially after Sonquist has shown interest in complementing it with 
a multiple correlation analysis tool. This algorithm was, meanwhile complemented by 
Messenger and Mandell
64
, in 1972, and Morgan and Messenger
65
, in 1973, with a tool for 
categorical outcomes using what was called the Theta Criterion, and resulted in the THAID 
(THeta AID) algorithm. 
Others, such as Gillo
66
, in 1972 or Guillo and Shelly
67
 in 1974, extended the AID algorithm for 
multivariate quantitative outcome variables, resulting in MAID (Multivariate AID). 
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Before these extensions of the AID algorithm, two other groups worked independently: 
Hunt’s group
68
, in 1966, has proposed a series of decision trees induction algorithms known 
as Concept Learning Systems (CLS-1 to CLS-9), explicitly developed in an Artificial Intelligent 
perspective for binary (CLS-1 to CLS-8) or multibranching (CLS-9) classification, while Press, 
Rogers and Shure
69
 developed, in 1969, an interactive tree growing tool, the Interactive Data 
Exploration and Analysis (IDEA) that allowed multibranching. 
With the exception of the Concept Learning System algorithms, all authors were mainly 
interested in finding alternatives to the restrictions of linear models, where the effect of 
explanatory variables are basically addictive, in order to detect important interactions, just 
to gain better knowledge about how outcomes are linked to explanatory factors, with no 
concern in improving predictions. 
 
2.4.2 Actual Decision Trees Algorithms 
One of the most simple decision tree algorithms is the ID3, developed by Quinlan
70
 which 
uses information gain for splitting criteria and stops either because all instances belong to a 
single value of the target or when the higher information gain is non-positive, without 
making any pruning. However, this algorithm does not perform any pruning, and it cannot 
work with numeric information or missing values. Algorithm ID3 evolutes to C4.5
71
, using the 
gain ratio as splitting criteria, stopping when the number of issues to split is below a given 
threshold and incorporating error-based pruning. Besides this, C4.5 can handle numeric 
information and missing values. 
In 1984, Breiman
55
 presesented the CART algorithm. The Classification and Regression Tree 
(CART) Algorithm is characterized by the construction of binary trees as each internal node 
has exactly two outgoing edges. The splits are selected using the twoing criteria and pruning 
process of the tree is done by cost-complexity. It is possible here to define a priori 
distribution. 
On the other hand, this type of procedure can generate regression trees, that is, these 
models can predict a real number instead of a class and, in this case, splits are generated in 
order to minimize the least-square deviation, that is, the squared error, and the prediction is 
each leaf is based on the weighted mean of the node. 
The evolution of AID to MAID and THAID has leaded to the development of the CHAID 
algorithm, in 1980, by Kass
56
. In fact, CHAID stands for CHi-square Automatic Interaction 
Detection so it can be viewed as an evolution of those primary methods, by using the p-
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value obtained by a statistical test to find out the pair of values that has least significant 
difference with respect to the target attribute. Initially, this algorithm was designed for 
nominal dependant variables so the Pearson Chi-square test was the only one to apply. 
However, actually it handles all types of dependent variables or target attributes so if its 
nature is ordinal then a likelihood-ratio test is used and in cases of quantitative attributes 
the F distribution is the one to use. For each selected pair, CHAID checks whether the 
adjusted p-value obtained is greater than a threshold and, if so, it merges values and 
searches for an additional potential pair to be merged, until no significant pairs are found, in 
order to have each child node made of a group of homogeneous values of the selected 
attribute. However, CHAID can also stop due to reaching maximum tree depth, or reaching 
the minimum number of cases in a child node or in a parent node, and it does not perform 
any pruning, in spite of handling missing values as a single valid category. 
The QUEST algorithm was developed by Loh and Shih
57
 in 1997, and the acronym stands for 
Quick, Unbiased, Efficient, Statistical Tree. It supports univariate and linear combination 
splits and, for each split, the association between each input attribute and target attribute is 
computed using ANOVA F-test or Levene’s test if their measurement level is, at least, 
ordinal, or Pearson’s Chi-square if variables are nominal. One advantage of QUEST is that it 
handles multinomial target attributes and, in this particular case, a two-means clustering is 
used to create two super-classes and the attribute that obtains the highest association with 
the target attribute is the one selected for splitting. The optimal splitting point for the input 
attribute is obtained by Quadratic Discriminant Analysis. This algorithm has a negligible bias, 
yields binary tree and performs ten-fold cross-validation to prune the tree. Moreover, 
QUEST is generally faster than CART or CHAID, but for very large data sets, the memory 
requirements are usually larger and its application may be impractical. Also, it cannot be 
applied to regression type problems. 
There are other algorithms available in literature, but most of them are variations of the 
previous ones. Decision trees are self-explanatory and an easy to follow procedure and they 
can easily be converted in a set of procedures, which handles nominal and numeric 
attributes simultaneously, and work with missing values. Moreover, they are considered a 
non-parametric method so assumptions about the space distribution and classifier structure 
are not needed. 
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However, some decision tree algorithms, like ID3 and C4.5 require the target attribute to 
have only discrete values. Quinlan
71
 points out that decision trees are over-sensitive to the 
training set in order to irrelevant attributes and noise.  
 
2.4.3 Growing the tree – splitting, stopping and pruning 
The aim of these primary methods was mainly segmentation of data into groups with as 
much difference as possible thus splitting criteria was basically obtained determining 
measures of association between outcome and split variables. Nowadays, the effort is in 
order to maximize homogeneity of each group by means of purity measures, and the 
splitting criteria depend on the nature of the dependent variable. 
In most cases, the discrete splitting functions are univariate in the sense that an internal 
node is split according to the value of a single attribute so that the inducer searches for the 
best attribute upon to split. These criteria is characterized according to the origin of 
measure, such as information theory, dependence and distance, related to measures of 
association, or according to measures of structure, such as impurity based criteria, 
normalized or not, or Binary criteria. 
An impurity measure can be defined as follows: given a random variable X with k discrete 
values , , … , Nk), distributed according to the vector: = P, P, … , PN, then an 
impurity measure is a function Φ: Q0,1RN →  which satisfies simultaneously72: 
 
bcd
ce Φ: ≥ 0Φ:	,	aaa	+	∃ ∈ G1,2, … , J: P = 1Φ:	,	agaa	+	∀ ∈ G1,2, … , J: P = NΦ:	,	,LaaWpo	pℎ	oW,PWp	pf	faPfWp,	f+	:Φ:	,	,affpℎ		p,	ogW	pℎgp	,, !++WoWpg
SW		p,	ogW
  
 
Note that if a component of P equals 1, it means that the variable X has only one value, and 
then the variable is defined as pure. On the other hand, if all components are equal, then 
the level of impurity reaches the maximum. 
Given a training set S, the probability vector of the target attribute Y is defined by
72 
 P = >B7>|| , … , B|i|||   
 
And the goodness-of-split due to discrete attribute g is defined as a reduction in impurity of 
the target attribute after partitioning S according to the values ,∈domg so that72 
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∆Φg,  = Φ/:V2 − ∑ B',.|| ×Φ:V T',.U|4'|   
 
Some measures of impurity that are often used are presented below: 
- Information Gain
73
 (IG) is an impurity-based criteria that has its origins on information 
theory and uses entropy (E) as a measure of impurity: 
 =g,  = qL,  − ∑ B',.|| × q TL, ',.U|4'|',.∈4'   
 
Where 
 qL,  = ∑ − B.|| × log B.||  .∈4   
 
- Gini Index (GI) is an impurity-based criteria which measures the divergence between 
probability distributions of the target attribute’s value, and is defined by: 
 =L,  = 1 − ∑ B.|| .∈4   
 
The evaluation criteria for selecting an attribute g is defined by the Gini Gain (GG) 
function as: 
 ==g,  = =L,  − ∑ B',.|| × = TL, ',.U',.∈4'   
 
- Likelihood-ratio Chi-squared Statistics was defined by Attneave
74
, in 1959, as =g,  =2× ln2 × || =g,  and is useful for measuring the statistical significance of the 
information gain criteria since it is tested under the null hypothesis that input and target 
attributes are independent and since =g, ~£4'$×4$. 
- The DKM criterion was designed by Dietterich, Learns and Mansour
75
 in 1996. Later, in 
1999, Kearns and Mansour
76
 have proven, theoretically, that this criterion requires 
smaller trees for obtaining the same error than other impurity indexes, such as 
Information Gain or Gini Index, and is defined by 
 ;¤¥L,  = 2 × %T>B7>|| U × >B)>||   
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However, the DKM impurity-based criterion and the other presented above are biased 
towards attributes with larger domain values. For this reason, it is important to normalize 
the impurity based measures, which may origin some of the following normalized 
Impurity based criteria: 
 
- The Gain Ratio (GR) normalizes the Information Gain in order to Entropy, as long as it is 
not null, by
72
 
 =g,  = 	¦@',	|§¨',  
 
- The Distance Measure (DM) normalizes the Impurity Measure, such as the Gain Ratio, but 
in a different way
72
 
 ∆©',
$∑ ∑ ª«¬'B',.∧BZ®ª|®| ×¯°±)²ª«¬'B',.∧BZ®ª|®| ³Z∈i',.∈i/¬'2
  
 
Other criterions have been used, such as the Binary criterion, developed for binary trees, is 
based on the division of the input attribute domain into two sub-domains. For instance, let g, !fag, !fag,  denote the binary criterion value for attribute g over the 
sample S when !fag and !fag are its correspondent sub-domains. Then, the value 
obtained for optimal division of the attribute domain into two mutually exclusive and 
exhaustive sub-domains is used for comparing attributes. Some examples of binary criteria 
are the following: 
- the Twoing criteria, used in recent CART algorithms, and preferred to the binary criteria 
when domain of target attributes is relatively wide
55
 and the Gini Index may encounter 
problems. However, if the target attribute is binary, then the Twoing and Gini criteria are 
equivalent. Note that in multi-class problems, the towing criteria prefer attributes with 
evenly divided splits. 
 pfg, !fag, !fag,  = 0,25 × ¬'∈i7/¬'2|| × ¬'∈i)/¬'2|| ×× ∑ µ¬'∈i7/¬'2∧B'¬'∈i7/¬'2 − '∈4− ¬'∈i)/¬'2∧B'¬'∈i)/¬'2 µ
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- The Orthogonal criteria (ORT) is defined through the angle formed by the two vectors :, 
and :,, which represent the probability distribution of the target attribute in the 
partitions '∈47' and '∈4)', respectively. This criterion performs better 
than information gain or the Gini index in some specific problems, and is defined by
72
 
 ¶·g, !fag, !fag,  = 1 − f,¸/:,, :,2  
 
Another binary criterion is the one proposed by Friedman, in 1977, and that applies the 
Kolmogorov-Smirnov distance and is useful to handle target attributes with multiple 
classes and missing values, and it has been suggested that it outperforms the gain ratio 
criteria. When assuming a binary target attribute !faL = Gg, gJ, the criteria is 
defined as
72
: 
 ¤g, !fag, !fag,  = ¬'∈i7/¬'2∧B7>B7> − ¬'∈i)/¬'2∧B)>B)>   
 
- The AUC-spliting criteria is defined by the selection of the attribute that maximizes the 
Area Under convex hull the ROC Curve, and this criteria has showed that it outperforms 
other splitting criteria both with respect to accuracy and area under the curve. However, 
this criteria does not perform a comparison between impurity of the parent node 
relatively to the weighted impurity of children nodes after splitting. 
 
Several authors have performed comparative studies of the criteria described above (and 
presented on Table 6), using methods such as Permutation Statistics
(76)
, mean posterior 
improvements and the use of the hyperbolic distribution measures
(77)
, but most of the 
comparisons are based on empirical results, although some theoretical conclusions were 
obtained. Most of the authors state that the choice of the splitting criteria will not make 
much difference on tree performance. The criteria that would improve the tree´s 
performance dramatically would be a multivariate splitting criteria, where several attributes 
may participate in a single node split test. Most of the multivariate split criteria are based on 
linear combinations of the attributes, which can be performed by a linear discriminate 
analysis. 
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Table 6: Main earlier and actual tree growing algorithms. 
Algorithm Local Split 
Dependant variable Splitting criteria 
quantitative qualitative Association Purity p-value 
Belson Binary  X X   
AID Binary X  X   
MAID Binary X  X   
THAID Binary  X X X  
CLS-1 to 9 n-ary  X X   
ELISEE Binary  X X   
IDEA n-ary X X X  X 
CHAID n-ary X X X  X 
CART Binary X X  X  
QUEST Binary X X  X  
 
The tree will continue to grow until some of the following conditions is achieved: 
- All instances in the training set belong to a single value of y 
- The maximum tree depth is reached 
- The number of cases in a terminal node is less than the minimum of cases for parent 
nodes 
- If the node were split, the number of cases in one or more child nodes would be less than 
the minimum number of cases for child nodes 
- The best splitting criteria is not greater than a certain threshold 
 
However, using tightly stopping criteria tends to create small and under-fitted decision trees, 
while using loosely stopping criteria tends to generate larger trees that are over-fitted to the 
training set so, pruning methods originally suggested by Breiman
55
 were developed for 
solving this problem. It has been suggested that a loosely stopping criteria should be used, 
letting the decision tree over-fit the training set, and then the over-fitted branches should be 
cut in order to create a smaller tree without he branches that are not contributing to the 
generalization accuracy. There are various techniques for pruning decision trees, most of 
them performing a top-bottom or bottom-up transversal to all nodes, where a node is 
pruned if this operation improves a certain criteria. Several studies aimed to compare the 
performance of different pruning methods, but results indicate that no pruning method 
tends to over-perform the others; in fact, while some methods (cost-complexity or reduced 
error pruning) tend to create smaller and less accurate trees (over-pruning), other methods 
(error-based, pessimist error and minimum error pruning) tend to be under-pruning. 
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M A T E R I A L  A N D  M E T H O D S  
 
 
1. Collecting data – general procedures 
Data were collected under the scope of the Diamarker project “Genetic susceptibility of 
multi-systemic complications of diabetes type 2 novel biomarkers for diagnosis and 
monitoring therapy”, under the supervision of the principal investigator Miguel 
Castelo-Branco. 
This project is a part of a bigger project DoIT – Development and Operationalization of 
Translational Research, promoted by Portugal Health Clusters and supported by QREN nº 
13853, with a total number of 21 partners among companies, Research and Development 
institutions and hospitals. 
This is an ongoing project which intends to recruit 300 type 2 diabetics and 300 controls in 
order to characterize phenotypes of diabetic retinopathy progression using multimodal 
imaging, and also other systemic complications with an emphasis on imaging of ocular, 
cardiac, brain and liver tissues, in correlation with clinical and biochemical signatures of 
diabetes type 2. 
This study was designed as a pilot, observational and prospective study with one visit where 
controls and type 2 diabetes mellitus patients performed multimodal imaging examinations, 
namely, ophthalmological, psychophysical, heart, liver and cerebral imaging, after signing an 
informed consent and being previously evaluated for eligibility. 
Inclusion criteria were as follows: men and women aged between 40 and 75 years, 
functionally independent, capable to provide written consent after proper education and 
discussion with the treating physician and/or the research physician, with type 2 diabetes for 
the diabetic group and without any type of diabetes for the control group. Exclusion criteria 
defined for the study were: history of neuropsychiatric, renal, heart, ocular or any other 
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severe non-age disease unrelated to diabetes, pregnancy or lactation.  
At baseline visit, eligible patients were asked to participate in the study and signed the 
informed consent form. Then, subjects completed a questionnaire on lifestyle, 
cardiovascular risk factors and family history of diabetes, current medication, physical 
activity, dietary pattern and quality of life. 
Afterwards, at the clinic, height, weight, waist and blood pressure were measured, and 
blood samples were collected for analysis of glucose markers, lipids, inflammatory and other 
biomarkers, and DNA analysis. An urine sample was also collected in the diabetic group. 
Thus, the assessment schedule comprised the following procedures: 
- Informed consent 
- Patient identification, demographic details and medical history 
- Inclusion/exclusion criteria 
- Concomitant medications and non-drug therapies 
- Blood collection 
- Urine collection 
- Vital signs (blood pressure) 
- Ophthalmic examination including best corrected visual acuity and intraocular pressure 
measurements 
- Visual psychophysical tests (Speed, Colour and Contrast Discrimination) 
- Multimodal imaging 
- Occurrence and details of adverse events 
- Study discharge 
 
Concerning multimodal imaging, cerebral, heart, liver and ophthalmological scanning was 
performed, according to the following procedures: 
- Cerebral Imaging 
- Arterial Spin Labelling (ASL) and Blood oxygen level dependent (BOLD) contrast 
- Magnetic resonance spectroscopy 
- Fluid attenuated inversion recovery (FLAIR) 
- Magnetization-prepared radio-frequency pulses and rapid gradient echo (MR RAGE) 
- Time of flight magnetic resonance (TOF MR) angiography 
- Heart Imaging 
- Ultrasound thickness of the intima-media complex in the carotid arteries 
Chapter 5 
63 
- Triglyceride accumulation (TG) spectroscopy 
- Calcium score  
- True fast imaging with steady state precession (True-FISP) 
- Liver Imaging 
- Gradient echo (GRE) 
- Intra-voxel Incoherent Motion Diffusion Weighted Imaging (IVIM DWI) 
- ME-GRE (Multiecho) 
- Triglyceride accumulation (TG) spectroscopy 
- Ophthalmological Imaging 
- Colour Fundus Photography 
- Optical Coherence Tomography (OCT) 
 
 
2. Selection of patients and data management 
The selection of patients and controls was performed by the University Hospital of Coimbra 
(CHUC) and the Unit of Research and Development of the CHUC that synchronized this 
process with all the hospital centres involved and with the Institute for Biomedical Imaging 
and Life Sciences (IBILI) articulated with the Faculty of Medicine of the University of Coimbra 
(FMUC). There was no randomization since it is an observational study.  
 
A database was developed in order to store all the data acquired, maintaining all the 
necessary confidentiality. Clinical data for all participants included in the study were storage 
in a SQL database with restrict access to the project investigators. Control of database was 
performed with am authentication login for users where the system would verify, using a 
login and password, the access credentials. The system administrator, under the supervision 
of the principal investigator, was responsible for the management of the database users, 
was authorized to insert new users, edit or remove actual users, and also to determine the 
access profile for users, so that investigators with edition profile were authorised to create, 
edit or eliminate data from the database, while visualization users could only use and 
perform queries about data stored, in an anonymous form, being denied the access to 
edition data pages as well as contact information, names and identification numbers.  
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3. Sample: train sample and test sample 
The sample used for this study consisted on data available at the database in the 31
th
 of 
December 2013 and was used as a training sample for the development of classification 
models. All the data inserted after that date formed a new sample, named test sample, on 
which developed classification models were tested. 
The training sample considered 96 subjects, equally distributed by gender (55 males and 41 
females), aged between 40 and 73 years, of which 49 (51.04%) were type 2 diabetics, 
diagnosed between one and 39 years before, and 47 (48.96%) were controls for this disease. 
In the diabetic group, 40 patients had ETDRS grading of diabetic retinopathy performed and 
registered in the database. Half of them (20 subjects) did not have diabetic retinopathy and 
the other half had non-proliferative diabetic retinopathy. None of the cases were diagnosed 
as having proliferative diabetic retinopathy. 
The test sample was composed by all the subjects that entered onto the database after the 
first of January 2014, and 57 subjects were considered, 30 of them controls (52.63%) and 27 
diabetics (47.37%), aged between 41 and 73 years old 
 
 
4. Variables measured in the training sample and measurement instruments 
For the training sample, data related to heart, liver and cerebral imaging, at the database, 
was still incomplete. We therefore decided to focus only blood sample measures, 
ophthalmic examination, visual psychophysical tests and eye imaging. Urine sample data was 
not used since they were only collected on type 2 diabetics. 
Patients were tagged by an identification number, and demographic details such as age, 
gender, medical history (namely for hypertension in order to identify subjects with 
diagnosed hypertension), family history of diabetes and vital signs were collected. 
Height (m) and weight (kg) were used in terms of body mass index (m/kg
2
) and abdominal 
perimeter was discarded of the analysis since it was measured/recorded for all the diabetic 
subjects, but only in seven controls at the time of data extraction. For the same reason, 
pulse, systolic and diastolic blood pressure and bioimpedance were discarded from the 
analysis. The number of controls with registers for those variables was, respectively, fifteen, 
nineteen and one, at that time. 
 
Blood and urine sample collection were for the analysis of metabolic and waste biomarkers 
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at the Coimbra Hospital and University Centre (CHUC), while genetic characterization is 
being performed at BIOCANT (Centre for Innovation in Biotechnology). 
Blood tests performed for all subjects were: 
- Blood glucose (mg/dL) and glycosylated haemoglobin. Glycosylated haemogloblin is 
reported in terms of the National Glycohemoglobin Standardization Programme (NGSP), 
expressed as percentage of HbA1C, and in terms of the International Federation of 
Clinical Chemistry Working Group (IFCC), expressed in mmol/mol. Although IFCC results 
are accuracy-based, and highly correlated with NGSP results ( = 0.018148 ×
 + 2.152), the later ones can be directly related to clinical outcomes and diabetes 
care goals, so both are presented; 
- Creatinine values (mg/dL) as a measure of renal function; 
- ALT, AST, alkaline phosphatase and gamma GT as measures of liver function. Alanine 
transaminase (ALT) and Aspartate transaminase (AST) are enzymes that measure hepatic 
lesion since they appear augmented in blood when there is a lesion, although the second 
one in not liver specific, since it also appears in red cells, skeletal and cardiac muscles; 
- Cholesterol (total, HDL and LDL), atherogenic index and triglycerides; 
- Apolipoprotein A1, B100 and their relation (A1/B100), and Lipoprotein. Apolipoprotein is 
a protein that binds lipids and is associated to cholesterol. It is classified into two types: 
the apolipoprotein A1 is synthetized in the liver and in the small intestine and is a part of 
the HDL cholesterol and has the role of simplifying the transportation of the HDL 
cholesterol to the liver; the apolipoprotein B100 is synthetized in the liver and is a part of 
the LDL cholesterol that is responsible for joining it to cellular receptors and may lead to 
atherosclerosis if accumulated in the arteries. Though, the ratio between those two 
apolipoproteins (B100/A1) may reflect the risk of developing cardiovascular disease;  
- Cell blood counts in cytometry: Leucocytes, Erythrocytes, Haemoglobin and Haematocrit, 
mean corpuscular volume (MCV), Mean corpuscular haemoglobin (MCH), Mean 
corpuscular haemoglobin concentration (MCHC), Erythrocyte variation coefficient (EVC), 
Platelet, Mean platelet volume (MPV), Plateleocrit and Platelet variation coefficient;  
- Hormonology measured Thyroid stimulating hormone (TSH) and connecting peptide 
(C-peptide) since they may affect diabetes control. 
 
Phenotyping of diabetic retinopathy includes ophthalmic characterization, psychophysical, 
and also optical coherence tomography and colour fundus photography. 
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The best corrected visual acuity (BCVA) was performed in both eyes, according to the Early 
Treatment Diabetic Retinopathy Study (ETDRS) protocol. The sequence of testing begun at 
4-meters, first in the right and then in the left eye, continuing if the eye or eyes with the 
BCVA measured at 4-meters was worse than 20/100 Snellen equivalent (fewer than 20 
letters read correctly on the 4 largest lines of the chart). In this case, the eye or eyes should 
be tested at 1 meter. 
 
The Colour Fundus photographs were taken with a resolution of at least 768x576 pixels, 
after pupil dilatation in the study eye for each patient to evaluate diabetic retinopathy and 
perform the ETDRS classification. Two 45º angular field-of-view images were acquired: one 
covering the macular region, centred on the fovea (Field 2) and one centred on the optic disc 
(Field 1M), as presented on Figure 12. At this point, intraocular pressure was also measured. 
 
Figure 12 – Modified 7-standard Fields Colour Photographs. Figure obtained from the Study Protocol. Field 1M 
(Disc), Field 2 (macula), Field 3M (temporal to macula), Field 4 (Superior Temporal), Field 5 (Inferior 
Temporal), Field 6 (Superior Nasal), Field 7 (Inferior Nasal). Font: Diamarker Study Protocol. 
 
Optical Coherence Tomography (OCT) was performed as a diagnostic imaging tool of the 
posterior segment eye structures, using low coherence interferometry to produce 
cross-sectional tomograms in those structures. An 840 nm light source emitted a probe 
beam of infrared light spitted between the eye and a reference mirror at known spatial 
locations, generating two beams that are reflected back to a photo detector. Those two 
beams are reflected back to a spectrometer, and thickness data of retina is obtained by 
measuring the time of flight delay of light back scattered from different layers in retina. 
These data are processed in an internal processor to produce enhanced images after 
adjusting for the movement of the eye and intraocular pressure variations and retinal 
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thickness is finally determined. An algorithm is used to determine the inner and outer retinal 
boundaries for each scan (several A-scans are performed, for each subject, along six B-scans 
in order to determine retinal thickness) 
The Frequency Domain Spectralis OCT (Heidelber Engineering, Heidelber, Germany) was 
used for this procedure, with software 5.4.6, and both eyes were used, at maximum 
dilatation to help insure optimal quality scans. The Macular Thickness Map was acquired for 
a volume scan 20ºx20º (in 25 sections, 10 frames, HS 512 A-scans) for each eye, and also an 
Optic Disc RNFL (retinal nerve fiber layer) thickness map was obtained (100 frames, HS RNFL 
Single Exam Report with FoDi).  
Optical Coherence Tomography is able to provide either qualitative information on 
morphology and reflectivity or quantitative information on thickness, mapping and volume, 
in real time, and is a non-invasive technique that has revolutionized the evaluation, 
treatment and prognosis of diabetic retinopathy. 
Volume scan density, in micrometers (µm), was acquired for the central subfield, within 
1mm of the centre of the macula. We also obtained the volume scan density for nasal, 
temporal, superior and inferior quadrants in the inner region (within 1 and 3 mm of the 
centre of the macula) and in the outer region, comprised between 3 and 6 mm of the centre 
of the macula, as shown in Figure 13. 
 
Figure 13 – Fields of volume scan density for Frequency Domain Spectralis OCT (Heidelber Engineering, 
Heidelber, Germany). 
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We were able to use, also, the retinal nerve fiber layers (RNFL) global thickness, on nasal and 
temporal quadrants, in micrometers (µm), and nasal superior and inferior, or temporal 
superior and inferior regions, obtained within pi mm of the centre of the macula, as shown in 
the following Figure 14: 
 
Figure 14 – RNFL quadrants for Frequency Domain Spectralis OCT (Heidelber Engineering, Heidelber, Germany). 
 
Computerized psychophysical tests from the multifunctional module of the threshold of 
visual discrimination measure the ability of subjects to detect movement (Speed test), 
achromatic contrast (Achromatic test) and chromatic contrast (according to Protan, Deutan 
and Tritan axes corresponding to distinct cone populations). All the tests use lateral, 
randomly moving pairs of dots, one being a reference point within each meridian used. 
Peripheral presented stimuli are of short duration, between 400 and 900 milliseconds, and 
also of short dimension and reduced spatial amplitude (about 1 degree of the visual angle). 
Periphery distances to the fixation point are of 7.5 visual degrees if the selected meridian 
was the 0º or 90º, or of 10 or 15 visual degrees on meridians 45º and 135º, respectively. 
Central fixation was controlled by an eye-tracker device, and that information was used in 
real time to validate the trial. If there was no central fixation, the trial would be successively 
repeated until validation. Response to each trial was given after sound stimuli, which occurs 
at the end of vertical fixation. Properties as screen background point size and central cross 
remained constant for all the tests (speed, achromatic and chromatic), and the only property 
(dependent variable) that changed was the one being analysed at each case. These tests 
return a threshold that represents the minimal difference between the properties being 
analysed to the asymptotic value at chance level. The screen background is achromatic 
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(grey) and the luminance used had a sufficient magnitude to guarantee that the test 
occurred in conditions of photopic response, that is, 30 candelas/m
2
. 
In the speed test, both points correspond to stimuli of maximum achromatic luminance 
(white), and differ only on the movement speed (one has constant velocity while the other 
starts at maximum velocity and loses acceleration until it gets closer to the reference speed, 
until as the subject is able to discriminate the faster moving point. 
Achromatic contrast discrimination or luminance test was performed defining stimuli as in 
the speed test, of short duration (400 to 900 milliseconds) and dimension, with short spatial 
amplitude (2º of visual angle). Speed of both points is equal and constant (5 visual degrees 
per second), and both are achromatic (grey), but they differ on the value of grey’s 
luminance. One point has constant luminance (reference point), and the other starts clearly 
brighter, and successively loses luminance under a staircase procedure until it reaches the 
reference point luminance, until the subject can correctly identify the brighter point. 
Chromatic contrast discrimination test was performed using the same peripheral stimuli as 
the speed discrimination test, with short duration (400 to 900 milliseconds) and dimension, 
with 2 degrees of visual angle amplitude of movement. The velocity of both points is equal 
and constant during the test, with the value of 5 visual degrees per second. The reference 
point consists in an achromatic constant stimulus (grey), while the test point has a very 
sharp colour at the beginning of the test, and successively begins to turn approximately with 
the same achromatic colour as the reference point, along the axes that isolate one type of 
cone (Protan, Deutan and Tritan, which respective deficiencies correspond to the patterns 
observed in Figure 15), until the subject correctly identifies the test point. 
These tests were performed only in the dominant eye.  
 
Figure 15 – Representation of normal and colour defects on chromatic vision. 
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5. Statistical methods 
5.1 Handling correlated data from both eyes – measures and graphics of agreement 
Naturally, as there was available data from optical coherence tomography (OCT) for both 
eyes, a critical decision should be made, along with the choice of unit of analysis. 
Although it seems obvious that if we are looking for type 2 diabetes classifiers, the unit of 
analysis is the person and only one eye should be chosen, when we are trying to develop 
models for diabetic retinopathy classification, then some confusion may arise. 
It seems that it is justifiable to waste one of the measurements since the unit of analysis is 
the person, not the eye so, another problem emerges: should we choose one eye, or the 
mean of both eyes? If we choose only one, which eye should we choose?  
The use of the mean of both eyes can be tendentious, if outliers are present. In this 
particular case, the mean can be deviated from the expected mean thus it seems more 
appropriate to use one of the eyes, even though we lose some information. 
Other criteria usually applied are the use of the best or of the worst eye. In this case, results 
may be biased, since we give an overestimation or an underestimation of the real values. 
It seems more adequate to assign measures to an eye, such as the dominant eye, or even 
better, to randomly assign one eye to study. As psychophysical tests were performed only in 
the dominant eye, it seems acceptable to choose the dominant eye from OCT to perform 
statistical analysis. However, if data from both eyes are uncorrelated, and large differences 
occur between eyes, then both eyes information should be used. According to this, initially 
we analysed correlation between two eyes measurements by applying Spearman´s rank 
order correlation due to the lack of normality, and Wilcoxon Matched pairs test for 
comparison of both eyes. 
However, and following Armstrong
32
 recommendations, other measures of agreement 
should be used, such as the intra-class correlation coefficient or concordance correlation 
coefficient. 
The Intra-class Correlation Coefficient (ICC) is recommended by Armstrong
32
 and is used to 
assess the consistency, or conformity, of measurements made by multiple observers 
measuring the same quantity, thus, it is a measure of the reliability of measurements. Since 
each eye was measured by the same instrument, we have chosen to use the ICC as a 
measure of absolute agreement, where systematic differences are relevant, instead of using 
ICC as a measure of consistency (systematic differences between measures are irrelevant). 
The value of the population intra-class correlation coefficient is a measure of the 
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homogeneity of observations within the classes of a random factor relative to the variability 
of such observations between classes. It will have the value of zero when the estimated 
effect of the random factor is zero, and it will reach the unity when the estimated effect of 
error is zero, given that the total variation of the observations is greater than zero
79
. 
Intra-class correlation coefficient can be estimated through single or average measures. The 
single measure of ICC is an index for the reliability of the ratings for one, typical single 
measure or one ratter, which is uncommonly, used in clinical reliability studies; the average 
measures model is an index for the reliability of different measures or ratters averaged 
together. Therefore, this second estimative is more useful in the case that is being studied. 
Three different models can be used to obtain that estimative: the two-way random model is 
used whenever we have random subjects and random items, measures or ratters (left and 
right eye measurements) while the two way mixed combines random subjects with fixed 
items, measures or ratters, as they are the only items, measures or ratters of interest; If we 
are interested in assessing each subject by a different set of randomly selected measures or 
ratters, then a one-way random model should be used. This model considers subject effects 
as random and its use is rare in clinical reliability studies. It seems that the two-way mixed 
model is the most appropriate for this study. 
Reliability estimates produced under the fixed or random ICC models are numerically 
identical, but their interpretation is different. Results of an analysis under the mixed effects 
model cannot be generalized to other measures or ratters; since other measures concerns 
other eyes for each person, measured by OCT, which, in fact, do not exist. 
The ICC is constructed to be applied to exchangeable measurements in which there is no 
meaningful way to order measures within a group as in this case; It does not matter which 
eye is measured first, the left or the right eye. Since ICC gives a composite of intra-observer 
and inter-observer variability, it can be difficult to interpret when observers are not 
exchangeable and alternative measures such as Cohen’s Kappa statistic or Fleiss kappa or 
concordance correlation coefficient have been proposed as more suitable measures of 
agreement among non-exchangeable observers
80
. 
From those three measures, the only one that can be applied to quantitative measurements 
is the Concordance correlation coefficient (CCC). 
The concordance correlation coefficient ρc81 evaluates the degree to which pairs of 
observations fall on the 45° line through the origin. It contains a measurement of precision ρ 
and accuracy Cb: ρc = ρCb, where ρ is a measure of precision since it is the Pearson 
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correlation coefficient, which measures how far each observation deviates from the best-fit 
line, and is a Cb is a measure of accuracy providing a bias correction factor that measures 
how far the best-fit line deviates from the 45° line through the origin.  
The concordance correlation coefficient is nearly identical to some of the measures called 
intra-class correlations. Carol Nickerson
80
 performed comparisons of the concordance 
correlation coefficient with an intra-class correlation on different data sets, and found only 
small differences between the two correlations in one case and on the third decimal.  
In this particular case, we have used a pseudo-concordance correlation coefficient (pCCC) 
determined using ρ as the Spearman correlation coefficient. As Spearman rank-order 
correlation coefficient was used for analysis, instead of Pearson’s Correlation Coefficient, 
due to the lack of normality in data distribution, a pseudo-Concordance correlation 
coefficient was determined replacing Pearson’s by Spearman’s correlation coefficient. 
Hypotheses about the value of the population correlation coefficient ρ between a pair of 
variables can be tested using the Fisher transformation
82,83
 applied to the sample correlation 
coefficient. This transformation is defined by 
  = ℎ =    ! "  
 
And it is known that Z has normal distribution with mean 
  #!#"	and standard error 
√&!'. 
The procedure for computing a statistical test to compare two correlation coefficients can 
then be performed, after transforming each correlation coefficient into a Z score (Z1 and Z2) 
and testing the difference between Z scores using the combined standard error as 
()*!)+ = , 1&*!3 + 1&+!3	where N1 and N2 are the number of pairs of scores used to determine 
Z1 and Z2, respectively. By doing this, it is easy to obtain a p-value for each comparison. 
Using the same methodology applied to the intraclass correlation coefficient, to the 
concordance correlation coefficient and pseudo-correlation coefficient, we can compute a z 
statistic for the difference between each pair of measures, since their values are measured 
in the same scale as corelation coefficient. However, comparing each pair of the three 
coefficients, type I error increases so, althought conservative, a Bonferroni correction was 
applied to each comparison. Therefore, we preferred to compare these three coefficients 
using a mountain plot. The idea of comparing these coefficients is in order to show that 
Chapter 5 
73 
concordance between eyes exists, independently of the coefficient used. 
A Mountain plot, or folded empirical cumulative distribution plot allows comparison of 2 or 
3 measurements. It computes a percentile for each ranked difference between a new 
method and a reference method. To get a folded plot, all percentiles above 50 are converted 
to a new percentile determined as new_percentile= 100 – old_percentile, and these new 
percentiles are then plotted against the differences between the two methods
84
. In this 
graph, it is easy to find 95% of the data, even when data is not normally distributed, and 
different distributions can be easily compared. 
 
Some graphical procedures can show this agreement between correlated data, such as eyes. 
Armstrong
32
 proposed the Bland and Altman Plot, but Youden Plot analysis could also be 
performed. 
Graphically, the Bland and Altman plot
44,85
 is a statistical method to compare two 
measurements techniques. In this graphical method, the differences or, alternatively, the 
ratios between the two techniques are plotted against the averages of the two techniques.  
Horizontal lines are drawn at the mean difference, and at the mean difference plus and 
minus 1.96 times the standard deviation (SD) of the differences. If the differences within 
mean ± 1.96 SD are not clinically important, the two methods may be used interchangeably.  
The plot is useful to reveal a relationship between the differences and the sample averages, 
to look for any systematic biases and to identify possible outliers.  
The Bland and Altman plot may be used to assess the repeatability of a technique by 
comparing repeated measurements using one single method on a series of subjects. In this 
case, the graph can also be used to check whether the variability or precision of a method is 
related to the size of the characteristic being measured. The original methodology of the 
Bland and Altman plot
44
 uses the differences plotted against the mean difference between 
measures (left and right eyes, in this case) but they also proposed
85
 two other 
methodologies, more useful when there is an increase in variability of the differences as the 
magnitude of the measurement increases: to plot differences as percentage of averages 
between measures or to plot ratios instead of differences. This last methodology will be 
used in this study, as there are no zero values. 
 
The Youden Plot is a graphical method to analyse inter-laboratory data, where all 
laboratories have analysed 2 samples. The plot visualises within-laboratory variability, as 
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well as between-laboratory variability. In this case, left and right eyes can be considered as 
two different laboratories, where data are correlated. 
For the original Youden plot
86
, the two samples must be similar and reasonably close in 
magnitude of the evaluated property, since the axes in this plot are drawn on the same 
scale: one unit on the x-axis has the same length as one unit on the y-axis. This is a useful 
method to evaluate correlation, as well as differences between left and right eyes. 
Each point in the plot corresponds to the results of one eye, and is defined by a first 
response variable on the horizontal axis and a second response variable 2 on the vertical 
axis.  
A horizontal median line is drawn parallel to the x-axis so that there are as many points 
above the line as there are below it. The same is done for the y-axis. Note that outliers are 
not used in determining the position of the median lines. We can then define de Manhattan 
median as the intersection point of the two median lines.  
A circle that should include 95% of the eyes is drawn, if individual systematic errors could be 
eliminated, and a 45º reference line is drawn through the Manhattan median.  
Using this information, we can state that points that lie near the 45-degree reference line 
but far from the Manhattan median indicate large systematic error, and that points that lie 
far from the 45º line indicate large random error. Points outside the circle indicate a large 
total error.  
It seems then that the Youden plot could be more likely a graphical interpretation of the 
concordance correlation coefficient. 
Adapting what is necessary, we can use different laboratories as the eyes (right and left), and 
the two samples are the two types of subjects (patients and controls); we can visualize 
variability within subjects of each group and between groups. The measures used are right 
and left eyes. 
To exemplify, we have randomly selected one patient and one measure from the OCT. Let 
A=(a1;a2) be the point that represents the values obtained respectively for the right (RE) and 
left (LE) eyes for the Nasal Superior region on the Retinal Nerve Fiber Layer measurements, 
for that given subject, and let the colour define if that subject is a control (blue) or a patient 
(red). This point A has coordinates (89; 113) and can be plotted on an orthonormal 
referential which as its origin (O) at the median values for the right and left eyes (the 
Manhathan’s Median), for that variable, that is, O = (99; 111). The 45º straight is expressed 
generally by :	. = /0 + 1,/ ≠ 0 , with / = 445º = 1  and 1 = 6789:; −
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6789=;, hence the equation of the straight is :	.  0  12 (Figure 16.A). 
The Euclidian distance from the Manhathan’s Median to A is the total error and is given by 
>?@AAAAAB>  C89 < 99  113 < 111	  10,20. As it is known, Total Error is the sum of 
random and systematic error, thus we need to determine the components of those errors 
(Figure 16.B). 
 
 
Figure 16 – Construction of a Youden plot for measurements performed in both eyes of the same subjects (A) 
and determination of the Total error of measurement between eyes (B). 
 
The Random component of the error is given by the minimal distance from A to the 45º 
straight, let’s say, the distance from A to I, with I being the interception point of the 45º 
straight (.  0  12) and a normal to this straight (let’s say s) containing the point A 
(F:	.  < G 0  1). This straight is given by F:	.  <0     and the Interception 
point I has general coordinates   H*H+IJKLHMNO!IJKLHMPO ; H*H+!IJKLHMNOIJKLHMPO ". 
For this example we have F:	.  <0  202 and   95; 107 so the Euclidian distance 
from I to A, >@AAAAB>  C89 < 95  113 < 107	  8,49 , represents the Random 
component of the error since it is the deviation from the point that is equally spaced from 
the Origin and so, it belongs to the 45º straight containing the Manhathan’s Median (Figure 
17.A). The distance from I to the origin (O) represents how far the point is from the median, 
if there was no random error, thus representing the systematic component of the error and 
is given by >?AAAAB>  C99 < 95  113 < 111	  5,66 (Figure 17.B). 
 
 
A B 
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Figure 17 – Determination of the Random (A) and systematic (B) components of the error. 
 
Since the Total Error is the sum of random and systematic errors, and as ?AAAAB  @AAAAB  ?@AAAAAB, 
the projection of these components given by ?AAAAB and @AAAAB onto the vector ?@AAAAAB can be 
expressed as a percentage of the magnitude of the total error, as observed in Figure 18: 
 
 
 
 
T8U/	VU	TV  @AAAAB?AAAAB  @AAAAB  >?@AAAAAB> 
.F7/9	VU	V  ?AAAAB?AAAAB  @AAAAB  >?@AAAAAB> 
 
 
Figure 18 – Determination of the Random and systematic errors. 
 
If the process is repeated for all the subjects in the sample, and if we sum the n squares of 
the random errors, we have a Total Variance in Random Error and the square root of the 
Variance, divided by n-1, represents the standard error of the mean random error, that is 
the standard error of the median values of right and left eyes for the Nasal Superior region 
measurements obtained by RNFL: V6=;  ,∑ =;+XYZ*M! . It is then possible to determine a 
95% confidence interval for the mean random error as the set of points that are at the same 
distance of the Manhattan Median, given by the circumference with centre in the 
Manhattan Median and radius [.\]^;M!  V6=; (Figure 19) For this example, the radius 
of the circle should be 21.58 that is, the 95% confidence interval for the mean random error 
follows the condition 0 < 99  . < 111  21,58, if all the systematic errors could 
A B 
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be eliminated. 
 
Figure 19 – Youden plot for measurements performed in both eyes of the same subjects. 
 
 
As the Youden plot is based on medians of each eye and Bland and Altman plots depend on 
the mean differences between eyes + 1.96 standard deviations, which suggests normal 
distributed data, we preferred the Youden plot method. 
 
However, we used Youden plots on another setting. For each variable obtained with OCT, we 
obtained Youden plots for controls and type 2 diabetics in order to evaluate random error of 
each group, and compare them. Random errors, for each one of the variables studied, in 
each group, are Gaussian, thus the squared radius of circles in an Youden plot follow a 
Chi-square distribution and if we use the ratio of the squared radius of patients and controls, 
we obtain a F distribution, since other values of the circles radius are constant. The number 
of degrees of freedom depends on the number of pair of eyes in analysis. Then, the 
right-sided probability associated to that F distribution is the p-value for the comparison of 
random errors in measurement for the pairs of eyes between groups, and we may establish 
which group is more likely to present higher dispersion on results, and lower concordance 
between eyes, since systematic errors should be similar between groups. 
This procedure was implemented just between controls and type 2 diabetics, and not 
between diabetic subjects with and without diabetic retinopathy, since it is expected that 
these two latest subgroups present less variability between them, as the systemic disease is 
present in both groups. 
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This procedure was developed with Microsoft Excel, and all the other methods referred 
were computed by MedCalc software (version 9.2.0.1, Frank Shoonjans, 1993-2006), and 
were evaluated at the significant level of 0.05. 
 
5.2 Computing a global measure for data obtained from each meridian in psychophysical 
tests 
Psychophysical tests (speed, achromatic and chromatic sensitivity measured in Protan, 
Tritam and Deutan axes) were measured in 4 different directions, or meridians, according to 
a given degree: at 0º, 45º, 90º and 135º. In order to have a global measure for each 
component (speed, achromatic and chromatic sensitivity), we plotted each one of the 
measures in a polar coordinate referential, obtaining four points, so that each point would 
have coordinates (ρ,θ) where ρ is the value obtained for the test at the meridian with θ 
degrees. 
For instance, if a given subject has the values of 0.88, 0.83, 0.82 and 0.90 in the speed test 
for the meridians 0º, 45º, 90º and 135º, respectively, we can plot these values on a polar 
coordinate system, obtaining Figure 20: 
 
Figure 20 – values measured for the Speed test (º/s) for each one of the meridians, plotted in a polar 
referential. 
 
If we join the point with line segments, passing at the origin of the referential, in order to 
obtain a polygon which area rises whenever a value in one of the meridian rises, we can 
trace a five-sided polygon like the one presented in the Figure 21: 
 
Figure 21 – 5-sided polygon obtained by joining the measure obtained for each meridian of the speed test (º/s), 
which represents the vertices, and the origin. 
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We may determine the area of those 5-sided polygons using the following theorem
87
: 
Let P be a simple polygon with n positive oriented vertices _L , 9 = 0,  − 1`` `` `` `` ``  such as  = _[, _, … , _M. since _M = _[. Let p be any point in the plan. Then, if _L = 0L. .L 
for 9 = 0,  − 1`` `` `` `` `` , in cartesian coordinates, then 
 @ = ∑ 0L × .L − .L × 0LM!Lb[   
 
Thus, after transforming values on polar coordinates to Cartesian coordinates, it is possible 
to have a global measure of each contrast sensitivity test. 
Cartesian coordinates are determined using the classical formula: 
 
c0 = dF7Θ. = dUFΘ  
 
Where d is the radius corresponding to the value measured in each meridian, and Θ	is the 
angle or the meridian for which the radius d was obtained. 
Polygon figures were designed using GeoGebra – Dynamic Mathematics for Everyone, 
version 4.4, a free package developed by the International GeoGebra Institute in Austria. 
 
5.3 Data reduction for classification 
At the beginning, we had one hundred variables in analysis for diabetes classification, and 
103 variables in analysis for diabetic retinopathy classification, as described in chapter 4. For 
the first goal, 96 cases were studied, and for the second aim we had 40 cases available to 
study on the training sample. 
This was the first problem since multivariate data analysis requires more cases than 
variables. It is methodologically incorrect to study more variables at once than cases 
available. 
Therefore, we started to reduce the number of variables in the analysis, by performing an 
univariate analysis for each variable in order to identify which variables could differentiate 
either diabetes presence or diabetic retinopathy presence. This was done applying an 
independent Student’s t test or a Mann-Whitney test to each one of the variables, according 
to its distribution fit to a normal, considering type (control or type 2 diabetic) or considering 
ETDRS grading divided into two categories (DR absent or DR present) as the independent 
variable. The adjustment to normal distribution was performed by the Kolmogorov-Smirnov 
test with Lillefors correction whenever we had at least 25 cases in the group and by the 
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Shapiro-Wilk test otherwise. We decided to use two independent variables instead of one 
variable with three levels (control / diabetic without DR / diabetic with DR) since there were 
some variables measured only for the diabetic group, as duration of the disease, and ETDRS 
grading. 
Those tests were performed through the Statistical Package for Social Sciences software 
(SPSS), version 20.0 (IBM Corporation, 1989-2011), and were analysed at a 5% significant 
level, although some graphics were obtained using STATISTICA, version 10, from the StatSoft 
Inc., 1984-2011, or using Microsoft Excel 2007. 
After identifying which variables were significantly different between groups, we performed 
a Receiver Operating Characteristic Curve Analysis (ROC) in order to identify which variables 
could be used as binary univariate classifiers for the presence of diabetes and for the 
presence of diabetic retinopathy in the diabetic group. This was performed using SPSS, 
version 20.0 (IBM Corporation, 1989-2011) and using the MedCalc software (version 
12.7.2.0, Frank Shoonjans, 1993-2013), particularly whenever was necessary to compare 
ROC curves for different variables, under no specific underlying distribution. 
The ROC curve was firstly used in the signal detection theory, during the Second World War 
with the intention of analysing radar signals, especially after the attack on Pearl Harbour in 
1941. Afterwards, ROC curves were applied in psychophysical to access human detection of 
weak signals and, nowadays, are extensively used in medicine, to evaluate diagnostic tests or 
in epidemiology and medical research simultaneously with evidence-based medicine. In 
radiology, it is a common method to evaluate and judge the accuracy of new radiology 
techniques. 
It is a graphical procedure which plots the true positive rate, on the Y-axis of a Cartesian 
referential, to the false positive rate, on the X-axis of that referential, at different threshold 
settings, and may be used to illustrate the performance of a binary classifier. The maximum 
possible area obtained is 1, since both axes vary between 0 and 1, forming a square with an 
area of 1. If the area is 0.5, then the test has no discriminant power, since the true positive 
rate equals the false positive rate so, thus the performed test intends to ask the question: is 
the area under the ROC curve significantly different (higher) than 0.50? 
By doing this, ROC analysis provides tools to select optimal models and discard the others, 
by using a 2x2 contingency table based on the number of True Positive (TP), True Negative 
(TN), False Positive (FP) and False Negative (FN) cases, for each possible cut-off point, as 
follows (Table 7): 
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Table 7 - General 2x2 contingency table used for ROC analysis 
 
Test Result 
Total 
Negative (f!) Positive (f) 
True condition 
(Gold Standard) 
Disease Absent (gh) f  ih  
Disease Present (g)  f i 
Total jk jl   
 
Some efforts have been made to use ROC curves in problems with more than two groups, 
but they are still very complex, and do not apply to the goals of this study. However, for the 
three group problem, the intention is to create a volume function which may represent the 
accuracy of that variable. 
We determined sensitivity (Sens), specificity (Spec) and the positive likelihood ratio (PLR) for 
variables that presented accuracy as univariate classifiers at the optimal cut-off, found by 
the determination of the maximum Youden Index (Y) which was calculated for different 
possible thresholds using the formulamUn87  7F99_9.  o79p99. < 1. 
Sensitivity is the probability of getting a positive test result (T
+
) in subjects with the disease 
(D), being computed as 7F99_9. = f|g = jrMs = jrjrt&, hence, it is related to the 
potential of a test to recognise subjects with the disease and discard with more certainty the 
presence of the condition since a test with high sensitivity is a test with few false negative 
results. Then, if a result is negative, it is most certainly a true negative case, and high 
sensitivity tests are usually applied to discard the presence of the conditions. However, if the 
test turns out to be positive, then there is a suspicious of the presence of the disease, and a 
more specific test must be performed. Therefore, tests with high sensitivity are used for 
screening of diseases. 
Specificity is a measure that is complementary to sensitivity, since it is defined as the 
proportion of subjects with negative results in the test within controls, that is, 
o79p99. = f!|gh = j&Msh = j&j&tr and it is related to the test ability to exclude the 
condition of interest. However, we should note that a test with high specificity is a test with 
few false positive cases so, if a test returns a positive result, it is most certainly a true 
positive case and high specificity tests are usually applied to confirm the presence of the 
disease. 
Neither sensitivity nor specificity is influenced by disease prevalence, so these parameters 
may be transposable for other populations. Unlike these measures, predictive values are 
dependant of the disease prevalence in the population and, therefore, predictive values 
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obtained in one study should not be used in other settings with different disease prevalence. 
The positive predictive value increases and negative predictive values decreases as the 
prevalence of the disease increases. 
The positive predictive value (PPV) is defined as the probability of having the condition or 
disease in subjects which had a positive value in the test, whereas the negative predictive 
value (NPV) refers to the probability of being healthy or having the condition absent when 
the test result is negative. However, predictive values are derived from sensitivity and 
specificity using the Bays theorem. If we think of the prevalence, as the prior probability of a 
given subject having the condition, or disease, predictive values may be thought as posterior 
probabilities for that subject to have the disease, after knowing the test result. Generally, 
predictive values are defined as: 
 
u  g|f  jrMvl 
jr
jrtr  
 
u  gh|f!  j&Mvk  j&j&t&  
 
If we want a measure of diagnostic accuracy not dependant from the prevalence of the 
disease, then it is useful to determine the Likelihood Ratios, since they reflect the link of the 
pre-test and post-test probability of a disease in a certain patient, as being defined as the 
ratio of the expected test result in subjects with a certain condition to subjects without the 
disease, quantifying how many times it is more likely that a test result is positive in subjects 
with the disease than in those without the condition. If both probabilities are equal, 
likelihood ratio is 1 and that test has no accuracy. We may then define Positive likelihood 
ratio (PLR) and Negative likelihood ratio (NLR) as: 
 
wT  rjl|irjl|ih  xJMyLzL{Lz|!x}J~LL~Lz|  
 
wT  rjk|irjk|ih  !xJMyLzL{Lz|x}J~LL~Lz|   
 
Observing these formulas, the positive likelihood ratio (PLR) reflects how much more likely is 
that a test returns positive in patients with the disease than in patients without the disease 
and is, usually, higher than 1, being the best indicator for ruling-in diagnose. On the other 
hand, the negative likelihood ratio (NLR) represents the ratio of the probability that a 
negative test result would occur in subjects with the disease, to the probability that the 
same result would occur in a control subject, that is, how much less likely is that a test turns 
negative in a patient than in a subject without the disease and is usually less than 1. 
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5.4 Statistical classification 
Statistical classification was performed using variables that presented statistical significant 
differences between groups, either concerning the absence or presence of diabetes, or 
concerning the absence or presence of diabetic retinopathy in the type 2 diabetic group. 
For the first objective which intended to find a classification function or classification 
algorithm that could separate controls from type 2 diabetics, we used the variables collected 
on the: 
- Subject 
- Age; 
- Body mass index; 
- Absence/Presence of diagnosed hypertension (blood pressure controlled by 
medication); 
- Blood Samples 
- related to the liver and billiar ductus: ALT, alkaline phosphatase and Gamma GT; 
- related to lipids: cholesterol (total, HDL, LDL), atherogenic index, triglycerides and 
apolipoprotein A1; 
- cytometry parameters: leucocytes, haemoglobin, haematocrit and erythrocytes 
variation coefficient; 
- Hormonology: Peptide C; 
- Eye 
- Best Corrected Visual Acuity; 
- Retinal Nerve Fiber Layer obtained with OCT: temporal quadrant; 
- Visual Psychophysical Tests 
- Speed test: all meridians and also the global area; 
- Achromatic contrast sensitivity: meridian 0º; 
- Chromatic contrast sensitivity 
- Protan: meridian 0º; 
- Deutan: meridian 0º and meridian 45º; 
- Tritan: all meridians (0º, 45º, 90º and 135º); 
For the second objective which was to find a classifier for diabetic retinopathy, the variables 
used were: 
- Subject 
- Duration of the disease; 
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- Blood Samples 
- cytometry parameters: erythrocytes, haemoglobin, and haematocrit; 
- Eye 
- Volume Scan obtained by OCT: Inner Nasal region; 
- Visual Psychophysical Tests 
- Chromatic contrast sensitivity 
- Deutan: meridian 0º; 
- Tritan: meridian 0º, meridian 135º, and global area; 
 
We performed classification using three different statistical methods, described later. 
Whatever the methodology used, for all classifiers obtained we determined group prediction 
based upon posterior probability for the presence of the condition (either presence of 
diabetes, in the first objective, or the presence of diabetic retinopathy, in the second 
purpose), using equal prior probabilities. Two of those methods were able to be used 
considering different prior probabilities. For instance, we could have used the prevalence of 
diabetes in the Portuguese population and the presence of diabetic retinopathy in the 
Diabetic Portuguese population as prior probabilities, but then we could not compare 
statistical classifiers since not all of them are able to consider different prior probabilities. On 
the other hand, by using equal prior probabilities, we are able to generalise statistical 
classifiers obtained for other populations or for changes on those values of prevalence. 
The accuracy of classifiers obtained was evaluated comparing the area under the ROC curves 
drawn for them, using MedCalc software (version 12.7.2.0, Frank Shoonjans, 1993-2013) 
through the methodology of DeLong
88
 for the calculation of the standard error of the area 
under the curve (AUC) and for the difference between AUC’s and, consequently, the p-values 
obtained (which were considered to be statistical significant if lower than 0,05), and with the 
determination of binomial exact confidence intervals for the AUC. Sensitivity, specificity and 
positive likelihood ratios were determined for the cut-off value of each classifier. We are 
mostly interested in getting a classifier with maximum positive likelihood ratio, despite the 
negative likelihood ratio, so that it can be used for screening. 
All the classifiers that presented a good performance on predictions were tested in a new 
sample, the test sample, described on chapter 3, and once more its performance was 
compared in this sample. This procedure could be done for type 2 diabetes classifiers, but 
not for the obtained diabetic retinopathy classifiers, since they could only be applied to 5 
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cases of the test sample, all without diabetic retinopathy. 
 
For the best statistical classifier obtained, either for type 2 diabetes, or for diabetic 
retinopathy, positive and negative predictive values were determined according to the 
respective disease prevalence. 
 
5.4.1 Development of the statistical classifiers 
Group classification was performed under three different statistical methodologies: 
discriminant analysis, logistic regression and decision trees. Each one was applied to 
determine the posterior probability for the presence of type 2 diabetes, or for presence of 
diabetic retinopathy in the type 2 diabetes group, according to the aim that is being 
considered. 
Discriminant analysis and Logistic regression methods were obtained using SPSS, version 
20.0 (IBM Corporation, 1989-2011), using a forward stepwise procedure, hence that each 
variable entering in the model would reflect the variable with more classification accuracy, 
within the group of variables left to enter. SPSS uses a general forward stepwise method on 
discriminant analysis, based on the probability of the F test (the variable is included if the 
model improves with a p-value smaller than 0.05 and the variable is excluded if that 
probability is higher than 0.10). Regarding logistic regression the forward stepwise method 
may be based upon the same general procedure, or based on the Likelihood Ratio or on the 
Wall Statistic. The best of these models of logistic regression was chosen to continue in 
analysis. 
Decision tree analysis was performed in STATISTICA (version 10, StatSoft Inc., 1984-2011) 
using the CART algorithm, the CHAID and Exhaustive CHAID algorithms and the QUEST 
algorithm. The best of models obtained was chosen to continue in analysis. 
The prior advantage of logistic regression models and decision tree analysis to discriminant 
analysis is that there are no prior assumptions in terms of distribution of the sample, but 
discriminant analysis may turn more powerful if those assumptions are met. 
 
5.4.1.1 Discriminant analysis 
As the intended classifiers are binary, only one discriminant function was obtained so the 
model is the Fisher’s Linear Discriminant Function, using the Wilk’s lambda test for stepwise 
analysis, using the SPSS package. 
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The discriminant function (and standardized discriminant function) was obtained in order to 
write the model: 
 0, 0, … 0M = 1[ + ∑ 1L × 0L}Lb   
 F88978	pn9U:	∗0, 0, … 0M = ∑ L × 0L}Lb   
 
where p is the number of variables of the model and the Β matrix (1xp) is estimated in order 
to maximize the variability of the scores of the discriminant function between groups and 
minimize it within the groups, that is, in order to maximize: 
  = xxtixx;i  
 
The classification of new and old cases may be performed using the closeness to group 
centroid, which may be done by dividing the discriminant function in two mutually exclusive 
subspaces separated by the frontier line defined previously, in Equation 4, as 
 p = M*K`*M+K`+M*M+ ,  
 
where 8̅ and 8̅ are the centroids for groups 1 and 2, respectively, and  and  the 
number of cases in each group. 
The accuracy of classifications was tested on the training sample by ROC analysis, and 
posterior probability function was developed in order to classify any new subject. 
Hence, for each one of the subjects in the training sample (0L) without missing values on the 
variables identified to belong to the discriminant function, the value obtained in that 
function (pL = p0L) was normalized in order to determine its Mahalanobis distance to each 
group centroid 8h,  = 1,2, considering the variance of the discriminant function for each 
group (F ), using the equation: 
 
8L = 8pL , 8h = Y!8h+y+ 	 ,  = 1, 2  
 
For each subject, two distances were obtained. For each group (), we know that the 
squared distances (g) follow a chi-square distribution with one degree of freedom 
(g~  so, we me may calculate the probability of obtaining that distance, given that the 
subject is classified as belonging to the group j, as: 
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g| = 	() > g  
 
Furthermore, by the Bayes theorem, we may obtain posterior probabilities for each group 
classification, using equal prior probabilities: 
 
g =
[,^×ri|
∑ [,^×ri|
+
Z*
,  = 1,2  
 
For classification purposes, the subject is classified as belonging to a group if that subject is 
on the left side or the right side of the frontier line, but we are also interested in knowing 
the posterior probability of belonging to the disease condition (which will be higher than 
50% in the group where the subject is classified into). We applied a ROC analysis to evaluate 
if there was a better frontier line for classification, and corresponding posterior probability. 
These probabilities either on the training sample or for new subjects may be automatically 
computed in a worksheet designed for the effect with Microsoft excel. 
 
Assumptions of discriminant analysis were evaluated either for the provenience of the 
samples from a multivariate normal distribution, or for the homogeneity of covariance 
matrices between groups. The first assumption was evaluated applying the 
Kolmogorov-Smirnov test when the number of cases was at least 25, or the Shapiro-Wilk test 
when the number of cases was below 25, assuming that we had a multivariate normal 
distribution if all the variables is both group were normally distributed. If this assumption is 
violated, discriminant analysis may be performed, according to Sharma
51
, since it does not 
affect type I error; it may affect type 2 error (and consequently, power) and rates of 
misclassification, in case of small samples.  
Homogeneity of covariance matrices was evaluated through the Box’s M test. The violation 
of this assumption may affect the type I error if groups do not have identical dimensions
51
. 
Two groups are said to have identical dimensions if the rate between the size of the biggest 
group and the size of the smallest group is less than 1.5, which is the case that is being 
studied, either for classification of type 2 diabetes, or classification of diabetic retinopathy. 
 
5.4.1.2 Logistic regression analysis 
The advantage of logistic regression to discriminant analysis is the lack of assumptions about 
normality and homogeneity of variance matrices. Even though, logistic regression performs 
better if independent variables are dicotomic, when compared to logistic regression models 
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that use quantitative independent variables. Therefore, variables identified as possible 
discriminators of the state being studied were dichotomized according to the cut-offs 
obtained by the application of ROC analysis, when data reduction was being performed. 
We used a forward stepwise method based on the probability of F distribution to enter a 
variable (< 0.05) or to remove a variable (> 0.10), and based on the Likelihood Ratio and on 
the Wall Statistic. We evaluated the adjustment of the model to data with the Hosmer and 
Lemeshow test, and the quality of the regression by the Nagelkerke R
2
. Is some overfitting 
was detected, either by the excellent values obtained in the two methods referred for 
regression evaluation, or because of the lack of significance on regression coefficients in a 
given step after they were significant at 5% level, the models were evaluated and some 
iterations were discarded, even if we had to lose some variables of interest.  
For this analysis, the probability of a given subject to have the condition of interest (coded 
with the value 1), as: 
 
(m = 1|0  Jl∑ YYYZ*Jl∑ YYYZ* 	U	m  1|0 
J∏ JYYYZ*
J∏ JYYYZ*
  
 
And the subject is classified as having the condition of interest if that probability is higher 
than 0.50. We performed ROC analysis on these probabilities to detect if there was a better 
cut-off for that probability. 
 
5.4.1.3 Decision Tree analysis 
Decision trees, as logistic regression, are widely used for its lack of assumptions on data 
distribution. Nowadays, the most popular algorithms for decision trees are the CART
55
, the 
CHAID
56
 or Exhaustive CHAID algorithms, and the QUEST algorithm57, thus those were the 
algorithms that we applied to grow the trees. When it was possible to define, we used equal 
prior probabilities so that algorithms could be compared, as well as with discriminant 
analysis results. On the other hand, decision tree may identify cut-offs for variables, in a 
multivariate context, which may correspond, or not, to those previously identified by ROC 
analysis.  
We used the quantitative variables, as in the discriminant analysis procedure, so that we 
could identify cut-offs for all identified variables in the model. Posterior probabilities were 
calculated based on the ratio of cases for each group in nodes composition. 
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5.4.2 Testing developed statistical classifiers 
Accuracy of developed models was compared using ROC analysis applied to the posterior 
probabilities. For group classifications, we used the Kappa coefficient of concordance to 
evaluate the percentage of correct decisions which is not due to the chance, and applied the 
McNemar test in order to evaluate if ratios of incorrect decisions were in the same 
proportion, that is, if classifiers had equal ratios of false positive and false negative decisions. 
For type 2 diabetes classifiers, it was possible to evaluate classifiers on a test sample (new 
cases) but for diabetic retinopathy classifiers, at the moment, it was not possible to evaluate 
them in new cases. 
Predictive values for the best classifiers, adjusted for disease prevalence, were determined. 
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1. Evaluation of  recommendations found in the Literature 
At this study, the outcome measures depend in general on individuals as units of 
measurement, and several parameters were collected, such as laboratory findings, liver, 
heart and brain images, visual psychophysical test measures for the dominant eye, and 
ophthalmological parameters obtained by OCT for both eyes. 
As findings will report to individuals and not to each eye, it seems adequate to use only one 
eye, and the same collected on visual tests, the dominant eye. However, we must evaluate 
correlation and differences between eyes collected for OCT. since we may be wasting useful 
data. 
 
 
2. Correlation among measurements 
Figure 21 shows that correlation between the left and right eye are strong, but not too close 
to one, and that some statistical significant asymmetries
89
 are detected on the RNFL at the 
Temporal quadrant, and at Nasal-Inferior and Nasal-Superior quadrants (Figure 22). 
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Figure 22 - Nonparametric Spearman Rank-Order Correlation Coefficient (*Statistical significant difference 
between eyes (p < 0.05) by Wilcoxon Matched-Pairs Test). 
 
As correlation coefficients for measurements of OCT Volume Scan have values between 
0.777 e 0.870 (respectively on the inner inferior and on the outer nasal quadrants) and for 
measurements of OCT RNFL are between 0.674 and 0.817 (respectively on the nasal 
quadrant and on the global measure), we can assume that there is a moderate to strong 
correlation between eyes, but not too close to one thus, according to Armstrong guidelines, 
measures of agreement between eyes should be used. On the other hand, no statistical 
significant differences between eyes were found in the Volume Scan, and few differences 
were found in RNFL (temporal, nasal-inferior and nasal-superior quadrants). In fact, 
estimates for the median difference between right and left eye, by the Hodges-Lehmann 
estimator, are +10.50 for the temporal quadrant, and -4.50 for the nasal-inferior quadrant 
and -3.00 for the nasal-superior quadrants. 
 
 
3. Concordance among measurements 
Armstrong guidelines suggest the use of measures of agreement such as the intra-class 
correlation coefficient (ICC) or the concordance correlation coefficient (CCC). As data do not 
follow a normal distribution, we used a pseudo concordance correlation coefficient (pCCC). 
These three measures of concordance are represented on Figure 23. 
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Figure 23 – Intra-class correlation coefficient, concordance correlation coefficient and pseudo-concordance 
correlation coefficient between left and right eyes on Volume Scan and RNFL. (*Statistical 
significant difference between eyes (p < 0.05) by Wilcoxon Matched-Pairs Test). 
 
The following mountain plots represented on Figure 24, shows that usually the pCC is closer 
to the ICC than the CCC, separately for coefficients obtained for volume scan and for RNFL of 
OCT: 
 
Figure 24 - Mountain plot for concordance correlation coefficient based on Pearson correlation coefficient 
(CCC) and on Spearman correlation coefficient (pCCC), compared to the Intra-class correlation 
coefficient separately for volume scan (A) and RNFL (B). 
 
In fact, a mountain plot can show that almost all absolute differences between ICC and CCC, 
either on Volume Scan or RNFL lie between 0.1 and 0.2. In fact, only 11% of the absolute 
differences in volume scan are inferior to 0.1 and none in RNFL, while 43% of absolute 
differences between ICC and the pseudo-CCC in Volume Scan are inferior to 0.1 and 44% of 
the differences is RNFL are inferior to 0.1. 
 
Comparing absolute differences between CCC and ICC (∆1) and CCC and pseudo-ICC (∆2), we 
found that ICC is closer to pseudo-CCC than to CCC in all the measures obtained for volume 
scan, and on 71.4% (5 out of the 7) regions of the RNFL analysed (table 8). 
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Table 8 - Comparison of measures of concordance. 
  
     
ICC vsersus CCC or Pseudo-CCC CCC versus Pseudo-CCC 
  
  
n ICC Measure ∆1 Ζ p Adj. p ∆2 Ζ p Adj. p 
O
C
T
 –
 V
o
lu
m
e
 S
ca
n
 
Central 
Subfield 
CCC 
98 0.690 
0.524 0.166 1.834 0.067 0.200 
-0.272 -3.486 < 0.001 0.001 
pCCC 0.796 -0.106 -1.652 0.099 0.296 
In
n
e
r 
Nasal 
CCC 
98 0.679 
0.512 0.167 1.804 0.071 0.213 
-0.307 -4.055 < 0.001 0.000 
pCCC 0.819 0.140 -2.250 0.024 0.073 
Superior 
CCC 
98 0.809 
0.677 0.132 2.072 0.038 0.115 
-0.115 -1.745 0.081 0.243 
pCCC 0.792 0.017 0.326 0.744 1.000 
Temporal 
CCC 
98 0.735 
0.579 0.156 1.920 0.055 0.165 
-0.267 -4.004 < 0.001 < 0.001 
pCCC 0.846 0.111 -2.084 0.037 0.111 
Inferior 
CCC 
98 0.715 
0.554 0.161 1.883 0.060 0.179 
-0.197 -2.420 0.016 0.047 
pCCC 0.751 0.036 -0.537 0.591 1.000 
O
u
te
r 
Nasal 
CCC 
98 0.735 
0.580 0.155 1.909 0.056 0.169 
-0.286 -4.510 < 0.001 < 0.001 
pCCC 0.866 0.131 -2.601 0.009 0.028 
Superior 
CCC 
98 0.880 
0.783 0.097 2.224 0.026 0.078 
-0.047 -0.931 0.352 1.000 
pCCC 0.830 0.050 1.293 0.196 0.588 
Temporal 
CCC 
98 0.647 
0.476 0.171 1.739 0.082 0.246 
-0.301 -3.584 < 0.001 0.001 
pCCC 0.777 0.130 -1.845 0.065 0.195 
Inferior 
CCC 
97 0.830 
0.708 0.122 2.091 0.037 0.110 
-0.122 -2.091 0.037 0.110 
pCCC 0.830 0.000 0.000 1.000 1.000 
O
C
T
- 
R
N
LF
 
Global 
CCC 
97 0.869 
0.766 0.103 2.183 0.029 0.087 
-0.044 -0.798 0.425 1.000 
pCCC 0.810 0.059 1.385 0.166 0.499 
Nasal 
CCC 
97 0.790 
0.651 0.139 2.018 0.044 0.131 
-0.020 -0.244 0.808 1.000 
pCCC 0.671 0.119 1.775 0.076 0.228 
N
a
sa
l 
Superior 
CCC 
97 0.815 
0.686 0.130 2.066 0.039 0.116 
-0.017 -0.225 0.822 1.000 
pCCC 0.703 0.112 1.841 0.066 0.197 
Inferior 
CCC 
96 0.835 
0.717 0.118 2.066 0.039 0.116 
0.011 0.152 0.879 1.000 
pCCC 0.706 0.129 2.218 0.027 0.080 
Temporal 
CCC 
96 0.846 
0.731 0.115 2.121 0.034 0.102 
-0.043 -0.678 0.498 1.000 
pCCC 0.774 0.072 1.443 0.149 0.447 
T
e
m
p
o
ra
l Superior 
CCC 
96 0.769 
0.622 0.147 1.975 0.048 0.145 
-0.052 -0.612 0.540 1.000 
pCCC 0.674 0.095 1.363 0.173 0.519 
Inferior 
CCC 
96 0.250 
0.141 0.109 0.774 0.439 1.000 
-0.382 -2.990 0.003 0.008 
pCCC 0.523 0.273 -2.217 0.027 0.080 
 
As observed in Table 8, we can only find statistical significant difference between the 
concordance correlation coefficient based on Pearson’s correlation coefficient and on 
Spearman’s correlation coefficient, but not between each one of these and the intra-class 
correlation coefficient.  
Whatever the concordance method used, we can assume that we can use the pseudo-
concordance correlation coefficient and that both eyes measurements are concordant, 
besides being correlated. 
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4. Graphical evaluation of random errors between controls and type 2 diabetics as a 
measure of concordance and accuracy of data for analysis 
Armstrong also suggests the use of Bland and Altman plots to evaluate concordance. 
However, data are not normally distributed and, consequently, the representation of mean 
differences and the interval of + 1.96 standard deviations around the mean difference may 
not be the most appropriate. Therefore, we present Youden plots, which are centred on the 
median of each eye and compare the errors between measurements performed in both 
eyes. 
Random errors between eyes are significantly higher in the diabetic group than in the 
control group for the inner-superior and inner-inferior subfields of the volume scan in OCT 
(Figure 25), but no other significant difference is found between groups in the random errors 
of measurements of both eyes, even on RNFL measures (Figure 26), meaning that the total 
error of measurement between eyes is similar between groups, with the exception of those 
regions on volume scan, since systematic error may be assumed to be constant.  
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Figure 25 – Global random error and comparison of the group 
random errors on Volume Scan OCT quadrants. 
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Figure 26 – Global random error and comparison of the group random errors on RNFL quadrants 
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 S E C T I O N  B  
 
S T A T I S T I C A L  C L A S S I F I E R S  
F O R  T Y P E  2  D I A B E T E S  
 
 
1. Training sample description 
For the training sample 96 subjects were studied, of which 49 (51.04%) were type 2 diabetics 
and 47 (48.96%) were controls for this disease (p = 0,919). 
The dominant eye was chosen for analysis. 
The best corrected visual acuity was measured in all the subjects and ranged between 0.20 
and 1.30, with a mean of 0.92 + 0.19, and at least 75% of the studied eyes had a minimum 
BCVA of 1.00. 
Intraocular pressure was measured in 50 eyes and ranged between 8 and 23 mmHg, with a 
mean of 15.08 + 3.56 mmHg, and 75% of the studied eyes had intraocular pressure below 18 
mmHg.  
Subjects were aged between 40 and 73 years at visit date, according to inclusion criteria, 
with a mean of 54.87 + 9.34 years (Table 9). 
 
Table 9 – Descriptive statistics on age and medical preliminary procedures measured in global sample. 
 N Min Max Mean SD P25 P50 P75 
Age (visit) 96 40 73 54.88 9.35 47.00 54.00 62.00 
Height (m)
*
 96 1.45 1.9 1.64 0.10 1.56 1.62 1.70 
Weight (kg)
 *
 96 45 115 74.65 14.23 63.15 73.70 84.78 
BMI (kg/m
2
) 96 18.5 43.7 27.86 4.89 24.40 26.95 31.05 
AP (cm)
 *
 54 71 140 100.28 13.44 91.75 100.00 109.25 
Pulse (bpm)
 *
 64 39 100 74.05 11.66 68.00 74.00 82.00 
SBP (mmHg) 68 100 189 130.72 20.21 115.25 127.50 145.50 
DBP (mmHg)
 *
 68 46 100 75.37 10.66 69.25 76.50 82.00 
Bioimpedance (%)
*
 40 12.3 61.9 35.32 10.44 27.30 34.10 41.23 
* Normally distributed variables 
BMI – Body mass index; AP – Abdominal perimeter; SBP – Systolic blood pressure; DBP – Diastolic blood 
pressure 
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The sample was homogeneous according to gender, eye dominance, previous family history 
of diabetes mellitus, and need for medication to control blood pressure, but, has expected, a 
predominance of the right hand for writing was observed, absence of previous gestational 
diabetes in women, and also a predominance of non-smokers, non-alcohol regular 
consumers or persons without regular exercise habits (Figure 27).  
 
Fig. 27 – Distribution of sociodemographic charateristics (Binomial Test or Adjustement Chi-square test). 
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2. Variable reduction 
2.1 Phase 1: Factors of differentiation in diabetes 
2.1.1 Clinical and demographic assessment 
There was no association between group type and characteristics such as gender, eye or 
hand dominance, and regular exercise practice but is more likely that patients with type 2 
diabetes have previous history of diabetes in family and need medication to control blood 
pressure: it also seems that there exists a tendency for controls to be smokers and regular 
alcohol consumers than diabetics, although no statistical significant association is found at 
the 5% level. (Figure 28) 
 
Figure 28 - Descriptive statistics and comparison of clinical and demographic measures assessed between 
controls and type 2 diabetics (Independence Chi-square; * Fisher exact test). 
 
Groups were not matched for age (Figure 29), and statistical significant differences were 
found in height, weight, BMI and Systolic blood pressure, with controls being around 8 years 
younger and having 2 kg/m
2
 less, in median, than patients (Table 10). 
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Figure 29 - age distribuion by group. 
 
Table 10 - Descriptive statistics and group comparison between clinical and demographic variables measured 
between controls and type 2 diabetics. 
 Type N Min Max Mean SD P25 P50 P75 p 
Age 
(visit) 
C 47 40.00 68.00 49.13 7.39 40.00 40.80 44.00 
< 0.001
**
 
D 49 45.00 73.00 60.39 7.58 46.50 49.00 54.50 
Height 
(m) 
C 47 1.50 1.90 1.66 0.10 1.53 1.55 1.58 
0.006
**
 
D 49 1.45 1.87 1.62 0.10 1.45 1.50 1.53 
Weight 
(kg) 
C 47 45.00 115.00 71.19 14.97 49.20 55.40 62.00 
0.019
*
 
D 49 53.10 104.00 77.97 12.77 53.30 60.80 68.60 
BMI 
(kg/m
2
) 
C 47 18.50 33.40 25.63 3.32 20.22 21.06 23.70 
< 0.001
**
 
D 49 21.00 43.70 30.00 5.21 22.40 23.30 26.25 
AP 
(cm) 
C 7 74.00 106.00 91.14 11.61 74.00 74.00 80.00 
0.053
*
 
D 47 71.00 140.00 101.64 13.26 76.40 85.00 94.00 
Pulse 
(bpm) 
C 15 51.00 100.00 72.33 14.64 51.00 52.20 60.00 
0.520
*
 
D 49 39.00 100.00 74.57 10.72 55.00 62.00 68.50 
SBP 
(mmHg) 
C 19 100.00 146.00 118.58 10.75 100.00 104.00 110.00 
< 0.001
*
 
D 49 101.00 189.00 135.43 21.11 105.00 110.00 116.00 
DBP 
(mmHg) 
C 19 60.00 80.00 72.95 7.04 60.00 61.00 70.00 
0.247
*
 
D 49 46.00 100.00 76.31 11.70 52.50 57.00 69.00 
Bioimpedance 
(%) 
C 1 26.40 26.40 26.40 0.00 - - - 
- 
D 39 12.30 61.90 35.55 10.47 21.20 23.90 28.80 
* Independent samples t-test; ** Mann-Whitney Test 
BMI – Body mass index; AP – Abdominal perimeter; SBP – Systolic blood pressure; DBP – Diastolic blood 
pressure 
 
Correlation analysis suggested similar profiles when analysing correlations between variables 
separately in control and patient groups. 
In controls, statistical significant correlations were found, as expected, between height and 
weight (r = 0.78; p < 0.001) or DBP (r = 0.50; p = 0.031), between weight and BMI (r = 0.89; p 
= 0.007) or SBP (r = 0.54; p = 0.017) and between BMI and abdominal perimeter (r = 0.92; p = 
0.003) or SBP (r = 0.63; p = 0.004).  
On the diabetic group, the pattern was similar, weight was correlated with BMI (r = 0.71; p < 
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0.001) and abdominal perimeter (r = 0.72; p < 0.001), being these two also correlated (r = 
0.69; p < 0.001). Moreover, in type 2 diabetics, systolic and diastolic blood pressure were 
also found to be correlated (r = 0.53; p < 0.001). 
Age was not significantly correlated with any of these measures in both groups; in the 
patients group no correlation was found to be significant or above 0.40, in absolute value, as 
observed in Figure 30. 
 
Figure 30 - Correlation between clinical and demographic variables measured in controls and in type 2 
diabetics. 
 
Aging has an important role in the natural decline of vision, and the study training sample 
was not homogenous between study groups according to age. In spite of this, we did not 
find any statistical significant correlation between age and blood tests values obtained in 
performed tests or between age and the evaluated ophthalmological procedures (OCT or 
visual psychophysical tests), either in the control group or the type 2 diabetic group. 
Hence, with multivariate statistical procedures, we may be able to determine whether 
statistical significant differences between study groups found in age, with univariate 
analysis, are due to age or to the presence of type 2 diabetes. We should point out, once 
more, that univariate comparisons between groups were performed just as an exploratory 
method to conduct a variable reduction, in order to enable multivariate classification. 
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2.1.2 Blood Tests 
2.1.2.1 Biochemistry 
As expected, and being this one of the known parameters used for the diagnosis and 
monitoring of diabetes, in spite of he expected effects of therapeutic intervention, patients 
had significantly higher levels on glucose and glycosylated haemoglobin (Table 11). 
Glycosylated haemoglobin is presented in mmol/mol, according to the International 
Federation of Clinical Chemistry (IFCC) and in percentage (%), according to the National 
Glycohemoglobin Standardization Program. Measure of glycosylated hemoglobin expressed 
as a percentage have the advantage of being directly related to clinical outcomes, in spite of 
the agreement between the American Diabetes Association (ADA), the European Association 
for the Study of Diabetes (EASD) and the International Diabetes Federation (IDF) in reporting 
values of glycosylated hemoglobin in mmol/mol. 
 
Table 11 - Descriptive statistics and group comparison of blood glucose between controls and type 2 diabetics.  
 Type N Min Max Mean SD P25 P50 P75 P 
Glucose 
C 45 74.00 124.00 90.80 10.18 83.50 89.00 95.00 
< 0.001
**
 
D 47 62.00 363.00 171.60 61.53 125.00 166.00 206.00 
HbA1C 
(NGSP) 
C 45 4.80 7.20 5.49 0.43 5.30 5.40 5.70 
< 0.001
**
 
D 48 5.20 17.30 9.46 2.38 7.70 9.30 10.88 
HbA1C 
(IFCC) 
C 45 29.00 55.00 36.47 4.75 34.00 36.00 39.00 
< 0.001
**
 
D 48 33.00 166.00 80.02 26.00 61.00 78.00 95.75 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
 
Observing biochemistry values, it seems that renal function evaluated through creatinine 
levels is similar between groups (Table 12). 
 
Table 12 – Descriptive statistics and comparison of creatinine values between controls and type 2 diabetics. 
 Type n Min Max Mean SD P25 P50 P75 p 
Creatinine 
C 45 0.42 1.19 0.73 0.17 0.61 0.73 0.86 
0.543
**
 
D 48 0.44 2.58 0.89 0.47 0.59 0.73 1.05 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
 
Some parameters of liver function, as ALT and AST, were also evaluated and, although no 
statistical significant difference was found between patients and controls on AST, patients 
showed  a significantly higher level on ALT. Note that ALT only exists in the liver and AST 
also exists on heart and muscles. Alkaline phosphatase and gamma GT, parameters related 
to the biliary ductus integrity, are significantly higher on type 2 diabetes mellitus (Table 13). 
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Table 13 - Descriptive statistics and group comparison of liver function parameters between controls and type 
2 diabetics. 
 Type N Min Max Mean SD P25 P50 P75 p 
ALT 
C 46 9.00 119.00 24.54 18.19 14.00 20.00 27.25 
0.029
**
 
D 49 9.00 81.00 30.51 17.83 18.00 25.00 36.00 
AST 
C 45 12.00 55.00 21.98 8.99 17.00 19.00 23.50 
0.094
**
 
D 49 10.00 79.00 26.33 13.54 18.00 22.00 31.50 
Alkaline 
Phosphatase 
C 46 29.00 134.00 64.07 20.14 51.00 60.00 73.25 
0.004
**
 
D 49 37.00 164.00 79.16 28.13 59.50 75.00 91.50 
Gamma GT 
C 46 9.00 83.00 28.85 18.95 15.75 22.50 34.50 
0.020
**
 
D 49 8.00 223.00 44.94 46.13 21.00 30.00 48.00 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
 
Concerning lipid parameters, we found that cholesterol levels, diabetics have better 
indicators than controls. The latters have significantly higher levels either of total cholesterol 
(p = 0.001), and of low density lipoproteins (p = 0.003). However, controls also showed 
higher levels on high density lipoproteins (p = 0.003) thus, probably, controls are at a higher 
risk but have nevertheless better levels for a putative indicator of protection concerning 
arteriosclerotic processes. The atherogenic index gives the coronary risk associated to 
problems with LDL cholesterol, and this is significantly higher in diabetics (p = 0.028). In fact, 
the atherogenic index represents the ratio between total and HDL cholesterol, so ideally, it 
should be below 5 units and, as we can observe in the following table, mean and median 
values in controls are respectively 5.5 and 3.35, and on diabetics this index has the values, 
respectively, of 9.30 and 4.00 (Table 14). 
Triglycerides are essential in terms of energetic needs, but harmful if stored in high 
quantities since they are associated with atherosclerosis and cardiovascular disorders. 
Usually, high values of triglycerides are associated to high values of LDL cholesterol or low 
values of HDL cholesterol. In this study, patients have significantly higher levels of 
triglycerides, in spite of having lower values of LDL cholesterol and higher of HDL cholesterol. 
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Table 14 - Descriptive statistics and group comparison of lipid related parameters between controls and type 2 
diabetics. 
 Type N Min Max Mean SEM P25 P50 P75 P 
Total 
Cholesterol 
C 46 117.00 292.00 200.78 5.61 175.25 197.00 227.75 
0.001
**
 
D 49 86.00 398.00 175.24 7.54 138.50 161.00 198.50 
Cholesterol 
HDL 
C 46 28.00 87.00 57.30 2.16 45.75 54.50 68.25 
< 0.001
*
 
D 49 14.00 65.00 42.18 1.63 34.00 41.00 50.00 
Atherogenic 
Index 
C 46 2.10 5.50 3.68 0.14 2.90 3.35 4.53 
0.028
**
 
D 49 2.30 9.30 4.38 0.22 3.20 4.00 5.15 
Cholesterol LDL 
C 46 67.00 198.00 133.50 4.54 114.00 133.00 151.25 
0.003
**
 
D 46 48.00 204.00 114.46 5.25 90.00 105.50 131.00 
Triglycerides 
C 46 44.00 362.00 117.72 10.35 77.50 94.00 135.25 
< 0.001
**
 
D 48 55.00 465.00 166.10 12.78 105.50 146.00 200.25 
Apolipoprotein 
A1 
C 46 82.00 250.00 165.87 4.93 142.75 161.50 186.00 
< 0.001
*
 
D 47 37.00 198.00 138.45 4.21 123.00 140.00 162.00 
Apolipoprotein 
B100 
C 46 43.00 173.00 94.48 3.31 79.00 95.50 103.25 
0.235
**
 
D 47 44.00 160.00 92.43 4.07 73.00 85.00 105.00 
B100/A1 
C 46 0.25 1.01 0.59 0.03 0.48 0.54 0.72 
0.073
**
 
D 47 0.30 2.74 0.72 0.06 0.51 0.58 0.84 
Lipoprotein 
C 45 2.33 68.00 20.13 2.47 9.31 12.10 28.05 
0.133
**
 
D 48 2.33 166.00 33.16 5.27 9.31 21.15 42.60 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
 
Apolipoprotein are families of proteins that joins lipids and are associated to cholesterol, and 
are classified into two main types: the apolipoprotein A1 is synthetized in the liver and in the 
small intestine and is a part of the HDL cholesterol and its role to facilitate the transportation 
of the HDL cholesterol to the liver; apolipoprotein B100 is synthetized in the liver and is a 
part of the LDL cholesterol that is responsible for joining it to cellular receptors and may lead 
to atherosclerosis if accumulated in the arteries. Thereby, the ratio between those two 
apolipoproteins (B100/A1) may reflect the risk of developing cardiovascular disease. 
Apparently, there is no distinction between groups either on apolipoprotein B100 levels (p = 
0.235), or in the ratio of apolipoproteins (p = 0.073), although is this last case there is a 
marginal tendency for diabetics to have higher values, which is related to the lack of 
difference in apolipoprotein B100 values and on the statistical difference on apolipoprotein 
A1 values (p < 0.001), which are lower in diabetics. 
 
2.1.2.2 Cell Blood Count Cytometry 
Circulating leucocytes are part of the immunological system acting and participating in the 
combat to eliminate microorganisms and chemical structures alien to the body partly 
through the generation of anti-bodies. We found that diabetic had significantly higher 
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number of leucocytes (p = 0.024), although no association was found between the type of 
diabetes and normal values of leucocytes (chi-square test using Monte-Carlo simulation:  = 1.000	 ∈ (1.000; 1.000)) since only two controls and three diabetic had the leucocytes 
counts below normal and only three controls and four diabetic patients had leucocytes 
counts above the usually defined as normal cut-off values (Table 15).  
 
Table 15 - Descriptive statistics and group comparison of leucocytes between controls and type 2 diabetics. 
 Type n Min Max Mean SEM P25 P50 P75 P 
Leucocytes 
C 46 3.90 15.50 6.37 0.33 4.98 5.95 6.85 
0.024
**
 
D 49 0.90 18.40 7.04 0.37 5.65 6.80 8.15 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
 
Erythrocytes counts are similar in controls and diabetics (p = 0.078), as observed in table 16, 
although there is a tendency for controls to have slightly higher number, with mean and 
median values within normal values for erythrocytes count and patients with mean and 
median slightly below the lower limit for normal values (women: 4.5 x 10
6
/mm
3
; men: 5 x 
10
6
/mm
3
). In fact, only one of the 46 controls (2.17%) presented an erythrocyte count below 
normal, being this number about eight times higher in diabetics (eight patients, 16.33%); on 
the other hand, the percentage of cases with erythrocytes counts larger than normal was 
36.96% (17 cases) in controls and 16.33% in diabetics. However, age may be acting as a 
confounding variable, thus further considerations will be evaluated with multivariate 
analysis. 
 
Table 16 - Descriptive statistics and group comparison of red cell counts between controls and type 2 diabetics. 
 Type n Min Max Mean SEM P25 P50 P75 p 
Erythrocytes 
C 46 3.76 5.67 4.53 0.06 4.16 4.44 4.89 
0.078
*
 
D 49 3.39 6.13 4.36 0.08 4.02 4.29 4.67 
Haemoglobin 
C 46 11.10 16.90 14.10 0.18 13.18 14.30 14.93 
0.004
*
 
D 49 10.30 15.70 13.29 0.20 12.25 13.10 14.65 
Haematocrit 
C 46 32.80 49.30 41.48 0.54 38.38 41.60 44.03 
0.006
*
 
D 49 30.70 48.00 39.18 0.60 35.75 38.50 43.30 
MCV 
C 46 82.30 98.20 91.14 0.54 89.60 91.35 93.35 
0.493
**
 
D 49 57.80 101.50 90.29 0.94 87.60 90.40 95.10 
MCH 
C 46 26.80 33.70 31.16 0.20 30.40 31.25 32.10 
0.242
**
 
D 49 18.70 35.00 30.65 0.34 29.50 30.90 32.00 
MCHC 
C 46 31.90 35.40 34.02 0.11 33.68 34.05 34.53 
0.546
*
 
D 49 32.40 35.60 33.92 0.12 33.35 34.00 34.50 
EVC 
C 46 11.80 15.80 13.22 0.11 12.70 13.10 13.63 
0.043
**
 
D 49 11.50 17.60 13.64 0.17 12.90 13.50 14.00 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
MCV – Mean corpuscular volume; MCH – Mean corpuscular haemoglobin; MCHC – Mean corpuscular 
haemoglobin concentration; EVC – Erythrocytes variation coefficient 
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Nevertheless, 64.21% of all cases presented normal counts of erythrocytes, 60.87% in the 
control group and 54.10% in diabetic group, suggesting an association between the presence 
of type 2 diabetes and a lower number of erythrocytes. 
In fact, the haemoglobin and the haematocrit, the ratio between the volume of all 
erythrocytes in a blood sample and the total volume of that blood sample are significantly 
lower in patients, when compared to controls (p = 0.004 and p = 0.006, respectively), as well 
as the erythrocytes variation coefficient (EVC) or the red cell distribution with, an index that 
measures variation in size, is significantly higher in patients (p = 0.043). 
However, mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), and 
mean corpuscular haemoglobin concentration (MCHC) are similar between groups. 
 
Platelets were analysed regarding to their size and quantity. We found no statistical 
significant differences (Table 17) in platelets counts, mean platelet volume (MPV) and 
plateleocrit, or even on platelet variation coefficient (PVC). 
  
Table 17 - Descriptive statistics and group comparison of platelet between controls and type 2 diabetics. 
 Type N min Max mean SEM P25 P50 P75 P 
Platelet 
C 46 141.00 461.00 233.33 10.14 186.50 222.00 248.25 
0.650
**
 
D 49 81.00 610.00 225.41 11.63 183.50 209.00 266.50 
MPV 
C 46 7.20 11.30 9.19 0.16 8.40 9.20 9.80 
0.068
*
 
D 49 7.10 13.20 9.64 0.19 8.90 9.70 10.40 
Plateleocrit 
C 46 0.13 14.00 0.51 0.30 0.18 0.20 0.24 
0.872
**
 
D 49 0.06 0.48 0.21 0.01 0.18 0.21 0.24 
PVC 
C 46 16.00 18.00 16.35 0.08 16.00 16.00 17.00 
0.285
**
 
D 48 16.00 18.00 16.50 0.09 16.00 16.00 17.00 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
MPV – Mean platelet volume; PVC – Platelet variation coefficient 
 
There was also no association between presence of diabetes and each one of the 
parameters referred categorised according to CHUC reference values, since almost all the 
values were classified within normal range of values.    
 
2.1.2.3 Hormonology 
Thyroid stimulating hormone (TSH) values were found to be identical between study groups 
(p = 0.184) but controls have significantly higher levels of the connecting peptide 
(C-peptide), as expected, since it serves as a linker between the A and B chains of insulin and 
facilitates assembly, folding and processing of insulin in the endoplasmic reticulum. It can be 
used as a marker of insulin secretion for the study of the pathophysiology of type 1 and type 
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2 diabetes (Table 18). 
 
Table 18 - Descriptive statistics and group comparison of TSH (3
rd
 generation) and Peptide C between controls 
and type 2 diabetics. 
 Type n min max mean SD P25 P50 P75 p 
TSH 
C 44 0.01 5.70 1.80 0.17 1.10 1.45 2.10 
0.184
**
 
D 48 0.10 5.10 2.06 0.17 1.13 1.95 2.48 
C-Peptide 
C 42 0.90 4.00 2.02 0.10 1.58 1.90 2.50 
0.002
**
 
D 47 0.10 4.80 1.56 0.18 0.70 1.30 2.10 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
 
In fact, 89.36% of the cases had normal values of TSH (41 controls and 43 patients), which 
represents respectively 91.11% and 87.7% of controls and diabetics. In the control group, 
only two subjects had lower values of TSH and other two had higher values of TSH, and in 
the diabetic group two and four subjects had, respectively, lower and higher values of TSH 
thus, no association was fount between diabetes and thyroid dysfunction (chi-square test 
using Monte-Carlo simulation:  = 0.877	 ∈ (0.868; 0.885)). 
Concerning the C-peptide, it is more probable to find diabetics with lower than normal levels 
than controls ( = 9.42;  = 0.002). In fact, 95.24% of controls have normal values of 
C-peptide and 70.21% of diabetics have normal values. 
 
2.1.3 Ophthalmological tests 
Intraocular pressure was identical between controls and type 2 diabetics (t48 = -0.878; p = 
0.384) but patients presented significantly lower BCVA (p = 0.001), in spite of the median of 
10/10 in both groups.   
 
2.1.3.1 Optical Coherence Tomography 
2.1.3.1.1 Volume Scan density 
The retinal structures evaluated by volume scan density could not differentiate groups, since 
no statistical significant differences were found (Table 19). The central subfield, as well as all 
the quadrants in the inner and outer regions of the macula in diabetic patients presented 
similar results when compared with controls. 
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Table 19 - Descriptive statistics and group comparison of Volume Scan measured by OCT between controls and 
type 2 diabetics. 
Volume Scan N Min Max Mean SEM P25 P50 P75 p 
Central 
Subfield 
C 46 242.00 318.00 280.91 2.68 265.00 283.00 293.00 
0.459
**
 
D 49 174.00 416.00 289.41 5.98 268.00 284.00 302.00 
In
n
e
r 
Nasal 
C 46 313.00 388.00 346.24 2.44 336.50 347.00 358.00 
0.803
**
 
D 49 242.00 415.00 344.71 4.03 335.00 345.00 356.00 
Superior 
C 46 250.00 391.00 341.98 3.12 332.75 345.50 353.25 
0.809
**
 
D 49 303.00 433.00 346.92 3.73 332.50 345.00 355.00 
Temporal 
C 46 300.00 374.00 332.22 2.27 319.50 334.00 342.25 
0.587
**
 
D 49 251.00 448.00 332.18 4.50 320.50 330.00 342.50 
Inferior 
C 46 313.00 385.00 341.26 2.38 329.75 341.00 353.00 
0.379
**
 
D 49 275.00 424.00 338.04 4.14 325.00 339.00 348.00 
O
u
te
r 
Nasal 
C 46 127.00 346.00 309.39 4.74 302.25 313.00 323.75 
0.994
**
 
D 49 262.00 416.00 315.00 3.59 302.00 311.00 323.50 
Superior 
C 46 269.00 324.00 298.39 1.93 291.75 298.50 305.25 
0.687
**
 
D 49 256.00 358.00 301.27 2.84 289.00 298.00 311.00 
Temporal 
C 46 252.00 395.00 288.17 3.22 275.75 288.50 295.50 
0.335
**
 
D 49 226.00 396.00 288.55 4.40 272.00 284.00 294.50 
Inferior 
C 46 252.00 320.00 286.54 2.49 274.75 286.50 298.00 
0.331
**
 
D 49 237.00 394.00 284.39 3.91 268.50 284.00 292.50 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
 
2.1.3.1.2 Retinal Nerve Fiber Layer 
However, it seems that subjects with type 2 diabetes have higher thickening of retinal nerve 
on the temporal field (p = 0.041), which is especially detected on the temporal inferior 
quadrant (p = 0.047) since no statistical significant differences were found on the 
temporal-superior quadrant (Table 20).  
 
Table 20 - Descriptive statistics and group comparison of Retinal Nerve Fiber Layer measured with OCT 
between controls and type 2 diabetics. 
RNFL n Min Max Mean SEM P25 P50 P75 P 
Global 
C 46 81.00 121.00 99.15 1.24 94.00 99.00 104.50 
0.916
**
 
D 48 68.00 118.00 98.17 1.45 97.00 99.00 103.75 
Nasal 
C 46 36.00 106.00 74.26 1.91 64.00 73.00 83.25 
0.881
*
 
D 48 37.00 97.00 74.65 1.73 66.00 76.00 85.00 
N
a
sa
l Superior 
C 46 51.00 151.00 106.15 3.39 88.75 107.00 124.50 
0.472
*
 
D 48 52.00 153.00 102.79 3.21 84.25 102.50 117.00 
Inferior 
C 46 87.00 175.00 125.96 3.30 112.00 125.00 140.00 
0.757
*
 
D 48 91.00 162.00 124.67 2.57 111.25 121.50 140.00 
Temporal 
C 46 46.00 106.00 68.78 1.64 61.00 67.50 76.00 
0.041
*
 
D 48 32.00 160.00 75.17 2.59 67.00 75.00 82.75 
T
e
m
p
. Superior 
C 46 80.00 192.00 140.59 3.32 127.75 142.50 156.00 
0.546
*
 
D 48 51.00 187.00 137.65 3.54 124.00 135.50 153.50 
Inferior 
C 46 86.00 186.00 132.74 4.13 112.00 132.50 157.50 
0.047
*
 
D 48 52.00 193.00 121.29 3.93 107.75 122.50 138.75 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
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2.1.3.2 Psychophysical tests 
Although aging has a role in the natural decline of vision, and sample of this study is not 
homogenous between study groups according to age, we found out that there are statistical 
significant differences between study groups on some of the areas. Later, it will be evaluated 
if differences are due to age or to the presence of type 2 diabetes. 
Psychophysical visual tests were evaluated on Speed, achromatic and chromatic vision, and 
each one of these tests was performed on meridians 0º, 45º, 90º and 135º. 
 
2.1.3.2.1 Speed 
The speed test has showed statistical significant differences in all the four meridians 
evaluated, showing also that controls always have a better performance, as observed in 
Table 21.  
 
Table 21 - Descriptive statistics and group comparison of Speed test measured in meridians 0º, 45º, 90º, 135º 
and global area generated by these meridians between controls and type 2 diabetics. 
Speed N Min Max Mean SEM P25 P50 P75 p 
M
e
ri
d
ia
n
 
0º 
C 44 0.15 2.90 1.03 0.10 0.56 0.88 1.47 
0,001
**
 
D 45 0.16 9.69 1.97 0.25 0.75 1.62 2.56 
45º 
C 44 0.16 7.46 1.27 0.19 0.48 0.83 1.62 
0,017
**
 
D 42 0.18 7.99 2.11 0.31 0.69 1.28 2.87 
90º 
C 43 0.16 4.48 1.09 0.13 0.47 0.82 1.38 
0,002
**
 
D 46 0.15 7.88 1.99 0.25 0.85 1.41 2.90 
135º 
C 44 0.16 7.13 1.13 0.16 0.58 0.90 1.32 
< 0,001
**
 
D 42 0.15 7.72 2.60 0.31 0.85 2.11 4.18 
Area 
C 40 0.18 20.13 1.64 0.50 0.41 0.83 1.47 
< 0.001
**
 
D 40 0.27 29.79 5.03 0.93 1.25 3.06 6.83 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
 
The area of the polygons generated by the median points measured in each one of the 
meridians is significantly different between controls and patients (p < 0.001), as presented 
on Figure 31.  
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Figure 31 - Speed test on meridians 0º, 45º, 90º, 135º and global area generated by these meridians in controls 
and type 2 diabetics. 
 
 
2.1.3.2.2 Achromatic contrast 
Achromatic contrast is similar in both groups (Table 22), although type 2 diabetics tends to 
have less sensitivity to achromatic contrast along meridian 90º (p = 0,005). 
 
Table 22 - Descriptive statistics and group comparison of the achromatic contrast test measured in meridians 
0º, 45º, 90º, 135º and global area generated by these meridians between controls and type 2 
diabetics. 
 N Min Max Mean SEM P25 P50 P75 P 
M
e
ri
d
ia
n
 
0º 
C 46 1.00 5.44 2.59 0.13 1.93 2.58 3.10 
0,415
**
 
D 45 1.00 10.47 2.74 0.27 1.55 2.31 3.30 
45º 
C 45 1.10 4.76 2.40 0.14 1.70 2.21 2.72 
0,081
**
 
D 43 1.20 18.72 3.46 0.45 1.80 2.64 3.76 
90º 
C 46 1.00 4.85 2.34 0.16 1.48 2.17 3.14 
0,005
**
 
D 46 1.00 8.52 3.19 0.23 2.21 2.84 3.91 
135º 
C 44 1.00 4.37 2.39 0.14 1.60 2.31 3.10 
0,305
**
 
D 42 1.00 10.77 2.94 0.31 1.48 2.60 3.50 
Area 
C 47 0.00 15.25 5.76 0.52 2.93 5.35 7.73 
0.250** 
D 49 0.00 115.30 9.95 2.43 3.48 6.39 11.83 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
 
The areas of the polygons created by the medians of each meridian, representing total 
achromatic contrast sensitivity are similar in both groups (Figure 32). 
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Figure 32 – Achromatic contrast test on meridians 0º, 45º, 90º, 135º and global area generated by these 
meridians in controls and type 2 diabetics. 
 
 
2.1.3.2.3 Chromatic Contrast 
Chromatic contrast is similar in controls and diabetics, regarding the measure obtained for 
the Protan axis, whatever the meridian evaluated, except for zero degrees, in which 
diabetics have a higher threshold for chromatic contrast sensitivity, in the Protan axis (Table 
23, Figure 33). 
 
Table 23 - Descriptive statistics and group comparison of Chromatic contrast test on the Protan axis, measured 
in meridians 0º, 45º, 90º, 135º and global area generated by these meridians between controls and 
type 2 diabetics. 
Protan n Min Max Mean SEM P25 P50 P75 P 
M
e
ri
d
ia
n
 (
x1
0
-3
) 
0º 
C 46 1.23 4.95 2.40 0.17 1.24 2.46 3.08 
0,043
**
 
D 45 1.23 9.49 3.09 0.26 1.55 3.07 4.31 
45º 
C 46 1.23 18.32 4.95 0.50 2.47 4.01 8.10 
0,747
**
 
D 44 1.23 33.96 7.13 1.16 2.25 4.83 8.42 
90º 
C 46 1.23 10.76 3.83 0.29 2.32 3.71 4.94 
0,555
**
 
D 46 1.23 27.34 4.61 0.77 1.85 3.48 5.10 
135º 
C 46 1.24 18.32 5.37 0.45 3.23 4.96 6.86 
0,462
**
 
D 42 1.23 17.05 5.27 0.54 2.47 4.20 7.44 
Area 
(x10
-6
) 
C 46 2.71 84.80 18.95 2.12 9.76 15.20 23.35 
0.980** 
D 42 2.42 453.00 31.25 10.76 7.87 15.90 27.75 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
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Figure 33 – Chromatic contrast test (Protan) on meridians 0º, 45º, 90º, 135º and global area generated by these 
meridians in controls and type 2 diabetics (meridian values should be read x10
-6
; area values 
should be read x10
-6
). 
 
The Deutan axis can discriminate patients from controls, as observed in Table 24, since the 
threshold of contrast sensitivity is lower, therefore better, in controls, at least when 
measured across the 0º and the 45º meridians (respectively p < 0.001 and p = 0.042).  
 
Table 24 - Descriptive statistics and group comparison of Chromatic contrast test on the Deutan axis, measured 
in meridians 0º, 45º, 90º, 135º and global area generated by these meridians between controls and 
type 2 diabetics. 
Deutan n Min Max Mean SD P25 P50 P75 p 
M
e
ri
d
ia
n
 (
x1
0
-3
) 
0º 
C 46 1.23 9.15 2.83 0.24 1.25 2.48 3.09 
< 0,001
**
 
D 43 1.24 55.95 6.59 1.41 2.48 4.33 7.08 
45º 
C 46 1.24 83.48 14.94 2.91 2.93 6.63 20.05 
0,042
**
 
D 41 1.24 364.53 29.21 8.98 4.99 12.15 31.43 
90º 
C 46 1.23 28.93 6.10 0.83 2.80 4.03 8.44 
0,120
**
 
D 45 1.23 86.43 14.74 3.08 2.79 4.95 15.26 
135º 
C 46 1.23 72.73 14.22 2.29 4.89 9.57 17.52 
0,379
**
 
D 40 1.23 69.83 21.24 3.39 4.38 10.40 35.71 
Area 
(x10
-6
) 
C 46 2.16 1450.00 128.78 41.18 11.83 32.15 83.85 
0.013** 
D 39 4.38 8820.00 509.06 231.72 18.10 80.90 277.00 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
 
Areas are also smaller in controls than in patients, with statistical significant differences (p = 
0.013), thus contrast sensitivity on the Deutan axis is better in controls (Figure 34). 
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Figure 34 – Chromatic contrast test (Deutan) on meridians 0º, 45º, 90º, 135º and global area generated by 
these meridians in controls and type 2 diabetics (meridian values should be read x10
-6
; area values 
should be read x10
-6
). 
 
All the meridians show higher threshold of contrast sensitivity on the Tritan axis, and the 
total contrast sensitivity on the Tritan axis, represented by the area of the polygon created 
by the medians measured in each one of the four meridians is also better in controls (p < 
0.001), as related on Table 25 and Figure 35. 
 
Table 25 - Descriptive statistics and group comparison of Chromatic contrast test on the Tritan axis, measured 
in meridians 0º, 45º, 90º, 135º and global area generated by these meridians between controls and 
type 2 diabetics. 
Tritan N Min Max Mean SD P25 P50 P75 p 
M
e
ri
d
ia
n
 (
x1
0
-3
) 
0º 
C 45 14.99 111.62 44.73 2.62 30.11 45.00 56.15 
< 0,001
**
 
D 45 25.00 401.57 85.52 11.20 43.46 57.82 99.20 
45º 
C 45 25.00 305.13 101.65 10.37 48.88 81.11 139.89 
0,005
**
 
D 42 25.00 411.62 154.10 15.38 67.32 134.06 207.98 
90º 
C 45 25.00 237.92 64.90 5.95 40.00 56.81 75.24 
< 0,001
**
 
D 46 25.00 425.51 131.91 15.83 46.66 79.45 193.50 
135º 
C 45 14.99 184.35 75.16 6.30 45.76 66.96 99.35 
0,001
**
 
D 41 35.23 568.07 160.58 19.29 54.48 129.54 238.77 
Area 
(x10
-6
) 
C 45 1070 53200 6409.11 1209.81 2730 4360 6580 
< 0.001** 
D 41 1080 140000 21004.15 4447.03 5755 9460 23350 
* 
Independent samples t-test; 
**
Mann-Whitney U Test 
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Figure 35 – Chromatic contrast test (Tritan) on meridians 0º, 45º, 90º, 135º and global area generated by these 
meridians in controls and type 2 diabetics (meridian values should be read x10
-6
; area values 
should be read x10
-6
). 
 
 
2.2 Phase 2: Univariate classifiers of Diabetes 
Receiver operating characteristic curves may be useful to detect which particular variables, 
one by one, may discriminate groups. In spite of being a procedure that does not enable the 
evaluation of interactions between variables in a set, it may be useful to identify clinically 
useful cut-offs isolated for each one of the continuous variables. 
Using variables related with clinical and demographic (Table 10), and although a statistical 
significant difference between groups was found in height, groups cannot be discriminated 
due to that variable, since area under the Receiver-Operating Characteristic curve is 0.613, 
without reaching statistical significance at the 5% level (p = 0.057). In fact, if such variable 
was used to discriminate diabetes, the sensitivity value would be of 27.45%, which is not 
admissible for clinical discrimination. As the body mass index is capable of separating groups 
and is a measure that involves either weight or height, with acceptable values either for 
sensitivity and specificity, with an area under the ROC curve statistical significant, it at least 
is preferable to use this variable. It is important to point out that if variables are 
discriminatory, they might, in this context, not be specific (in the sense of the existence of 
other clinical entities and not in the sense of specificity as defined in ROC analysis). Note that 
abdominal perimeter may also discriminate groups, as systolic blood pressure (Table 26). 
However, these parameters were measured in few cases and, hence, they will not be used 
on multivariate classifiers. On the other hand, there is a large percentage of cases with blood 
Results – Statistical classifiers for type 2 diabetes 
117 
pressure controlled by medication, therefore variables related to blood pressure would 
insert a bias on the analysis, if used. 
 
Table 26 - Accuracy of medical clinical outcome measures for univariate classification of type 2 diabetes. 
Variable AUC SEM P LBCI UBCI Cut-off Sensitivity Specificity +LR 
Height 0.613 0.06 0.056 0.501 0.726 < 1.53 27.45 97.87 12.89 
Weight 0.663 0.06 0.006 0.552 0.774 > 68.05 77.55 53.19 1.66 
BMI 0.752 0.05 < 0.001 0.654 0.850 > 26.95 71.43 72.34 2.58 
AP 0.733 0.09 0.049 0.549 0.916 > 93.50 78.72 71.43 2.76 
Pulse 0.563 0.10 0.461 0.376 0.751 - - - - 
SBP 0.735 0.06 0.003 0.616 0.854 > 131.00 61.22 94.74 11.64 
DBP 0.615 0.07 0.144 0.483 0.747 - - - - 
BMI – Body mass index; AP – Abdominal perimeter; SBP – Systolic blood pressure; DBP – Diastolic blood 
pressure. 
 
Apparently, body mass index is the variable within this set that best discriminated diabetics, 
since it is the one with highest area under the ROC curve and smallest p-value, and it is the 
only one that presents acceptable values in all the four indexes presented (sensitivity, 
specificity, positive and negative predictive values). In terms of the area under the ROC curve 
(AUC), abdominal perimeter and systolic blood pressure present similar values, but in terms 
of indexes, weight is the only variable that has all four indexes above 50%. Comparing 
discriminative power between body mass index and each one of the referred variables, we 
can state that there is a significant difference between BMI and weight (Z = 2.227; p = 
0.026), but not between BMI and abdominal perimeter (Z=0.523; p = 0.600) or BMI and 
systolic blood pressure (Z = 0.579; p = 0.563). 
 
Concerning blood tests, as expected, either glucose or glycosylated haemoglobin have 
excellent discriminant power, with no statistical significant difference between them (Z = 
0.822; p = 0.411), which means that any of them may be used to classify diabetes. Note that 
the positive likelihood ratio for glucose is higher than 49, which means that it is about 39 
times more probable to have fasting blood glucose equal or higher than 114.50 in diabetics 
than is controls. The glycosylated haemoglobin, as a metabolic control of glucose parameter, 
appears abnormal much more frequently (21 times) in diabetics than in controls (Table 27). 
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Table 27 - Accuracy of blood glucose and glycosylated haemoglobin for univariate classification of type 2 
diabetes. 
Blood AUC SEM p LBCI UBCI Cut-off Sens Spec +LR 
Glucose 0.943 0.03 < 0.001 0.884 1.000 > 114.50 87.23 97.78 39.29 
HbA1C (NGSP) 
0.972 0.02 < 0.001 0.936 1.000 
> 6.25 
93.75 95.56 21.11 
HbA1C (IFCC) > 44.50 
 
Renal function evaluated through creatinine does not allow discrimination between groups 
(AUC = 0.537; p = 0.544) and liver function but liver function may separate diabetics from 
controls. In fact, either an ALT value not lower than 26.50, or and alkaline phosphatase value 
not lower than 64.50 or even a gamma GT value not inferior to 24.50 may classify a subject 
as having diabetes with a probability always higher than 62.50% (respectively, 68.57%, 
66.67% and 62.75%), although less than 50% of diabetics have ALT values not inferior to 
26.50. This fact is reflected on the positive likelihood ratio for these variables, which is 
around 2 for each one of them (Table 28). 
 
Table 28 - Accuracy of liver function parameters for univariate classification of type 2 diabetes. 
Variable AUC SEM p LBCI UBCI Cut-off Sens Spec +LR 
ALT 0.630 0.06 0.029 0.518 0.742 > 26.50 49.98 76.09 2.09 
AST 0.600 0.06 0.095 0.486 0.714 - - - - 
Alkaline 
Phosphatase 
0.670 0.06 0.004 0.561 0.778 > 64.50 65.31 65.22 1.88 
Gamma GT 0.639 0.06 0.020 0.527 0.750 > 24.50 65.31 58.70 1.58 
 
Within lipid related parameters, the ones that most separate groups are cholesterol HDL, 
apolipoprotein A1, triglycerides and total cholesterol, cholesterol LDL and atherogenic index, 
as presented in Table 29:  
 
Table 29 - Accuracy of lipid related parameters for univariate classification of type 2 diabetes. 
Variable AUC SEM p LBCI UBCI Cut-off Sens Spec +LR 
Total Cholesterol 0.702 0.06 0.001 0.595 0.809 < 182.50 69.39 69.57 2.28 
Cholesterol HDL 0.789 0.05 < 0.001 0.699 0.879 < 45.50 69.39 76.09 2.90 
Atherogenic 
Index 
0.631 0.06 0.028 0.520 0.742 > 3.35 71.43 50.00 1.43 
Cholesterol LDL 0.682 0.06 0.003 0.569 0.795 < 114.50 63.04 76.09 2.64 
Triglycerides 0.704 0.05 0.001 0.598 0.811 > 119.00 68.75 69.57 2.26 
Apolipoprotein 
A1 
0.736 0.06 < 0.001 0.636 0.836 < 132.50 46.81 89.13 4.31 
Apolipoprotein 
B100 
0.571 0.06 0.235 0.452 0.690 - - - - 
B100/A1 0.608 0.06 0.073 0.493 0.723 - - - - 
Lipoprotein 0.590 0.06 0.136 0.473 0.707 - - - - 
 
Concerning cytometry and blood cell counts, diabetic patients tend to have higher values of 
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leucocytes and lower values of haemoglobin and haematocrit, but erythrocytes present 
higher variation coefficient in this group. Nevertheless, sensitivity of predictions based upon 
haemoglobin or haematocrit is inadequate, presenting more than 50% of false negative 
cases. The referred parameters have high specificity, which means that they may be used to 
classify presence but not absence of diabetes. Concerning the leucocyte and erythrocyte 
variation coefficient, the positive likelihood ratio is quite small compared to haematocrit and 
especially to the haemoglobin (Table 30). 
 
Table 30 - Accuracy of Blood cell counts for univariate classification of type 2 diabetes. 
Variable AUC SE P LBCI UBCI Cut-off Sens Spec +LR 
Leucocytes 0.635 0.06 0.024 0.521 0.748 > 6.55 63.27 65.22 1.82 
Erythrocytes 0.607 0.06 0.072 0.494 0.721 - - - - 
Haemoglobin 0.659 0.06 0.008 0.548 0.769 < 12.65 38.78 93.48 5.95 
Haematocrit 0.652 0.06 0.011 0.542 0.763 < 38.25 48.98 80.43 2.50 
MCV 0.46 0.06 0.439 0.427 0.665 - - - - 
MHC 0.570 0.06 0.242 0.454 0.686 - - - - 
MCHC 0.534 0.06 0.571 0.417 0.650 - - - - 
EVC 0.621 0.06 0.043 0.507 0.734 > 13.25 63.27 63.04 1.71 
Platelet 0.527 0.06 0.650 0.409 0.645 - - - - 
MPV 0.607 0.06 0.072 0.493 0.721 - - - - 
Plateleocrit 0.510 0.06 0.873 0.392 0.627 - - - - 
PVC 0.554 0.06 0.364 0.438 0.671 - - - - 
 
Hormonology parameters, such as thyroid stimulating hormone do not enable group 
discrimination (AUC = 0.590; p = 0.184) but peptide C levels can separate groups, mainly for 
confirming presence of type 2 diabetes rather than its absence, since the ratio of false 
negative cases is almost 50% (Table 31). 
 
Table 31 - Accuracy of Hormonology for univariate classification of type 2 diabetes. 
Variable AUC SE p LBCI UBCI Cut-off Sens Spec +LR 
TSH 0.590 0.06 0.184 0.462 0.699 - - - - 
C-Peptide 0.688 0.06 0.002 0.575 0.802 < 1.35 51.06 88.10 4.29 
 
Performing Receiver Operating Characteristic curve analysis on variables that presented 
significant differences, we find out that although there is a statistical significant difference 
on the retinal nerve fiber layer regarding the temporal-inferior quadrant, this measure 
cannot differentiate groups. Nevertheless, the thickening of the retinal nerve fiber layer on 
the temporal hemi field may separate diabetic patients from controls, mainly by excluding 
the presence of the disease, since the value obtained for specificity is unacceptable (Table 
32).  
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Table 32 - Accuracy of OCT tests for univariate classification of type 2 diabetes. 
Variable AUC SE p LBCI UBCI Cut-off Sens Spec +LR 
IOP 0.583 0.082 0.317 0.421 0.744 - - - - 
BVCA 0.649 0.057 0.012 0.537 0.761 < 0.90 38.78 93.48 5.95 
O
C
T
 
V
S
 
CS 0.544 0.060 0.459 0.428 0.661 - - - - 
In
n
e
r 
N 0.485 0.060 0.803 0.368 0.602 - - - - 
S 0.514 0.060 0.809 0.397 0.631 - - - - 
T 0.468 0.060 0.587 0.350 0.585 - - - - 
I 0.448 0.060 0.380 0.331 0.564 - - - - 
O
u
te
r 
N 0.500 0.060 0.994 0.383 0.618 - - - - 
S 0.524 0.060 0.688 0.406 0.642 - - - - 
T 0.443 0.060 0.335 0.326 0.559 - - - - 
I 0.442 0.060 0.331 0.326 0.558 - - - - 
R
N
F
L 
Global 0.506 0.060 0.916 0.387 0.626 - - - - 
Nasal 0.524 0.060 0.683 0.407 0.642 - - - - 
N 
S 0.465 0.060 0.563 0.347 0.583 - - - - 
I 0.483 0.060 0.782 0.365 0.602 - - - - 
Temporal 0.642 0.060 0.018 0.530 0.754 > 67.50 72.92 50.00 1.46 
T 
S 0.548 0.060 0.425 0.431 0.665 - - - - 
I 0.599 0.060 0.100 0.484 0.713 - - - - 
 
Evaluating the area under the ROC curve for each one of these psychophysical parameters 
(Figure 36), we find out that diabetic patients can be discriminated by the speed test 
integrated on the psychophysical tests, according to all meridians, being the 135º meridian 
the one that presents higher accuracy in prediction (AUC = 0,731; p < 0,001), in spite of no 
statistical difference (p = 0,186) to meridian 45º, the measure with the worst accuracy. Note 
that all of these measures may separate groups, but each one of them only presents 
acceptable values either in sensitivity, or in specificity, but not in both. Thus, if used for 
detecting diabetes, they should be applied sequentially, that is, first we should look at 
meridians 90º and 135º. Afterwards, if they present abnormal values, equal or higher than 
cut-offs defined in Table 33, and if values are also higher in meridians 0º and 45º, probably 
we have a type 2 diabetic case. Thereby, speed area involving all this four meridians may be 
used to detect diabetes, with a positive likelihood ratio of 5.25. 
  
Table 33 - Accuracy of Speed test for univariate classification of type 2 diabetes. 
Speed AUC SE p LBCI UBCI Cut-off Sens Spec +LR 
M
e
ri
d
ia
n
 0º 0.707 0.06 0.001 0.599 0.814 > 1.59 55.56 81.82 3,06 
45º 0.649 0.06 0.018 0.533 0.765 > 2.17 35.71 88.64 3,14 
90º 0.687 0.06 0.002 0.577 0.797 > 0.86 76.09 53.49 1,64 
135º 0.731 0.0 < 0.0001 0.619 0.844 > 1.62 64.29 59.09 1,57 
Area 0,728 0.06 < 0.0001 0.614 0.840 > 2.86 52.50 90.00 5.25 
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Figure 36 - ROC curve for Speed test. 
 
 
As expected, since no statistical significant differences were found in achromatic vision in 
meridians 0º, 45º and 135º, none of the values measured in each one of these three 
meridians evaluated, or even in the area of the polygons generated by the median points of 
each meridian, are capable of separating controls from patients (Figure 37). However, for 
the 90º meridian, almost 70% of type 2 diabetics have values higher than 2.32, and 65% of 
controls present values below 2.32. In fact, it is two times more probable that a value equal 
or higher than 2.32 shows in a type 2 diabetic than in a control (Table 34). 
 
Table 34 - Accuracy of Achromatic contrast sensitivity test for univariate classification of type 2 diabetes. 
Achromatic AUC SE p LBCI UBCI Cut-off Sens Spec +LR 
M
e
ri
d
ia
n
 0º 0.450 0.062 0.416 0.329 0.572 - - - - 
45º 0.608 0.061 0.082 0.488 0.727 - - - - 
90º 0.671 0.056 0.005 0.560 0.782 > 2.32 69.57 65.22 2.00 
135º 0.564 0.063 0.306 0.440 0.688 - - - - 
Area 0.580 0.06 0.179 0.463 0.696 - - - - 
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Figure 37 - ROC curve for Achromatic contrast sensitivity test. 
 
Concerning chromatic contrast sensitivity, the Tritan axis is the one that most discriminates 
groups, since we can only find discrimination between patients and diabetics relatively to 
the Protan axis at the 0º meridian, and at the 0º and 45º meridians of the Deutan axis. In the 
Tritan axis, all the four meridians enable discrimination between groups, as well as the total 
area of the polygon generated by the medians of each one of the meridians (Table 35). 
Moreover, we should point out that positive likelihood ratio is 10 for the 0º meridian. ROC 
curves for this discriminating parameters are presented on Figures 38 (Protan), 39 (Deutan) 
and 40 (Tritan). 
 
Table 35 - Accuracy of Chromatic contrast vision test for univariate classification of type 2 diabetes. 
Axis/Merid. AUC SE p LBCI UBCI Cut-off Sens Spec PPV 
C
h
ro
m
a
ti
c 
C
o
n
tr
a
st
 
P
ro
ta
n
 
0º 0.623 0.06 0.043 0.508 0.738 > 2.47 x 10
-3
 69.57 65.22 2.00 
45º 0.520 0.06 0.747 0.397 0.643 - - -  
90º 0.464 0.06 0.555 0.345 0.584 - - -  
135º 0.454 0.06 0.462 0.330 0.579 - - -  
Area 0.499 0.06 0.987 0.377 0.621 - - -  
D
e
u
ta
n
 
0º 0.725 0.05 < 0.001 0.619 0.832 > 3.40 x 10
-3
 65.12 78.26 3.00 
45º 0.627 0.06 0.042 0.509 0.745 > 8.34 x 10
-3
 60.98 63.04 1.65 
90º 0.595 0.06 0.120 0.477 0.713 - - -  
135º 0.555 0.07 0.380 0.428 0.682 - - -  
Area 0.657 0.06 0.013 0.541 0.773 - - -  
T
ri
ta
n
 
0º 0.724 0.05 < 0.001 0.620 0.828 > 67.20 x 10
-3
 44.44 95.56 10.01 
45º 0.674 0.06 0.005 0.561 0.787 > 59.99 x 10
-3
 90.48 40.00 1.51 
90º 0.715 0.05 < 0.001 0.610 0.821 > 77.13 x 10
-3
 58.70 80.00 2.94 
135º 0.716 0.06 0.001 0.605 0.828 > 109.11 x 10
-3
 60.98 82.22 3.43 
Area 0.731 0.06 < 0.001 0.624 0.829 > 6.16 x 10
-3
 75.61 71.11 2.62 
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Figure 38 - ROC curve for chromatic contrast sensitivity test (Protan). 
 
Figure 39 - ROC curve for chromatic contrast sensitivity test (Deutan). 
 
Figure 40 - ROC curve for chromatic contrast sensitivity test (Tritan). 
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3. Multivariate Models for Diabetes Classification 
The following analyses were performed using as independent variables all the previous 
categorical variables that presented association with diabetes, such as blood pressure 
controlled by medication (diagnosed hypertension), considering age, body mass index and 
best corrected visual accuracy as covariates, and all numerical variables which presented 
statistical differences between groups and achieved statistical significance in area under the 
ROC curve, such as: 
- parameters of the liver and biliar ductus: ALT, alkaline phosphatase and gamma GT; 
- parameters associated to lipids: cholesterol (total, HDL and LDL), atherogenic index, 
triglycerides and apolipoprotein A1; 
- cytometry parameters: leucocytes, haemoglobin, haematocrit and erythrocyte variation 
coefficient; 
- retinal nerve fiber layer from OCT: temporal quadrant; 
- visual psychophysical tests: speed (all meridians and global area), achromatic vision 
(meridian 0º), chromatic vision on Protan (meridian 0º), Deutan (meridians 0º and 45º) 
and Tritan (all meridians and global area) axes. 
These parameters were dichotomized by determining the optimal cut-off to use on logistic 
regression, but discriminant and decision tree models used the quantitative variables, in 
order to evaluate and compare models and to reach the best one for diabetes classification. 
Glucose levels and glycosylated haemoglobin were not considered since these were the ones 
used to diagnose diabetes. 
 
3.1 Discriminant Function Analysis 
One single discriminant function was obtained, using the Wilks’ lambda method and a 
stepwise procedure based on the F probability (< 0.050 to enter; > 0.100 to remove), and 
classification was performed based on the minimization of the within groups covariance 
matrix. 
Although numerical variables are not from a multivariate normal distribution (Figure 41) and 
covariate matrices are not homogeneous (Box’s M F(28, 13141) = 3.57; p < 0.001), 
discriminant analysis may be performed, as explained in the methods section, with the 
possible consequence of increasing the number of cases classified as diabetic; however, 
since groups are distributed in identical proportions, that is unlikely to occur. 
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Figure 41 - p-values obtained from the Kolmogorov-Smirnov or the Shapiro-Wilk test to variables in analysis 
presented as |log |, in logarithmic scale. The horizontal lines reflect the values of 0.01 
(|log 0.01|  2.00) and 0.05 (|log 0.05|  1.30) for type I errors. All bars below horizontal 
lines represent variables with normal distribution in the group. 
 
Wilk’s lambda identifies seven variables (Table 36) for group discrimination, and age was not 
identified as a separating variable, although it was initially considered as a potential 
discriminator, since groups were not matched for age. Thus, we may consider that 
coefficients of the identified variables are adjusted to age. 
 
Table 36 - Variables included in the discriminant model (Wilks’ Lambda method). 
Variables 
Wilks' Lambda 
Statistic df1 df2 df3 
Exact F 
Statistic df1 df2 Sig.  Hypertension 0.606 1 1 63 41.03 1 63 < 0.001  Chrom. Cont. Tritan (135º) 0.497 2 1 63 31.41 2 62 < 0.001  Cholesterol HDL 0.449 3 1 63 25.00 3 61 < 0.001  Peptide C 0.380 4 1 63 24.43 4 60 < 0.001  RNFL (Temporal) 0.341 5 1 63 22.77 5 59 < 0.001  Triglycerides 0.301 6 1 63 22.43 6 58 < 0.001   BMI 0.280 7 1 64 20.95 7 57 < 0.001 
 
After seven steps, one discriminant function is obtained with an eigenvalue of 2.57, 
explaining 100% of the variance, and a canonical correlation of 0.849 (λWilks=0.280: 
χ2(7)=75.77; p < 0.001) between variables entering into the model and group classification. 
The discriminant function can be written as: 
 !
  "3.233 # 1.548 # 3.274 " 0.039 " 0.998 # 0.034 # 0.008 # 0.090   
 
or, after standardizing coefficients, 
 !$
  0.606 # 0.295 " 0.490 " 0.945 # 0.548 # 0.538 # 0.345   
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Function at group centroids assume the values of -1.462 for controls and +1.706 for 
diabetics, and pairwise group comparisons show significant differences between centroids 
(F(7,57) = 20.95; p < 0.001), meaning that the function can separate or discriminate groups 
and may be used for classification. 
Classical classification may be performed using classification functions, obtained from the 
discriminant function, although we get no information about posterior probabilities. A case 
will be classified as diabetic as long as it has the value of the classification function for that 
group is higher than for the control group. The classification functions are given by: 
 
% &'())*  "59.203 − 1.820 + 5.168 + 0.457 − 1.761 + 0.327 + 0.051 + 2.213 &'())+ = −65.832 + 3.084 + 15.539 + 0.334 − 4.992 + 0.437 + 0.075 + 2.497   
 
In order to obtain posterior probabilities, classification is performed so that a new or an old 
case is classified into the group which the centroid is closer and, in this specific case of two 
groups, it can be thought as dividing the discriminant space into two mutually exclusive 
regions, defining the frontier line by the weighted mean of the centroids, which leads to the 
value , = +0.122. The notion of closeness to centroid is performed by the determination 
of the Mahalanobis distance from the score obtained in the discriminant function to the 
centroid, and based upon this it is possible to improve the classification procedure since we 
become able to determine the probability of a given subject to be classified in a group, given 
the score obtained in the discrimination function. For points in the frontier line, this 
probability is 50%. 
Using the discriminant function we can predict posterior probabilities for each subject and 
classify the subject, or new ones, according to the highest probability. For the determination 
of the posterior probabilities for a given subject, we need to obtain the squared 
Mahalanobis distances between the score obtained in the discriminant function for that 
subject, f(x), and each group centroid. These distances, -* and -+ , follow a chi-square 
distribution with one degree of freedom, and are given by: 
 
.-* = /(0)1..23-+ = /(0)4. .33   
 
Posterior probabilities are given applying Bayes rule to the probability of obtaining that 
distance given that the subjects belong to a defined group and are defined as: 
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Where  and  are the prior probabilities, which were assumed to be equal (0.50). The 
subject is classified as control or type 2 diabetic according to the highest posterior 
probability. 
 
We can apply a ROC analysis either to the discriminant function, or to the posterior 
probabilities, and a cut-off of +0,264 for the frontier line is obtained as the optimal cut-off, 
corresponding to the posterior probability of 61.04% (Table 37). This means that we may 
improve the specificity of the classification, since the number of false positive cases 
decreases, without losing sensitivity; consequently, the positive likelihood ratio increases 
three times which is preferable. Note that concordance between models is excellent thus 
any of them may be used for classification. 
 
Table 37 - Discriminant classifier accuracy using two different cut-offs for posterior probability: classical (50%) 
and obtained by ROC analysis (61,04%). 
Model AUC (p) 
Cut-off 
Function 
 
% 
Correct 
k p between 
 
McNemar 
(p) 
 Sens Spec +LR 
DF 0.985 
(< 0.001) 
0.122 
(50.00%) 
 92.31% 0.846 < 0.001 
0.949 
(p < 0.001) 
 
1.000  92.31% 92.31% 12.00 
DROC 
0.264 
(61.04%) 
 94.87% 0.897 < 0.001 
 
0.625  92.31% 97.44% 36.00 
 
On the following scaterplott of the probability for group classification (Figure 42), we can 
observe the posterior probability of belonging to the control or diabetic group according to 
the value obtained in the discriminant function, and its distance to the correspondent 
centroid. Horizontal lines mark the cut-offs defined by discriminant analysis (50%) and ROC 
analysis (61.04%) for group classification while vertical lines mark the cut-offs defined by the 
definition frontier line (0.12) or obtained by ROC analysis (0.26), used for classification in the 
discriminant function. 
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Figure 42 - Scaterplott of the probability for group (y) control (blue) or diabetic (red), based on the value of the 
discriminant funcion (d). Horizontal lines mark the cut-offs defined by discriminant analysis (50%) 
and ROC analysis (62,16%) for group classification while vertical lines mark the cut-offs defined by 
the definition frontier line (-0,12) or obtained by ROC analysis (-0,28), used for classification in the 
discriminant function; big circles mark the centroid for the discriminant function (at 50% 
probabilituy) for each group. 
 
 
3.2 Regression procedures 
When discriminant analysis fails the assumptions, it is usual to perform logistic regression. 
Logistic regression is a method designed to handle either numerical or categorical 
independent variables. Usually, logistic regression can not quantify differences in one unit of 
each independent variable, especially when there is a large dispersion, and it behaves better 
when categorical variables are used. Therefore, only categorised variables (according to 
cut-offs determined in ROC analysis) will be used, with exception to age at visit date, given 
the relevance of explaining away this variable. Initially, we intended to test both numeric 
and categorical variables in order to compare the performance of discriminant and 
regression procedures, but no model could be obtained when numerical variables were 
used. Three models are proposed in order to evaluate and compare classification power. The 
methodology was based on a forward stepwise procedure (with a probability of F to enter < 
0.050 and probability of F to remove > 0.100), based either on the conditional statistic, or 
the Likelihood Ratio (LR) or the Wald statistic. 
Basically, models obtained using the conditional statistic or the likelihood ratio lead to the 
same final results, after seven iterations, which are very similar to the results obtained when 
applying the Wald statistic and all models present statistical significant improvement in 
every step until the seventh step is reached. When variable age is included in the model, 
there is a significant improvement in models using conditional statistic or LR, but model 
which applies the Wald statistic looses significance (Table 38). 
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Table 38 - Significance of models and improvement, step by step, on forward stepwise logistic regression model 
(Conditional, Likelihood Ratio and Wald’s methods). 
Step Variable 
Improvement (
2
(df); p) Model (
2
(df); p) 
Cond. LR Wald Cond. LR Wald 
 Hypertension 27.55(1); <0.001 27.55(1); <0.001 27.55(1); <0.001 27.55(1); <0.001 27.55(1); <0.001 27.55(1); <0.001  Achrom. 90º 13.68(1); <0.001 13.68(1); <0.001 13.68(1); <0.001 41.23(2); <0.001 41.23(2); <0.001 41.23(2); <0.001  BMI 9.24(1); 0.002 9.24(1); 0.002 9.24(1); 0.002 50.47(3); <0.001 50.47(3); <0.001 50.47(3); <0.001  Alipoprotein A1 8.2(1); 0.004 8.2(1); 0.004 8.2(1); 0.004 58.67(4); <0.001 58.67(4); <0.001 58.67(4); <0.001  RNFL (T) 9.83(1); 0.002 9.83(1); 0.002 9.83(1); 0.002 68.5(5); <0.001 68.5(5); <0.001 68.5(5); <0.001  C-Peptide 7.93(1); 0.005 7.93(1); 0.005 7.93(1); 0.005 76.43(6); <0.001 76.43(6); <0.001 76.43(6); <0.001   Age 13.29(1); <0.001 13.29(1); <0.001 -8.87(1)*; 0.003 89.72(7); <0.001 89.72(7); <0.001 67.57(5); <0.001 
* a negative chi-square indicates that the chi-square value has decreased from previous step 
 
Furthermore, there is an excellent adjustment to data in every step, given by the Hosmer 
and Lemeshow test which is always not significant, and the pseudo R-squared given by 
Nagelquerke R Square shows that there is a high degree of concordance and explained 
variability given by the selected variables. However, we should not consider steps six and 
seven, since there is a notorious over-fitting of the solution found with conditional and LR 
statistic, and a loss when using the Wald statistic (Table 39). This means that, despite of 
differences in age, between groups, there must be some correlation between age and values 
of C-peptide with the other variables previously included into the model, until step 5, which 
present higher risk for development of type 2 diabetes. 
This means that despite of the differences in age, between groups, there must be some 
correlation between age and values of C-peptide with the other variables previously 
included into the model, which present higher risk for type 2 diabetes than age or C-peptide 
levels. 
 
Table 39 - Adjustment of the model, step by step, to observed data, and overall correlation. 
Step Variable 
Nagelkerque R square Hosmer and lemeshow test (
2
(df); p) 
Cond. LR Wald Cond. LR Wald  Hypertension 0.462 0.462 0.462 0(0); - 0(0); - 0(0); -  Achrom. 90º 0.628 0.628 0.628 1.72(2); 0.423 1.72(2); 0.423 1.72(2); 0.423  BMI 0.721 0.721 0.721 2.37(6); 0.883 2.37(6); 0.883 2.37(6); 0.883  Alipoprotein A1 0.794 0.794 0.794 1.42(6); 0.964 1.42(6); 0.964 1.42(6); 0.964  RNFL (T) 0.870 0.870 0.870 0.51(7); 0.999 0.51(7); 0.999 0.51(7); 0.999  C-Peptide 0.924 0.924 0.924 1.94(6); 0.925 1.94(6); 0.925 1.94(6); 0.925   Age 1.000 1.000 0.864 0.00(5); 1.000 0.00(5); 1.000 1.89(6); 0.930 
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Note that the model with best adjustment to data is reached on step six, since there is a loss 
on data adjustment between step six and steps five and four. To join this, coefficients 
obtained show statistical significance until step five, inclusive, losing their statistical 
significance if iterations go beyond step five, thus the model that will be presented for 
classification is the model obtained after five iterations. 
In fact, the performance of predictions is the presented in the nest table (Table 40), but it is 
clear that there is an over-fitting of the studied models. The model obtained at step five is 
more realistic, since it presents a good fitting and all coefficients are significant, therefore it 
is the one to be used. 
 
Table 40- Evaluation of the accuracy of developed logistic regression models. 
Step Model AUC (p) 
p 
(AUC) 
 
% 
Correct 
k p 
 
McNemar 
(p) 
 Sens Spec +LR 
Final 
Cond./
LR 
0.980 
(< 0.001) 
0.121 
 97.53% 0.951 < 0.001 
 
1.000  97.56% 97.50% 39.02 
Wald 
0.950 
(< 0.001) 
 87.80% 0.755 < 0.001 
 
0.344  92.86% 82.50% 5.31 
5 All* 
0.942 
(< 0.001) 
-  89.66% 0.793 < 0.001 
 
0.508  83.87% 90.48% 8.81 
* Cut-off for posterior probability obtained by ROC analysis presented the probability value equal or higher 
than 51.03%, resulting in the same sensitivity, specificity and positive likelihood ratios.  
 
Thereby, to avoid over-fitting and keep statistical significance of the coefficients for 
classification, the model obtained after five steps for determination of the probability for 
type 2 diabetes is  
 9F
 = GH<<.IJKLJ.MNMO<LM.NKNO@LM.PK<OMLJ.II@OJLJ.<<MOK1GH<<.IJKLJ.MNMO<LM.NKNO@LM.PK<OMLJ.II@OJLJ.<<MOK, Q ∈ R0,1T, U = 1,5VVVV 
 
Significance of model coefficients and confidence intervals for odds ratio for the model 
explicit on the previous equation are presented on the next table (Table 41): 
 
Table 41 - Odds ratio and confidence intervals for variables identified on logistic regression model (step 5). 
 B SE Wald df Sig. Odds Ratio 
95% CI for Odds Ratio 
Lower Upper 
Hypertension 6.57 2.29 8.23 1.00 0.004 711.00 8.01 63144.17 
Achrom. 90º 4.93 1.80 7.54 1.00 0.006 138.25 4.10 4664.25 
BMI 3.85 1.59 5.89 1.00 0.015 47.06 2.10 1054.84 
Alipoprotein A1 4.00 1.62 6.14 1.00 0.013 54.69 2.31 1296.07 
RNFL (T) 4.11 1.75 5.52 1.00 0.019 61.14 1.98 1889.53 
 
The traditional cut-off for this classification is the probability of 50%, thus, given a subject, 
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he will be classified as control or diabetic according to the following rule: 
 
WFU(XYZU[	U,	9F
 ≥ 0.5&]^Z_]'	U,	9(F) < 0.5   
 
However, we may perform a ROC analysis on that probability, and the obtained optimal 
cut-off is 51.03%. By lowering the cut-off, there is no gain in sensitivity or in specificity, the 
models are exactly equal, presenting a perfect agreement with the one used with the cut-off 
of 0.50 (Cohen’s kappa = 1.000; p < 0.001), hence the classical cut-off for classification will be 
used. 
 
3.3 Decision trees 
Decision trees are a multivariate process without assumptions on data distribution, except 
for multicolinearity, as logistic regression, but both handle quite well with this problem since  
decision trees are constructed based on a stepwise algorithm, as stepwise logistic 
regression. 
Trees were constructed applying the CART, the CHAID or Exhaustive CHAID, and the QUEST 
algorithms, using continuous independent variables, exception made for diagnosed 
hypertension. Moreover, decision tree analysis may identify multivariate cut-off values for 
classification.  
The obtained models were similar two by two, as observed on Figure 43: 
- the CART and the QUEST algorithms use age as the first discriminating variable, thus 
predictions may be used separately according to the age group, and markers of type 2 
diabetes are different according to age considering the cut-off of 51 years and 6 months. 
In fact, both algorithms leads to similar results in the older group (age > 51.5), since the 
loss chromatic contrast sensitivity over the Tritan axis measured at 45º is chosen as a 
classifier for diabetes, with the same cut-off obtained by ROC analysis (59.99x10
-3
), but 
while the QUEST algorithm stops splitting here, the CART algorithm splits the diabetic 
group into two more nodes, considering haemoglobin (whatever the gender) as a splitting 
variable. 
In the younger group splitting may be done using results on Speed test (CART) or body 
mass index (QUEST), and both identify diabetes with 80% probability.  
- the CHAID and the Exhaustive CHAID algorithms choose the presence of hypertension as 
the first splitting variable, classifying a subject as type 2 diabetic with 83.61% probability 
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in the presence of hypertension. For normotensive subjects, both models are able to 
identify if value measures on the 135º meridian at the Tritan axis on chromatic vision 
exceed 134x10
-3
 and, therefore, the subject is classified as a type 2 diabetic with 
probability of 87.50%. 
 
Models obtained using CART or QUEST algorithms perform quite well on the training sample, 
and with similar accuracy, evaluated by the area under the ROC curve, than models obtained 
using CHAID or Exhaustive CHAID algorithms. In fact, these two models are the ones that 
present higher sensitivity (Table 42), in spite of lower specificity which is concordant to 
statistical differences found with the McNemar test. 
  
Table 42- Evaluation of the accuracy of developed decision tree models. 
Model AUC (p) p  % Correct k p 
 
McNemar (p)  Sens Spec +LR 
T1 
0.882 
(< 0.001) 
* 
 82.29% 0.629 < 0.001 
 
0.332  82.86% 81.97% 4.59 
T2 
0.800 
(0.048) 
 80.43% 0.615 < 0.001 
 
< 0.001  94.29% 71.93% 3.36 
T3 
0.789 
(< 0.001) 
 79.35% 0.591 < 0.001 
 
0.004  91.43% 72.93% 3.26 
T4 
0.860 
(< 0.001) 
 81.25% 0.619 < 0.001 
 
0.031  88.57% 77.05% 3.86 
* No statistical differences (De Long Test) were found between area under the ROC curve for posterior 
probabilities of all pairs of decision tree models; the minimum p-value obtained, unadjusted for multiple 
comparisons, was between T1 and T3 (p = 0.052). 
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Figure 43 – Decision trees obtained with CART, CHAID / Exhaustive CHAID and QUEST algorithms. 
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1. Model Comparison – applying obtained models on a test sample 
The presented models will be identified according to the used statistical methodology: Df or 
DROC for models obtained by discriminant analysis; Lf or LROC for Logistic regression; T1 and T4 
for Decision Tree analysis. Note that models DF and DROC, or models LF or LROC give the same 
formula for determining the posterior probabilities, but they differ due to the cut-off used 
for classification. In the training sample results were the same but they are not necessarily 
equal on the test sample. 
The test sample considered 57 subjects, 30 of them controls (52.63%) and 27 diabetics 
(47.37%). Controls were aged between 41 and 72 years (53.53 + 9.20), with median 50 years, 
and type 2 diabetics were aged between 47 and 73 years old (60.11 + 7.90), with median 61 
years. However, the application of the previously developed models was possible in fewer 
cases, since not all the data are available yet. Therefore, further confirmation must be 
obtained in the future. 
Descriptive statistics obtained for the test sample are presented below (Table 43): 
 
Table 43 - Descriptive statistics on the test sample. 
  
N Min Max Mean SD P50 P25-P75 Low Risk Hight Risk 
Age 
C 30 41.00 72.00 53.63 9.20 50.00 46.25-61.75 3 (13.64%) 19 (86.36%) 
D 27 47.00 73.00 60.11 7.90 61.00 53.00-65.00 16 (76.19%) 5 (23.81%) 
BMI 
C 23 19.90 33.30 24.55 3.39 24.10 21.70-27.30 17 (73.91%) 6 (26.09%) 
D 21 20.50 38.30 30.49 4.99 30.60 26.95-34.70 5 (23.81%) 16 (76.19%) 
Cholesterol 
HDL 
C 25 33.00 75.00 58.20 13.39 57.00 47.00-72.50 20 (80%) 5 (20%) 
D 26 23.00 56.00 36.04 9.14 35.00 28.00-40.25 4 (15.38%) 22 (84.62%) 
Triglycerides 
C 25 49.00 224.00 108.52 46.33 100.00 75.50-124.00 17 (68%) 8 (32%) 
D 26 75.00 318.00 138.96 52.77 122.00 103.25-158.00 10 (38.46%) 16 (61.54%) 
Apolipoprotein 
A1 
C 26 121.00 216.00 165.27 26.12 170.50 138.75-187.25 22 (84.62%) 4 (15.38%) 
D 27 88.00 170.00 120.63 20.23 116.00 108.00-132.00 6 (22.22%) 21 (77.78%) 
Hemoglobin 
C 24 7.90 16.70 14.13 1.74 14.60 13.30-15.00 22 (91.67%) 2 (8.33%) 
D 25 9.20 16.30 13.25 1.92 13.30 11.95-14.70 14 (56%) 11 (44%) 
RNFL 
(Temporal) 
C 13 57.00 124.00 77.62 19.17 79.00 60.00-86.50 5 (38.46%) 8 (61.54%) 
D 13 45.00 84.00 62.62 11.42 62.00 53.50-71.50 10 (76.92%) 3 (23.08%) 
Achrom. 
Contrast (90º) 
C 16 1.00 3.61 2.02 0.80 2.06 1.25-2.59 11 (68.75%) 5 (31.25%) 
D 20 1.51 5.92 3.18 1.09 3.10 2.26-3.93 5 (25%) 15 (75%) 
Chrom. Cont. 
Tritan (45º) 
C 17 0.03 0.22 0.09 0.06 0.08 0.04-0.12 7 (41.18%) 10 (58.82%) 
D 12 0.05 0.37 0.17 0.11 0.18 0.06-0.24 3 (25%) 9 (75%) 
Chrom. Cont. 
Tritan (135º) 
C 17 0.02 0.26 0.11 0.07 0.11 0.03-0.16 9 (52.94%) 8 (47.06%) 
D 11 0.05 0.24 0.15 0.07 0.15 0.08-0.21 4 (36.36%) 7 (63.64%) 
Speed (Area) 
C 14 0.12 29.42 2.95 7.63 0.85 0.61-1.43 13 (92.86%) 1 (7.14%) 
D 15 0.17 8.01 1.74 1.96 1.19 0.29-2.44 14 (93.33%) 1 (6.67%) 
 
As observed in the previous table (Table 43), data were not available for all the subjects, 
considering all the variables, therefore, we tested discriminant analysis classifier in 23 
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subjects (7 controls and 16 diabetics), the logistic regression models in 33 subjects (10 
controls and 23 diabetics) and decision tree models in 57 subjects (18 controls and 39 
diabetics). 
 
The percentage of agreement observed is good to very good. Agreement was not due to 
chance, being moderate when measured by Cohen’s kappa when decision tree algorithms 
are applied, especially with the CART algorithm since the Cohen’s kappa is 0.404. 
Discriminant analysis models are the ones with higher concordance, which can be stated as 
substantial to good (k = 0.620; p = 0.002), followed by models T3 and T4, with moderate to 
substantial concordance (Table 44). All the models present similar rates of false positive and 
false negative values, since McNemar test does not detect any significant differences. 
 
Table 44 - Evaluation of developed models on the test sample – concordance and disagreement. 
Model  % Correct K P 
 
McNemar (p) 
DF  82.61% 0.620 0.002 
 
0.625 
L  81.82% 0.570 0.001  1.000 
T1  71.93% 0.404 0.002  0.210 
T2  86.67% 0.676 < 0.001  0.667 
T3  86.67% 0.502 0.001  0.667 
T4  80.70% 0.547 < 0.001 
 
1.000 
 
The model accuracy is presented by the area under the ROC curve determined for posterior 
probabilities and the 95% of expected values for sensitivity, specificity and positive likelihood 
ratio are determined (Table 45). 
 
Table 45 - Evaluation of the accuracy of the developed models on the test sample. 
Model AUC (p)  
Sensivity 
(95% CI) 
Specificity 
(95% CI) 
+LR 
(95% CI) 
DF 0.937 (0.001)  81.25% 54.4%-96.0% 85.71% 42.1%-99.6% 5.69 0.90-35.40 
L 0.935 (< 0.001)  86.96% 66.4%-97.2% 70.00% 34.8%-93.3% 2.90 1.10-7.60 
T1 0.769 (0.001)  71.79% 55.1%-85.0% 72.22% 46.5%-90.3% 2.58 1.20-5.60 
T2 0.894 (< 0.001)  87.88% 71.8%-96.6% 83.33% 51.6%-97.9% 5.27 1.50-18.80 
T3 0.894 (< 0.001)  87.88% 71.8%-96.6% 83.33% 51.6%-97.9% 5.27 1.50-18.80 
T4 0.822 (< 0.001)  87.18% 72.6%-95.7% 66.67% 41.0%-86.7% 2.62 1.30-5.10 
 
Models developed by discriminant analysis or logistic regression procedures, based on 
different cut-offs for the probability of presence of type 2 diabetes, lead to the same 
solution when applied to this test sample. Decision tree algorithms lead to different 
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solutions and the model based upon the CART algorithm (T1) presents the lowest accuracy 
(AUC = 0.769), being also the one that shows lower positive likelihood ratio, although it is 
very similar to the tree generated by the QUEST algorithm. Note that all the models present 
reasonable to good values on observed specificity, but none of them shows statistical 
significance on this parameter, since confidence intervals include the 50% value, meaning 
that specificity may be below 50% on the population. On the other hand, models obtained 
by discriminant analysis methods do not reach significance on the positive likelihood ratio, 
since value one is included in 95% confidence intervals.  
From this point of view, and as we intend to build the simplest classification model with the 
highest sensitivity for a screening purpose, as well as the highest positive likelihood ratio 
which is, in this case, related to the smallest false positive rate. Therefore, we may discard 
models obtained by discriminant analysis and decision trees based on the CART algorithm. 
On the other hand, the logistic regression model and the decision tree based on the QUEST 
algorithm (T4) present non-adequate 95% confidence intervals for specificity, which is an 
indicator that the false positive rate may be higher than 50%. These motives lead us to the 
choose the models obtained by decision tree analysis based on CHAID or Exhaustive CHAI 
algorithms, which have exactly the same solution. 
 
In clinical practice, for screening purposes, we are interested in a model that optimizes 
positive predictive values rather than negative predictive values, that is, a model that give us 
a posterior probability higher than 50% when the disease is present. As this depends on prior 
probability, that is, on prevalence of the disease, then we will have the predictive values 
presented on Figure 43, according to group’s prevalence for Portugal, published in 2013 by 
the National Observatory for Diabetes. 
In fact, models with highest positive predictive value, whichever the prevalence, are the 
ones obtained by discriminant analysis (D), CHAID (T2) and Exhaustive CHAID (T3) 
algorithms, as observed in Figure 44. In fact, these classifiers may be used with higher 
accuracy in subjects on the age group of 60 to 75 years old, or with body mass index above 
30 kg/m
2
. 
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Figure 44 – Predictive values (positive – PPV and negative – NPV) according to disease prevalence (prevalence 
data published by the National Observatory for Diabetes, in 2013). 
 
As explained before, discriminant analysis classifier will be dropped-down, and the proposed 
final model is the one obtained with CHAID or Exhaustive CHAID algorithms in decision tree 
analysis. We will use the CHAID model as it is simpler. 
 
The model may be applied mainly in subjects with at least 60 years old or with at least 30 
kg/m
2
 of body mass index, as presented on Table 46. It classifies all subjects with diagnosed 
hypertension, under treatment for this condition, as type 2 diabetics with a posterior 
probability of 82.61%. For all the other subjects, the model may be written as follows: 
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Table 46 - Expected predictive values for the final classifier of Diabetes (T2) and other indicators or accuracy, 
 
Diabetes 
Prevalence 
 
Predictive Values 
 
Accuracy and 
Concordance 
 Sensitivity and 
Specificity 
 
Likelihood 
Ratios Positive (95% CI) 
 
Negativ
e 
(95% CI) 
 
Global 12.90% 43.84% (37.27% - 50.42%) 97.89% (95.99% - 99.79%) 
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Age Group 
40-59 12.70% 43.40% (36.84% - 49.97%) 97.93% (96.04% - 99.81%) 
60-75 27.00% 66.10% (59.83% - 72.37%) 94.90% (91.98% - 97.81%) 
Gender 
Male 15.40% 48.97% (42.35% - 55.59%) 97.42% (95.32% - 99.52%) 
Age 
Group 
40-59 17.60% 52.96% (46.35% - 59.57%) 96.99% (94.72% - 99.25%) 
60-75 30.30% 69.62% (63.53% - 75.71%) 94.05% (90.92% - 97.19%) 
Female 10.60% 38.46% (32.02% - 44.91%) 98.30% (96.59% - 100.01%) 
Age 
Group 
40-59 8.20% 32.01% (25.83% - 38.19%) 98.72% (97.23% - 100.21%) 
60-75 20.30% 57.31% (50.76% - 63.87%) 96.43% (93.97% - 98.89%) 
BMI 
< 25 5.80% 24.50% (18.81% - 30.2%) 99.11% (97.87% - 100.35%) 
[25, 30[ 12.70% 43.40% (36.84% - 49.97%) 97.93% (96.04% - 99.81%) 
> 30 20.30% 57.31% (50.76% - 63.87%) 96.43% (93.97% - 98.89%) 
 
 
 S E C T I O N  C  
 
S T A T I S T I C A L  C L A S S I F I E R S  
F O R  D I A B E T I C  R E T I N O P A T H Y  
I N  T Y P E  2  D I A B E T I C S  
 
 
1. Training sample description 
From the training sample used for models obtained in Part II of the Results section, we 
performed a similar analysis for the diabetic group, in order to attempt to infer a model 
which enables classification of diabetic retinopathy. This was performed separately in order 
to use the duration of the disease, which is a known factor for retinopathy development, 
and that was only collected for these subgroups. Likewise, ETDRS grading was performed 
only for the diabetic subgroup, since the design of the study did not allow to attempt to 
identify a global diabetes and diabetic retinopathy classifier. 
For the diabetic group, the duration of the disease follows a normal distribution, although it 
has a large dispersion: values range from 1 to 39 years with mean 14.13 + 1.41 SEM. 
Diabetic patients ranged age between 45 and 73 years old, with a mean of 49.98 + 1.20 SEM 
and a median of 61 years old (inter-quartile range between 54.25 and 67 years old). ETDRS 
grading was performed in 40 of the 49 diabetic patients, and 20 of them had diabetic 
retinopathy. Considering the obtained sample, we may only attempt to identify predictors 
of the presence of diabetic retinopathy, but not of proliferative diabetic retinopathy since 
there were no cases with that condition; it was also not possible to attempt to discriminate 
subjects according to their ETDRS grading of non-proliferative diabetic retinopathy, since 
there were not enough data available in each group, as seen in Figure 45. All the subjects 
were right handed. 
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2.  
3.  
4.  
5.  
6.  
7.  
8.  
Figure 45 – Distribution of ETDRS grading 
and duration of the disease, in years. 
 
According to gender, 45.00% of the cases in the sample (18) were male, and 55.00% of the 
cases (22) were female (Binomial test: p = 0.635). In this subgroup, only four cases (18.18%) 
have been previously diagnosed with gestational diabetes (Binomial test: p = 0.007), but 
there is no registry of the number of gestations for women. Hence this parameter will not 
be considered for classification models, which could be done for the female group. 
The majority had right eye dominance (25 cases, 62.50%) and the other fifteen cases 
(37.50%) had left eye dominance (Binomial test: p = 0.155). Hereditary factor based upon 
family history of diabetes was present in 28 subjects, corresponding to 70.00% of the 
sample (Binomial test: p < 0.001). 
Regarding daily habits, only three cases (7.50%) were regular smokers (Binomial test: p < 
0.001), eight cases (20.00%) were regular drinkers (Binomial test: p = 0.003) and thirteen 
cases (32.50%) practiced regular exercise (Binomial test: p = 0.055). Three quarters of the 
sample (30 cases) had diagnosed hypertension, being currently medicated for that disease. 
Concerning quantitative variables, all of them were normally distributed and descriptive 
statistics are presented in the following table (Table 47): 
 
Table 47 – Descriptive statistics of clinical and demographic variables. 
 N Min Max Mean SD P25 P50 P75 
Height (m)
*
 40 1.45 1.87 1.61 0.02 1.53 1.61 1.68 
Weight (kg)
 *
 40 53.10 104.00 78.11 2.03 68.38 80.60 86.00 
BMI (kg/m
2
) 40 22.10 43.70 30.24 0.85 26.20 29.95 33.50 
AP (cm)
 *
 38 71.00 140.00 101.34 2.28 94.00 100.00 110.00 
Pulse (bpm)
 *
 40 39.00 100.00 74.43 1.78 68.00 74.00 82.00 
SBP (mmHg) 40 101.00 179.00 134.08 3.09 116.00 134.50 150.00 
DBP (mmHg)
 *
 40 46.00 100.00 76.73 1.91 69.25 78.00 85.00 
Bioimpedance (%)
*
 31 21.20 61.90 34.89 1.82 26.80 32.80 40.40 
* Normally distributed variables  
BMI – Body mass index; AP – Abdominal perimeter; SBP – Systolic blood pressure; DBP – Diastolic blood 
pressure 
49 Patients 40 patients performed ETDRS grading 
 Dominant eye 
 DR Absent DR present  
 20(50.00%) 20 (50.00%)   
     
 NPDR PDR  
 20 (100.00%) 0 (0.00%)  
  Mild: 10    
 Moderate: 7  
  Moderately severe: 2 
 Severe: 1   
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2. Variable reduction 
2.1 Phase 1: Factors differentiating Diabetic Retinopathy 
2.1.1 Clinical and demographic assessment 
Groups were homogeneous concerning gender and eye dominance. Note that groups were 
equally distributed regarding family history of diabetes (on both groups, the majority of the 
cases had previous family history of diabetes), diagnosed and treated hypertension and 
alcohol habits. Only a small part of the global sample corresponds to actual smokers, and 
subjects that practice regular exercise (Table 48). 
 
Table 48 - Distribution of diabetic retinopathy for factor, and association with each factor (p-values for the 
independence Chi-square test). 
 
Diabetic Retinopathy 
p 
No Yes 
Gender 
Male 7 (38.89%) 11 (61.11%) 
0.204 
Female 13 (59.09%) 9 (40.91%) 
Eye dominance 
Right 15 (60%) 10 (40%) 
0.102 
Left 5 (33.33%) 10 (66.67%) 
Family history 
No 6 (50.00%) 6 (50.00%) 
1.000 
Yes 14 (50.00%) 14 (50.00%) 
HTA 
No 5 (50.00%) 5 (50.00%) 
1.000 
Yes 15 (50.00%) 15 (50.00%) 
Smoker 
No 1 (33.33%) 2 (66.67%) 
0.597 
Yes 19 (51.35%) 18 (48.65%) 
Alcohol 
No 16 (50.00%) 16 (50.00%) 
1.000 
Yes 4 (50.00%) 4 (50.00%) 
Exercise 
No 13 (50.00%) 13 (50.00%) 
0.821 
Yes 5 (50.00%) 5 (50.00%) 
 
For the female subgroup, despite the number of pregnancies, 2 cases (15.40%) from the 
subgroup of 13 females without diabetic retinopathy had gestational diabetes, and 2 cases 
within the other 8 (25.00%) with diabetic retinopathy had gestational diabetes.  
 
Age distribution, height, weight, body mass index and bioimpedance were similar between 
type 2 diabetics without or with diabetic retinopathy. There was also no statistical significant 
difference between groups for pulse, systolic or diastolic blood pressure. Yet, and 
unsurprisingly, regarding the duration of the disease, the group with diabetic retinopathy 
had diabetes mellitus for a longer time (Table 49). In fact, the 95% confidence interval for 
the mean difference of duration of diabetes, between the group with diabetic retinopathy 
and the group without retinopathy, range between 2 and 12 years. 
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Table 49 - Descriptive statistics and group comparison of clinical and demographic variables measured between 
type 2 diabetics without and with diabetic retinopathy. 
 DR n Min Max Mean SEM P25 P50 P75 P 
Age 
(visit) 
No 20 46.00 73.00 59.50 1.87 54.25 58.00 67.00 
0.699
*
 
Yes 20 45.00 72.00 60.45 1.56 55.00 61.50 66.75 
Duration 
(Years) 
No 20 1.00 31.00 10.50 14.50 4.75 9.50 14.50 
0.008
*
 
Yes 20 3.00 39.00 17.75 30.60 19.50 21.75 30.60 
Height 
(m) 
No 20 1.45 1.84 1.60 0.02 1.53 1.58 1.68 
0.552
*
 
Yes 20 1.45 1.87 1.62 0.02 1.53 1.65 1.69 
Weight 
(kg) 
No 20 53.10 93.70 74.25 3.04 61.60 78.15 84.98 
0.108
**
 
Yes 20 63.60 104.00 81.98 2.47 71.40 82.50 88.78 
BMI 
(kg/m
2
) 
No 20 22.10 43.00 28.98 1.16 24.70 27.95 32.40 
0.139
*
 
Yes 20 23.30 43.70 31.50 1.20 27.33 31.00 34.90 
AP 
(cm) 
No 20 71.00 125.50 98.70 3.25 88.00 100.00 110.00 
0.226
*
 
Yes 18 87.00 140.00 104.28 3.13 94.75 102.00 110.00 
Pulse 
(bpm) 
No 20 39.00 100.00 73.70 3.00 67.25 75.50 81.50 
0.689
*
 
Yes 20 59.00 90.00 75.15 1.99 68.50 73.50 82.00 
SBP 
(mmHg) 
No 20 106.00 179.00 134.45 4.81 115.25 134.00 149.75 
0.905
*
 
Yes 20 101.00 158.00 133.70 4.01 117.00 135.00 150.00 
DBP 
(mmHg) 
No 20 46.00 100.00 78.40 2.62 70.50 79.00 85.50 
0.388
*
 
Yes 20 51.00 94.00 75.05 2.81 65.25 76.50 85.00 
Bioimpedance 
(%) 
No 15 21.20 61.90 35.75 3.12 25.70 31.00 47.00 
0.662
*
 
Yes 16 24.30 57.80 34.09 2.07 29.20 32.95 37.23 
*
Independent samples t-test; 
**
Mann-Whitney U test 
BMI – Body mass index; AP – Abdominal perimeter; SBP – Systolic blood pressure; DBP – Diastolic blood 
pressure. 
 
2.1.2 Blood Tests 
2.1.2.1 Biochemistry 
Groups without and with diabetic retinopathy presented similar results regarding fasting 
blood glucose levels (p = 0.622), and glycosylated haemoglobin, with mean values of 9.41 
and 9.44 on the NGSP scale (p = 0.967), respectively, and 79.40 and 79.84 on the IFCC scale 
(p = 0.959), respectively (Table 50).  
 
Table 50 - Descriptive statistics and group comparison of Blood glucose and glycosylated haemoglobin values 
between type 2 diabetics without and with diabetic retinopathy. 
 DR N Min Max Mean SEM P25 P50 P75 p 
Glucose 
No 19 96.00 291.00 166.11 11.44 125.00 164.00 210.00 
0.622* 
Yes 19 62.00 363.00 176.21 16.82 125.00 169.00 225.00 
HbA1C 
(NGSP) 
No 20 5.20 17.30 9.41 0.63 7.63 9.30 10.45 
0.967* 
Yes 19 6.30 12.60 9.44 0.44 7.80 9.30 10.90 
HbA1C 
(IFCC) 
No 20 33.00 166.00 79.40 6.87 60.25 78.00 90.50 
0.959* 
Yes 19 45.00 114.00 79.84 4.78 62.00 78.00 96.00 
*
Independent samples t-test; 
**
Mann-Whitney U test 
 
Creatinine values were similar between groups (p = 0.191), as well as the hepatic function 
and lipid related parameters, that showed no statistical differences between groups, as seen 
in the following tables (Table 51, 52 and 53).  
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Table 51 - Descriptive statistics and group comparison of creatinine values between type 2 diabetics without 
and with diabetic retinopathy. 
 DR n Min Max Mean SEM P25 P50 P75 p 
Creatinine 
No 19 0.44 2.58 0.84 0.12 0.55 0.64 0.93 
0.191** 
Yes 20 0.48 1.61 0.90 0.08 0.60 0.81 1.10 
*
Independent samples t-test; 
**
Mann-Whitney U test 
 
Liver parameters evaluated do not enable group differentiation. 
 
Table 52 - Descriptive statistics and group comparison of liver function parameters between type 2 diabetics 
without and with diabetic retinopathy. 
 DR N Min Max Mean SEM P25 P50 P75 P 
ALT 
No 20 9.00 74.00 28.05 3.72 17.25 23.50 30.75 
0.850** 
Yes 20 12.00 81.00 29.80 3.94 18.25 23.00 36.25 
AST 
No 20 12.00 45.00 21.65 1.76 17.25 19.00 23.50 
0.136** 
Yes 20 15.00 58.00 28.00 2.95 18.00 22.50 38.00 
Alkaline 
Phosphatase 
No 20 44.00 137.00 76.65 5.97 57.25 71.00 87.00 
0.440* 
Yes 20 40.00 164.00 83.85 7.03 60.25 79.00 103.00 
Gamma GT 
No 20 8.00 190.00 36.75 8.76 17.75 25.00 40.75 
0.064** 
Yes 20 12.00 223.00 50.10 10.25 28.00 37.50 61.75 
*
Independent samples t-test; 
**
Mann-Whitney U test 
 
Parameters related to lipid metabolism are identical between groups. 
 
Table 53 - Descriptive statistics and group comparison of lipid related parameters between type 2 diabetics 
without and with diabetic retinopathy. 
 DR N Min Max Mean SEM P25 P50 P75 P 
Total 
Cholesterol 
No 20 86.00 398.00 190.10 15.38 150.50 177.50 236.50 
0.126** 
Yes 20 116.00 229.00 161.65 7.91 131.75 154.00 187.00 
Cholesterol 
HDL 
No 20 28.00 65.00 44.85 2.49 35.50 43.50 54.00 
0.237* 
Yes 20 14.00 64.00 40.50 2.63 32.75 40.50 47.50 
Atherogenic 
Index 
No 20 2.50 6.50 4.25 0.28 3.18 3.70 5.50 
0.925** 
Yes 20 2.30 9.30 4.39 0.41 3.20 4.05 4.93 
Cholesterol LDL 
No 19 48.00 195.00 119.89 8.96 94.00 111.00 159.00 
0.223** 
Yes 19 71.00 175.00 105.42 6.77 79.00 100.00 123.00 
Triglycerides 
No 20 63.00 465.00 168.55 21.13 100.00 143.50 200.25 
0.527** 
Yes 19 55.00 386.00 160.05 22.07 103.00 123.00 170.00 
Apolipoprotein 
A1 
No 19 112.00 186.00 145.63 4.91 129.00 147.00 164.00 
0.166* 
Yes 19 37.00 198.00 132.00 8.30 108.00 134.00 159.00 
Apolipoprotein 
B100 
No 19 44.00 155.00 94.74 7.57 70.00 86.00 125.00 
0.479* 
Yes 19 50.00 142.00 88.16 5.22 74.00 85.00 97.00 
B100/A1 
No 19 0.33 1.12 0.65 0.05 0.50 0.56 0.85 
0.603** 
Yes 19 0.30 2.74 0.79 0.13 0.53 0.60 0.83 
Lipoprotein 
No 20 2.33 154.00 34.49 8.67 9.31 21.35 51.40 
0.430** 
Yes 19 2.40 117.00 24.59 6.12 9.31 15.20 35.90 
*
Independent samples t-test; 
**
Mann-Whitney U test 
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2.1.2.2 Cell Blood Count Cytometry 
Leucocytes do not present statistical differences between groups (Table 54). 
 
Table 54 - Descriptive statistics and group comparison of leucocytes between type 2 diabetics without and with 
diabetic retinopathy. 
 DR n Min Max Mean SEM P25 P50 P75 P 
Leucocytes 
No 20 3.80 11.60 6.85 0.42 5.45 6.75 7.70 
0.570** 
Yes 20 0.90 18.40 7.37 0.79 4.98 7.25 8.55 
*
Independent samples t-test; 
**
Mann-Whitney U test 
 
However, the group with diabetic retinopathy presents significantly lower values for 
erythrocytes, haemoglobin and haematocrit than the group which do not have diabetic 
retinopathy (Table 55). No other measures related to red cell counts differentiate these 
groups. 
 
Table 55 - Descriptive statistics and group comparison of red cell counts between type 2 diabetics without and 
with diabetic retinopathy. 
 DR N Min Max Mean SEM P25 P50 P75 p 
Erythrocytes 
No 20 3.68 5.26 4.52 0.10 4.20 4.54 4.82 
0.023** 
Yes 20 3.39 6.13 4.19 0.14 3.72 4.10 4.58 
Haemoglobin 
No 20 11.20 15.70 13.75 0.28 12.73 13.55 14.90 
0.010* 
Yes 20 11.10 15.20 12.70 0.27 11.85 12.35 13.33 
Haematocrit 
No 20 34.50 45.90 40.25 0.78 37.63 39.65 43.55 
0.014** 
Yes 20 32.90 45.20 37.41 0.84 34.58 36.10 39.48 
MCV 
No 20 81.20 98.50 89.18 0.84 87.23 88.90 91.63 
0.159** 
Yes 20 57.80 101.50 90.25 2.02 87.83 90.70 95.85 
MCH 
No 20 27.60 32.80 30.45 0.33 29.33 31.00 31.28 
0.304** 
Yes 20 18.70 35.00 30.68 0.74 29.75 30.70 32.88 
MCHC 
No 20 32.50 35.50 34.14 0.19 33.55 34.20 34.83 
0.501* 
Yes 20 32.40 35.60 33.97 0.17 33.63 34.05 34.40 
EVC 
No 20 11.60 16.30 13.49 0.26 12.83 13.15 14.55 
0.144** 
Yes 20 12.30 17.60 14.01 0.28 13.33 13.70 14.55 
*
Independent samples t-test; 
**
Mann-Whitney U test 
MCV – Mean corpuscular volume; MCH – Mean corpuscular haemoglobin; MCHC – Mean corpuscular 
haemoglobin concentration; EVC – Erythrocytes variation coefficient 
 
None of the measures related to platelet show statistical differences between groups, as 
observed in Table 56: 
 
 
 
 
 
 
Results – Statistical classifiers for diabetic retinopathy in type 2 diabetics 
145 
Table 56 - Descriptive statistics and group comparison of platelet between type 2 diabetics without and with 
diabetic retinopathy. 
 DR N Min Max Mean SEM P25 P50 P75 p 
Platelet 
No 20 90.00 610.00 242.95 22.22 194.50 220.00 265.25 
0.091** 
Yes 20 81.00 322.00 203.50 13.86 166.00 190.50 264.50 
MPV 
No 20 7.90 11.20 9.44 0.18 9.00 9.30 9.88 
0.583* 
Yes 20 7.10 13.10 9.66 0.35 8.38 9.60 10.63 
Plateleocrit 
No 20 0.09 0.48 0.23 0.02 0.19 0.22 0.25 
0.125** 
Yes 20 0.06 0.27 0.19 0.01 0.17 0.20 0.24 
PVC 
No 20 16.00 18.00 16.35 0.13 16.00 16.00 17.00 
0.066** 
Yes 20 16.00 18.00 16.70 0.15 16.00 17.00 17.00 
*
Independent samples t-test; 
**
Mann-Whitney U test 
MPV – Mean platelet volume; PVC – Platelet variation coefficient 
 
2.1.2.3 Hormonology 
Likewise, hormonology parameters measured in these groups were similar (Table 57). 
 
Table 57 - Descriptive statistics and group comparison of TSH and C-Peptide between type 2 diabetics without 
and with diabetic retinopathy. 
 DR N Min max mean SEM P25 P50 P75 p 
TSH 
No 19 0.53 5.10 2.20 0.28 1.30 1.90 2.90 
0.779** 
Yes 20 0.74 5.10 2.10 0.28 1.13 1.90 2.48 
C-Peptide 
No 20 0.10 4.80 1.66 0.30 0.63 1.40 2.55 
0.545** 
Yes 19 0.10 4.40 1.37 0.28 0.20 1.30 1.80 
*
Independent samples t-test; 
**
Mann-Whitney U test 
 
 
2.1.3 Ophthalmological tests 
Intraocular pressure was measured in 23 type 2 diabetics, 14 of which without diabetic 
retinopathy, and 9 with diabetic retinopathy. The first group ranged between 10 and 20 
mmHg (mean 15.36 + 0.75 mmHg), while the second one ranged between 8 and 23 mmHg 
(mean 15.78 + 1.75 mmHg), and no statistical significant differences were found between 
groups (independent samples t-test p = 0.829). 
Concerning the best corrected visual acuity, both groups presented a median value of 1.00, 
with and inter-quartile range from 0.80 to 1.00 so, groups were statistically identical 
(Mann-Whitney p = 0.925). 
 
2.1.3.1 Optical Coherence Tomography 
2.1.3.1.1 Volume Scan density 
Groups presented similar values for volume scan, with exception of the Inner Nasal region, 
where the group with diabetic retinopathy is expected to have an increased density when 
compared to the group without diabetic retinopathy (Table 58). In fact, the expected median 
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increase lies between 1 and 28 units, with 95% confidence (Hodges-Lehmann confidence 
interval). 
 
Table 58 - Descriptive statistics and group comparison of Volume Scan measured by OCT between type 2 
diabetics without and with diabetic retinopathy. 
Volume Scan DR N Min Max Mean SEM P25 P50 P75 p 
Central 
Subfield 
No 20 227.00 329.00 276.90 5.41 262.50 278.00 293.75 
0.090* 
Yes 20 174.00 416.00 300.15 12.07 272.00 291.00 319.25 
In
n
e
r 
Nasal 
No 20 242.00 384.00 336.30 6.17 330.50 339.00 351.75 
0.026** 
Yes 20 289.00 415.00 353.85 6.74 338.25 354.00 369.00 
Superior 
No 20 316.00 378.00 342.35 3.88 326.50 342.50 351.00 
0.157* 
Yes 20 303.00 433.00 354.30 7.31 334.25 349.00 373.25 
Temporal 
No 20 309.00 356.00 330.30 2.98 321.25 329.50 337.75 
0.626** 
Yes 20 251.00 448.00 340.05 9.65 321.50 331.00 347.00 
Inferior 
No 20 275.00 422.00 336.50 6.49 325.00 335.50 346.50 
0.267** 
Yes 20 282.00 424.00 344.50 6.87 336.00 341.50 355.50 
O
u
te
r 
Nasal 
No 20 290.00 383.00 314.35 4.55 299.00 311.00 323.75 
0.850** 
Yes 20 270.00 416.00 317.85 7.02 302.25 309.00 332.75 
Superior 
No 20 269.00 335.00 299.05 3.34 292.25 298.50 307.75 
0.336* 
Yes 20 256.00 358.00 305.45 5.64 289.00 300.50 323.75 
Temporal 
No 20 262.00 396.00 293.35 7.97 271.25 284.50 295.25 
0.914** 
Yes 20 247.00 357.00 290.25 6.23 273.25 282.00 311.75 
Inferior 
No 20 262.00 394.00 289.05 6.25 273.00 286.00 296.50 
0.579** 
Yes 20 239.00 369.00 284.50 6.48 264.25 281.00 296.50 
*
Independent samples t-test; 
**
Mann-Whitney U test 
 
2.1.3.1.2 Retinal Nerve Fibre Layer 
Retinal thickness presents similar values in both groups, as shown in the following table 
(Table 59). 
 
Table 59 - Descriptive statistics and group comparison of Retinal Nerve Fibre Layer measured with OCT 
between type 2 diabetics without and with diabetic retinopathy.  
RNFL DR n Min Max Mean SEM P25 P50 P75 P 
Global 
No 20 77.00 113.00 98.45 2.02 97.25 99.50 103.00 
0.833** 
Yes 19 68.00 118.00 97.16 2.85 93.00 101.00 104.00 
Nasal 
No 20 57.00 88.00 73.10 2.49 61.25 74.00 84.75 
0.536** 
Yes 19 37.00 93.00 74.63 3.08 66.00 78.00 86.00 
N
a
sa
l Superior 
No 20 61.00 127.00 102.20 3.96 89.75 108.00 116.75 
0.849* 
Yes 19 52.00 142.00 103.47 5.38 82.00 111.00 118.00 
Inferior 
No 20 91.00 145.00 127.65 3.76 113.50 135.00 143.00 
0.211** 
Yes 19 97.00 154.00 121.68 3.63 109.00 118.00 139.00 
Temporal 
No 20 49.00 160.00 79.70 4.87 69.25 75.50 83.75 
0.151** 
Yes 19 32.00 91.00 70.26 3.10 64.00 71.00 80.00 
T
e
m
p
. Superior 
No 20 108.00 181.00 140.95 4.75 123.75 138.00 157.25 
0.730* 
Yes 19 51.00 187.00 138.00 7.14 124.00 135.00 156.00 
Inferior 
No 20 65.00 170.00 115.70 5.53 101.00 115.50 132.00 
0.475* 
Yes 19 52.00 193.00 122.11 7.00 110.00 124.00 140.00 
*
Independent samples t-test; 
**
Mann-Whitney U test 
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2.1.3.2 Psychophysical tests 
Tests of contrast sensitivity produce identical results for the diabetic group, when comparing 
subjects with and without diabetic retinopathy. In fact, results are similar when evaluating 
speed and achromatic vision. Regarding chromatic contrast sensitivity, we could 
differentiate groups only at Deutan and Tritan axes of the chromatic contrast sensitivity 
function, as presented below. 
 
2.1.3.2.1 Speed 
Type 2 diabetics without and with diabetic retinopathy presented similar results for the 
speed test, whichever the meridian analysed. There was also no statistical significant 
difference between groups for the overall measure of speed discrimination (Table 60). 
 
Table 60 - Descriptive statistics and group comparison for the speed test, measured in meridians 0º, 45º, 90º, 
135º and global area generated by these meridians between type 2 diabetics without and with 
diabetic retinopathy. 
Speed DR n Min Max Mean SEM P25 P50 P75 p 
M
e
ri
d
ia
n
 
0º 
No 19 0.50 5.64 2.03 0.30 0.85 1.77 2.73 
0,753** 
Yes 18 0.16 9.69 2.24 0.54 0.52 2.08 2.72 
45º 
No 18 0.18 7.99 1.90 0.43 0.55 1.28 2.86 
0,503** 
Yes 17 0.56 7.98 2.31 0.52 0.80 1.42 3.30 
90º 
No 19 0.32 3.12 1.53 0.20 0.99 1.30 2.25 
0,620** 
Yes 18 0.15 7.88 2.33 0.53 0.84 1.42 3.67 
135º 
No 19 0.38 5.50 2.44 0.39 0.70 2.05 4.17 
0,802** 
Yes 17 0.15 7.72 2.94 0.61 0.78 2.53 5.29 
Area 
No 18 0.55 18.36 4.40 1.04 1.32 3.61 5.63 
0.597** 
Yes 16 0.27 29.79 6.44 1.94 1.42 2.74 10.34 
*
Independent samples t-test; 
**
Mann-Whitney U test 
 
2.1.3.2.2 Achromatic contrast 
There was no significant statistical difference between groups concerning achromatic 
discrimination test, meaning that this measure is not able to classify diabetic retinopathy 
(Table 61). 
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Table 61 - Descriptive statistics and group comparison for the achromatic vision test, measured in meridians 0º, 
45º, 90º, 135º and global area generated by these meridians between type 2 diabetics without and 
with diabetic retinopathy.  
Acrhom. DR N Min Max Mean SEM P25 P50 P75 P 
M
e
ri
d
ia
n
 
0º 
No 19 1.00 4.28 2.22 0.23 1.41 1.90 3.03 
0,098** 
Yes 18 1.00 10.47 3.29 0.56 2.05 2.66 3.57 
45º 
No 18 1.20 8.37 3.17 0.48 1.75 2.39 3.79 
0,938** 
Yes 18 1.20 7.03 2.97 0.37 2.05 2.62 3.26 
90º 
No 19 1.00 5.43 3.19 0.29 2.24 2.86 4.47 
0,707** 
Yes 18 1.20 6.35 3.08 0.37 1.60 2.72 3.91 
135º 
No 19 1.00 10.77 3.32 0.51 1.41 2.90 4.61 
0,217** 
Yes 16 1.00 4.47 2.45 0.24 1.63 2.50 3.11 
Area 
No 18 3.82 39.36 10.79 2.25 4.48 6.51 14.85 
0.597** 
Yes 16 3.14 18.02 8.54 1.18 3.76 7.99 12.13 
*
Independent samples t-test; 
**
Mann-Whitney U test 
 
2.1.3.2.3 Chromatic Contrast 
Chromatic contrasts discrimination may differentiate groups, but only in some measures. 
Measures obtained according to the Protan axis are similar between subjects without and 
with diabetic retinopathy (Table 62)- 
 
Table 62 - Descriptive statistics and group comparison for the chromatic contrast test for the Protan axis, 
measured in meridians 0º, 45º, 90º, 135º and global area generated by these meridians between 
type 2 diabetics without and with diabetic retinopathy.  
Protan DR n Min Max Mean SEM P25 P50 P75 P 
M
e
ri
d
ia
n
 (
x1
0
-3
) 
0º 
No 19 1.23 4.52 2.51 0.24 1.25 2.47 3.09 
0,258** 
Yes 18 1.23 9.49 3.38 0.50 1.25 3.07 4.78 
45º 
No 19 1.23 21.53 5.40 1.14 2.25 3.72 8.23 
0,845** 
Yes 18 1.24 28.66 6.55 1.75 1.69 4.01 9.60 
90º 
No 19 1.24 18.32 4.39 0.88 1.85 3.49 5.54 
0,988** 
Yes 18 1.23 27.34 5.67 1.69 1.85 3.59 5.10 
135º 
No 19 1.23 17.05 5.44 0.93 2.47 3.72 7.42 
0,616** 
Yes 17 1.23 13.25 5.52 0.76 3.48 4.32 7.85 
Area 
(x10
-6
) 
No 19 2.00 105.00 22.63 5.45 6.00 19.00 29.00 
0.731** 
Yes 17 4.00 453.00 40.00 25.88 9.00 12.00 19.00 
*
Independent samples t-test; 
**
Mann-Whitney U test 
 
On the other hand, contrast sensitivity along meridian 0º of the Deutan axis may 
differentiate groups (p = 0.041). None of the other measures are possible classifiers of 
diabetic retinopathy (Table 63). 
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Table 63 - Descriptive statistics and group comparison of Chromatic contrast test for the Deutan axis, measured 
in meridians 0º, 45º, 90º, 135º and global area generated by these meridians between type 2 
diabetics without and with diabetic retinopathy.  
Deutan DR N Min Max Mean SEM P25 P50 P75 P 
M
e
ri
d
ia
n
 (
x1
0
-3
) 
0º 
No 18 1.24 11.26 3.90 0.63 1.71 3.62 4.64 
0,041** 
Yes 17 1.25 55.95 9.99 3.36 3.39 4.75 7.98 
45º 
No 18 1.24 74.08 15.17 4.28 2.48 7.71 25.30 
0,096** 
Yes 17 1.24 76.32 24.10 5.17 7.99 19.71 37.00 
90º 
No 19 1.24 86.43 14.48 5.58 3.70 4.33 14.63 
0,684** 
Yes 17 1.23 59.95 14.53 4.45 1.85 6.19 21.25 
135º 
No 18 1.23 69.83 20.87 5.06 5.20 14.05 27.91 
0,878** 
Yes 16 1.85 57.12 20.72 5.26 4.32 9.78 46.85 
Area 
(x10
-6
) 
No 18 0.00 1616.00 204.78 93.66 14.75 80.00 153.50 
0.506** 
Yes 16 6.00 2077.00 373.44 149.81 33.75 67.50 580.25 
*
Independent samples t-test; 
**
Mann-Whitney U test 
 
Contrast sensitivity for the Tritan axis is the measure that possibly has more 
discriminative power (Table 64), since it presents statistical differences between groups 
for meridians 0º and 135º, and also for the global measure of the Tritan axis, given by 
the 5-sided polygon generated by the values measured for each one of the meridians 
and the (0,0) point. 
 
Table 64 - Descriptive statistics and group comparison of chromatic contrast test for the Tritan axis, measured 
in meridians 0º, 45º, 90º, 135º and global area generated by these meridians between type 2 
diabetics without and with diabetic retinopathy. 
Tritan DR n Min Max Mean SEM P25 P50 P75 p 
M
e
ri
d
ia
n
 (
x1
0
-3
) 
0º 
No 19 33.32 132.10 55.28 5.72 40.00 46.66 62.82 
0.003** 
Yes 18 25.00 401.57 119.57 23.83 55.98 83.99 155.74 
45º 
No 18 25.00 310.36 132.75 20.16 66.24 127.01 192.81 
0.339** 
Yes 18 53.48 411.62 172.52 26.12 86.90 134.06 271.83 
90º 
No 19 25.00 267.24 89.51 15.01 43.33 56.81 133.78 
0.081** 
Yes 18 40.00 425.51 148.45 28.66 62.15 82.90 219.58 
135º 
No 18 38.48 391.88 107.50 21.54 45.01 63.35 148.88 
0.002** 
Yes 17 35.23 568.07 229.62 32.46 135.69 198.36 298.41 
Area 
(x10
-3
) 
No 18 1.08 40.91 11.78 2.86 3.38 5.76 17.46 
0.017** 
Yes 17 2.65 139.83 28.46 8.24 8.41 15.90 36.20 
*
Independent samples t-test; 
**
Mann-Whitney U test 
 
 
2.2 Phase 2: Univariate classifiers of Diabetic Retinopathy 
In this section, we will present the results of univariate classifiers for diabetic retinopathy. As 
we can observe in Tables 65 to 75, few variables from the previous identified variables as 
possible classifiers are identified. 
From the sociodemographic parameters, duration of diabetes is the only one that may be 
identified as a possible discriminator (ROC curve presented in Figure 46), where a subject 
with less than 18.50 years of duration of the disease is classified has type 2 diabetic without 
Chapter 6 
150 
diabetic retinopathy with a probability of 90.00%. In fact, it is 5.50 times more likely that the 
duration of the disease is, at least, 18.50 years, in a subject with diabetic retinopathy than in 
a subject without diabetic retinopathy (Table 65) thus, longer duration of diabetes mellitus 
(type 2) represents an increased risk factor for the development of diabetic retinopathy. 
 
Table 65 - Accuracy of medical preliminary procedures measured for univariate classification of diabetic 
retinopathy in type 2 diabetics. 
Variable AUC SEM p LBCI UBCI Cut-off Sensitivity Specificity +LR 
Age 0.538 0.09 0.685 0.352 0.723 - - - - 
Height 0.564 0.09 0.490 0.380 0.747 - - - - 
Weight 0.649 0.09 0.108 0.478 0.820 - - - - 
BMI 0.646 0.09 0.114 0.473 0.819 - - - - 
AP 0.565 0.09 0.492 0.380 0.750 - - - - 
Pulse 0.525 0.09 0.787 0.343 0.707 - - - - 
SBP 0.510 0.09 0.914 0.327 0.693 - - - - 
DBP 0.576 0.09 0.409 0.394 0.758 - - - - 
Bioimpedance 0.502 0.11 0.984 0.283 0.721 - - - - 
Duration 0.748 0.08 0.007 0.593 0.902 > 18.5 55.00% 90.00% 5.50 
BMI – Body mass index; AP – Abdominal perimeter; SBP – Systolic blood pressure; DBP – Diastolic blood 
pressure. 
 
 
Figure 46 – ROC curve for duration of disease since diagnosis. 
 
Parameters such as glycaemia and glycosylated haemoglobin, creatinine, or parameters 
related to the hepatic function or lipids are not capable of differentiating between subjects 
without or with diabetic retinopathy (Tables 66 to 69). 
 
Table 66 - Accuracy of glycaemia and glycosylated haemoglobin for univariate classification of diabetic 
retinopathy in type 2 diabetics. 
Blood AUC SEM P LBCI UBCI Cut-off Sensitivity Specificity +LR 
Glucose 0.536 0.10 0.704 0.348 0.724 - - - - 
HbA1C (NGSP) 
0.541 0.09 0.663 0.357 0.725 
- 
- - - 
HbA1C (IFCC) - 
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Table 67 - Accuracy of creatinine values for univariate classification of diabetic retinopathy in type 2 diabetics. 
Variable AUC SEM p LBCI UBCI Cut-off Sensitivity Specificity +LR 
Creatinin 0.622 0.09 0.191 0.443 0.801 - - - - 
 
Table 68 - Accuracy of hepatic function parameters for univariate classification of diabetic retinopathy in type 2 
diabetics. 
Variable AUC SEM p LBCI UBCI Cut-off Sensitivity Specificity +LR 
ALT 0.518 0.09 0.850 0.335 0.700 - - - - 
AST 0.638 0.09 0.137 0.463 0.812 - - - - 
Alkaline 
Phosphatase 
0.570 0.09 0.449 0.390 0.750 - - - - 
Gamma GT 0.671 0.09 0.064 0.501 0.841 - - - - 
 
Table 69 - Accuracy of lipid related parameters for univariate classification of diabetic retinopathy in type 2 
diabetics. 
Variable AUC SEM p LBCI UBCI Cut-off Sensitivity Specificity +LR 
Total Cholesterol 0.641 0.09 0.126 0.467 0.816 - - - - 
Cholesterol HDL 0.593 0.09 0.317 0.415 0.770 - - - - 
Atherogenic Index 0.509 0.09 0.925 0.325 0.692 - - - - 
Cholesterol LDL 0.616 0.09 0.220 0.436 0.797 - - - - 
Triglycerides 0.559 0.09 0.527 0.375 0.743 - - - - 
Apolipoprotein A1 0.620 0.09 0.204 0.439 0.802 - - - - 
Apolipoprotein B100 0.537 0.10 0.693 0.349 0.726 - - - - 
B100/A1 0.551 0.10 0.589 0.364 0.739 - - - - 
Lipoprotein 0.574 0.09 0.431 0.392 0.755 - - - - 
 
However, subjects with diagnosed diabetic retinopathy are more likely to have lower values 
regarding erythrocytes, haemoglobin and, especially, haematocrit, as presented in Table 70. 
Parameters respecting hormonology do not differentiate groups (Table 71). 
 
Table 70 - Accuracy of Blood cell counts for univariate classification of diabetic retinopathy in type 2 diabetics. 
Variable AUC SE p LBCI UBCI Cut-off Sensitivity Specificity +LR 
Leucocytes 0.553 0.09 0.570 0.368 0.737 - - - - 
Erytrocytes 0.710 0.08 0.023 0.547 0.873 < 4.23 65.00% 75.00% 2.60 
Haemoglobin 0.746 0.08 0.008 0.591 0.902 < 13.20 75.00% 70.00% 2.50 
Haematocrit 0.728 0.08 0.014 0.569 0.886 < 36.25 55.00% 90.00% 5.50 
MCV 0.630 0.09 0.160 0.453 0.807 - - - - 
MHC 0.595 0.09 0.304 0.414 0.776 - - - - 
MCHC 0.583 0.09 0.372 0.399 0.766 - - - - 
EVC 0.635 0.09 0.144 0.457 0.813 - - - - 
Platelet 0.656 0.09 0.091 0.479 0.834 - - - - 
MPV 0.554 0.10 0.561 0.366 0.742 - - - - 
Plateleocrit 0.641 0.09 0.126 0.468 0.815 - - - - 
PVC 0.650 0.09 0.105 0.477 0.823 - - - - 
MCV – Mean corpuscular volume; MCH – Mean corpuscular haemoglobin; MCHC – Mean corpuscular 
haemoglobin concentration; EVC – Erythrocytes variation coefficient; MPV – Mean platelet volume; PVC – 
Platelet variation coefficient 
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Table 71 - Accuracy of Blood cell counts for univariate classification of diabetic retinopathy in type 2 diabetics. 
Variable AUC SE p LBCI UBCI Cut-off Sensitivity Specificity +LR 
TSH 0.526 0.09 0.779 0.342 0.710 - - - - 
C-Peptide 0.557 0.09 0.546 0.373 0.740 - - - - 
 
In Figure 46, we may observe the ROC curves for each variable that have previously shown 
statistical differences between groups. From these, only the ones represented in blue are 
able to actually separate groups. Although haematocrit presents higher positive likelihood 
ratio, there is no statistical significant difference between haematocrit and the others 
regarding the classification accuracy (Figure 47). 
 
Figure 47 – ROC curves for biochemistry, cell blood counts cytometry and immunology parameters presenting 
statistical differences between groups. Curves plotted with blue present significant area under the 
ROC curve. 
 
OCT values of volume scan density may separate groups for the measured values in the nasal 
quadrant, where it is about 5 times more likely that a subject with diabetic retinopathy 
presents values of, at least, 355.50 than subjects without diabetic retinopathy. This variable 
will be used for the development of a multivariate statistical classifier (Table 72). 
However, the retinal nerve fibre thickness has no sufficient accuracy for classifying diabetic 
retinopathy. 
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Table 72 - Accuracy of OCT tests for univariate classification of diabetic retinopathy in type 2 diabetics. 
Variable AUC SE p LBCI UBCI Cut-off Sens Spec +LR 
IOP 0.528 0.14 0.825 0.252 0.803 - - - - 
BVCA 0.508 0.09 0.935 0.326 0.689 - - - - 
O
C
T
 
V
S
 
CS 0.670 0.09 0.066 0.501 0.839 - - - - 
In
n
e
r 
N 0.705 0.08 0.027 0.539 0.871 > 355.50 50.00% 90.00% 5.00 
S 0.610 0.09 0.234 0.432 0.788 - - - - 
T 0.545 0.09 0.626 0.362 0.728 - - - - 
I 0.603 0.09 0.267 0.424 0.781 - - - - 
O
u
te
r 
N 0.518 0.09 0.850 0.334 0.701 - - - - 
S 0.549 0.10 0.598 0.362 0.735 - - - - 
T 0.490 0.09 0.914 0.306 0.674 - - - - 
I 0.551 0.09 0.579 0.368 0.734 - - - - 
R
N
F
L 
Global 0.520 0.10 0.833 0.330 0.710 - - - - 
Nasal 0.558 0.09 0.536 0.374 0.742 - - - - 
N 
S 0.522 0.10 0.811 0.336 0.709 - - - - 
I 0.617 0.09 0.211 0.438 0.796 - - - - 
Temporal 0.634 0.09 0.152 0.459 0.810 - - - - 
T 
S 0.512 0.09 0.899 0.326 0.697 - - - - 
I 0.596 0.09 0.305 0.414 0.779 - - - - 
 
Results obtained for visual psychophysical tests, either on speed (Table 73), or in achromatic 
contrast (Table 74), are not able to separate between subjects without and with diabetic 
retinopathy. 
 
Table 73 - Accuracy of the speed test for univariate classification of diabetic retinopathy in type 2 diabetics. 
Speed AUC SE P LBCI UBCI Cut-off Sens. Spec. +LR 
M
e
ri
d
ia
n
 0º 0.532 0.10 0.738 0.336 0.728 - - - - 
45º 0.569 0.10 0.488 0.372 0.765 - - - - 
90º 0.550 0.10 0.605 0.357 0.742 - - - - 
135º 0.526 0.10 0.788 0.328 0.725 - - - - 
Area 0.556 0.10 0.581 0.355 0.756 - - - - 
 
Table 74 - Accuracy of the achromatic test for univariate classification of diabetic retinopathy in type 2 
diabetics. 
Achromatic AUC SE P LBCI UBCI Cut-off Sens. Spec. +LR 
M
e
ri
d
ia
n
 0º 0.659 0.09 0.098 0.480 0.839 - - - - 
45º 0.508 0.10 0.937 0.313 0.702 - - - - 
90º 0.538 0.10 0.693 0.347 0.729 - - - - 
135º 0.625 0.10 0.208 0.437 0.813 - - - - 
Area 0.556 0.10 0.581 0.356 0.755 - - - - 
 
From previously identified measures for chromatic contrast discrimination presenting 
statistical significant differences between groups, all of them showed sufficient accuracy for 
separating between subjects without and with diabetic retinopathy. The one with higher 
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positive likelihood ratio is contrast sensitivity along meridian 135º, on the Tritan axis (PLR = 
6.35), as observed in Table 75, but the one with highest sensitivity is the global area 
generated by the 5-sides polygon formed by the values measured in each meridian and the 
origin (94.12%). 
 
Table 75 - Accuracy of the chromatic vision test for univariate classification of diabetic retinopathy in type 2 
diabetics. 
Axis/Meridian AUC SE P LBCI UBCI Cut-off Sens. Spec. PPV 
C
h
ro
m
a
ti
c 
C
o
n
tr
a
st
 
P
ro
ta
n
 
0º 0.610 0.10 0.254 0.418 0.801 - - - - 
45º 0.520 0.10 0.832 0.330 0.711 - - - - 
90º 0.503 0.10 0.976 0.313 0.693 - - - - 
135º 0.551 0.10 0.601 0.357 0.745 - - - - 
Area 0.534 0.10 0.727 0.336 0.732 - - - - 
D
e
u
ta
n
 
0º 0.701 0.09 0.042 0.528 0.874 > 4.46x10
-3
 58.82% 77.78% 2.65 
45º 0.665 0.09 0.096 0.483 0.847 - - - - 
90º 0.542 0.10 0.669 0.347 0.737 - - - - 
135º 0.517 0.10 0.863 0.318 0.717 - - - - 
Area 0.568 0.10 0.501 0.371 0.764 - - - - 
T
ri
ta
n
 
0º 0.776 0.08 0.004 0.616 0.936 > 63.25 x10
-3
 72.22% 78.95% 3.43 
*45º 0.594 0.10 0.335 0.405 0.783 - - - - 
90º 0.668 0.09 0.081 0.493 0.844 - - - - 
135º 0.792 0.08 0.003 0.633 0.952 > 174.81 x10
-3
 70.59% 88.89% 6.35 
*Area 0.735 0.09 0.017 0.566 0.905 > 5.94 x10
-3
 94.12% 55.56% 2.12 
 
In Figure 48 we may observe the ROC curves for parameters which presented significant 
areas under the ROC curve. 
 
Figure 48 – ROC curves for OCT Volume Scan and Visual psychophysical tests that presented statistical 
differences between groups. Curves plotted in blue, green and orange present significant area 
under the ROC curve. 
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3. Multivariate models for Diabetic Retinopathy Classification 
The following analyses were performed using as independent variables all the previous 
variables that presented association with the presence of diabetic retinopathy and achieved 
statistical significance in area under the ROC curve, such as: 
- duration of the disease, in years; 
- cytometry parameters: erythrocytes, haemoglobin and haematocrit; 
- volume scan in the inner nasal quadrant; 
- visual psychophysical tests: chromatic vision for The Deutan axis (meridian 0º) and for the 
Tritan axis (meridians 0º and 135º) and the area of the polygon generated by the four 
meridians and the origin for the Tritan axis. 
Discriminant analysis and tree analysis used these quantitative variables, but on logistic 
regression they were dichotomized according to previous ROC results. 
 
3.1 Discriminant Function Analysis 
Some of the independent variables do not follow a normal distribution, as observed in Figure 
49, but there is homogeneity on the covariate matrices (Box’s M F(10, 4552) = 4.79; p = 
0.942). 
 
Figure 49 - p-values obtained from the Kolmogorov-Smirnov or the Shapiro-Wilk test to variables in analysis 
presented as |log |, in logarithmic scale. The horizontal lines reflect the values of 0.01 
(|log 0.01|  2.00) and 0.05 (|log 0.05|  1.30) for type I errors. All bars below horizontal 
lines represent variables with normal distribution in the group. 
 
 
Wilk’s lambda identifies 4 variables (Table 76) as group discriminators: 
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Table 76 - Variables included in the discriminant model (Wilks’ Lambda method). 
Entered 
Wilks' Lambda 
Statistic df1 df2 df3 
Exact F 
Statistic df1 df2 Sig.  Chrom. Cont. Tritan (135º) 0.783 1 1 31 8.611 1 31 0.006  Duration 0.632 2 1 31 8.745 2 30 0.001  Haemoglobin 0.497 3 1 31 9.801 3 29 < 0.001  VS Inner Nasal 0.413 4 1 31 9.942 4 28 < 0.001 
 
After four steps, one discriminant function is obtained with an eigenvalue of 1.42, explaining 
100% of the variance, and a canonical correlation of 0.766 (λWilks=0.280: χ2(4)=25.63; p < 
0.001) between variables considered for the model and group classification. 
 
The discriminant function can be written as: 
   −1.672 + 5.215 + 0.109 − 0.590 + 0.021  
 
or, after standardizing coefficients, 
  = 0.613 + 0.925 − 0.678 + 0.596  
 
Function centroids are significantly different (F(4,28) = 9.94; p < 0.001) and assume the 
values of -1.12 for subjects without diabetic retinopathy and +1.19 for those who have 
diabetic retinopathy. This means that the function can separate or discriminate groups and 
may be used for classification. 
We obtained the classification functions, which may be used to classify, although that was 
not the methodology used for classification. Classification functions may be written as: 
 
  !!"#	%&'()* = −144.254 − 0.883 + 0.409 + 9.263 + 0.457 !!#	,-('()*" = −148.198 + 11.170 + 0.660 + 7.900 + 0.506  
 
The method for classification is based upon the closeness to the centroid, and distance from 
the frontier line, which has the value of. = +0.002. Based on this frontier, and on the 
Mahalanobis distance from the score in the discrimination function and the centroid, we 
may also obtain posterior probabilities and classify a given subject according to the highest 
probability. 
As it was previously referred, Mahalanobis squared distances between the score in the 
discriminant function and group centroids follow a Chi-square distribution with one degree 
of freedom, which enables the determination of posterior probabilities. These distances, 
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/"#	%&'()*  and /"#	,-('()* , in this particular case, are given by: 
 
0 /"#	%&'()*  123..45/"#	,-('()* = 167.5.55   
 
Posterior probabilities may be calculated applying Bayes’ rule to the probability of obtaining 
each one of the distances, given that the subjects belongs to a defined group: 
 
89:
9; <=>?&'()*|/"#	%&'()*  = ,@2ABC@DEFGH	IJKLMND O,@2ABC@DEFGH	IJKLMND O3,D2APC@DEFGH	QRLKLMND S
<B=>A-('()*T/"#	,-('()* O = ,D2ABC@DEFGH	QRLKLMND O,@2ABC@DEFGH	IJKLMND O3,D2APC@DEFGH	QLKLMND S
  
 
Where  and  are the prior probabilities, which were assumed to be equal (0.50). The 
subject is classified as DR absent or DR present according to the highest posterior 
probability. 
 
We can apply a ROC analysis either to the discriminant function, or to the posterior 
probabilities, and a cut-off of +0.264 for the frontier line is obtained as the optimal cutoff, 
corresponding to the posterior probability of 58.46%. This means that we may improve 
specificity of classification, since the number of false positive cases decreases, without losing 
sensitivity; consequently, the positive likelihood ratio increases three times which is 
preferable. Note that concordance between models is excellent, thus any of them may be 
used for classification (Table 77). 
 
Table 77 - Discriminant classifier accuracy using two different cut-offs for posterior probability: classical (50%) 
and obtained by ROC analysis (58.46%). 
Model AUC (p) 
Cut-off 
Function (Prob) 
 
% 
Correct 
k P K between 
 
McNemar 
(p) 
 Sens Spec +LR 
DF 0.931 
(< 0.001) 
0.002 (50.00%)  88.57% 0.770 < 0.001 1.000 
(p < 0.001) 
 
0.625  82.35% 94.44% 14.82 
DROC 0.214 (58.46%)  88.57% 0.770 < 0.001  
0.625  82.35% 94.44% 14.82 
 
Similarly, Figure 50 represents the scatterplot of the probability for group classification, 
where blue points represent controls and red points represent type 2 diabtetics. There, we 
may observe the posterior probability of belonging to the control or diabetic group 
according to the value obtained in the discriminant function, and its distance to the 
correspondent centroid. Horizontal lines mark the cut-offs defined by discriminant analysis 
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(50%) and ROC analysis (58.46%) for group classification while vertical lines mark the cut-offs 
defined by the definition frontier line (0.002) or obtained by ROC analysis (0.214), used for 
classification with the discriminant function.  
 
Figure 50 - Scaterplott of the probability for group (y) control (blue) or diabetic (red), based on the value of the 
discriminant funcion (d). Horizontal lines mark the cut-offs defined by discriminant analysis (50%) 
and ROC analysis (58.46%) for group classification while vertical lines mark the cut-offs defined by 
the definition frontier line (-0.12) or obtained by ROC analysis (-0.28), used for classification with 
the discriminant function; big circles mark the centroid for the discriminant function (at 50% 
probability) for each group. 
 
Cut-offs defined lead exactely to the same solution, thus the 50% posterior probabily will be 
used. In the left half, cases are classified as type 2 diabetics without diabetic retinopathy, 
and in the upper-left quarter we have the true negative cases; on the other hand, true 
positive cases are represented in the right-upper quarter, and false positive cases in the 
right-bottom quarter of Figure 50. 
 
3.2 Regression procedures 
Logistic regression was performed using the same independent variables as the ones used 
with discriminant analysis, but they were previously dichotomised according to the cut-offs 
defined by ROC analysis. We attempted to build three models based on a forward stepwise 
procedure (with a probability of F to enter < 0.050 and a probability of F to remove > 0.100), 
using the conditional statistic, the Likelihood Ratio (LR) and the Wald statistic. 
Curiously, the first two models identified the duration of the disease, haematocrit, and 
global chromatic contrast at the Tritan axis (area), while the last model identified only the 
duration of the disease as a discriminator variable. However, none of the models presented 
statistical significance regarding the coefficients of independent variables. 
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The following tables present the adjustment and accuracy of the models (Tables 78 and 79). 
We may observe a statistical significant improvement with the inclusion of each variable in 
the model. We may also observe that the quality of the adjustment of the models obtained 
with conditional or likelihood ratio criteria for stepwise regression are quite good. However, 
Wald’s criteria for stepwise regression do not allow the achievement of a good model (Table 
78). 
 
Table 78 - Significance of models and improvement, step by step, on forward stepwise logistic regression model 
(Conditional, Likelihood Ratio and Wald’s methods).  
Step/Variable 
Improvement (χ2(df); p) Model (χ2(df); p) 
Cond. LR Wald Cond. LR Wald  Chrom. T (area) 12.48(1); < 0.001 12.48(1); < 0.001 12.48(1); < 0.001 12.48(1); < 0.001 12.48(1); < 0.001 12.48(1); < 0.001  Duration 6.01(1); 0.014 6.01(1); 0.014 - 18.49(2); < 0.001 18.49(2); < 0.001 -  Haematocrit 4.75(1); 0.029 4.75(1); 0.029 - 23.24(3); < 0.001 23.24(3); < 0.001 - 
 
Table 79 - Adjustement of the model, step by step, to observed data, and overall correlation. 
Step/Variable 
Nagelkerque R square Hosmer and lemeshow test (χ2(df); p) 
Cond. LR Wald Cond. LR Wald  Chrom. T (area) 0.531 0.531 0.531 0(0); - 0(0); - 0(0); -  Duration 0.707 0.707 - 0(2); 1.000 0(2); 1.000 -  Haematocrit 0.818 0.818 - 0(3); 1.000 0(3); 1.000 - 
 
However, as stated before, coefficients do not show statistical significance; in fact, they 
reveal there must be some redundancy between variables which may lead to some over 
fitting of the models, due to standard error obtained for the coefficients (Table 80). 
 
Table 80 - Odds ratio and confidence intervals for variables identified on logistic regression model (models 
Conditional and Likelihood ratio). 
 B SE Wald df Sig. Odds Ratio 
95% CI for Odds Ratio 
Lower Upper 
Chrom. T (area) 21.621 1.57 3.663 1.00 0.056 20.00 0.93 429.90 
Duration 2.996 14736.21 0.000 1.00 0.998 1.17x10
17
 - - 
Haematocrit 39.299 14736.21 0.000 1.00 0.998 0.000 - - 
 
In fact, only the global area is nearly significant, and the following variables indicate 
redundancy. Hence, a new model was designed, using only the global area of the polygons 
generated by the origin and the four meridians measured at the Tritan axis, concerning 
chromatic contrast sensitivity. This variable explains 36.60% of the variance obtained for the 
probability of a type 2 diabetic person to develop diabetic retinopathy, since the Nagelkerke 
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r-squared is 0.366. The model may be written as  
 
<=>A-('()* = (UD.VWVXD.YYZ[\]R^_`3(UD.VWVXD.YYZ[\]R^_` and abcde 	0, g.	hbi 	abcde j 5.94 [ 1071, g.hbi 	abcde k 5.94 [ 107  
 
In fact, this variable presents a value of significance for the prediction of 0.008, and when 
the area of the polygon (Figure 51) generated by the values measured in the four meridians 
and the origin is, at least, 5.94x10
-3
, the mean risk of a type 2 diabetic to have diabetic 
retinopathy is 20 times higher, with a 95% confidence interval of 2.16 to 184.87. 
 
Figure 51 - Chromatic contrast test (Tritan) on meridians 0º, 45º, 90º, 135º and global area generated by these 
meridians in type 2 diabetes without and with diabetic retinopathy (meridian and area values 
should be read x10
-6
; area values should be read x10
-6
) 
 
This model correctly classifies 73.61% at the training sample, although Kappa’s Coefficient of 
concordance is only 0.456 (p < 0.001). The problem is that this model has a high false 
positive rate, statistically different from the false negative rate which is 5.88% (McNemar 
p-value < 0.001).  
Using the cut-off of 37.88% for the predicted probability regarding diabetic retinopathy 
(identified has the optimal cut-off by ROC analysis on those probabilities), there is absolutely 
no gain, since classification is the same as the one obtained using the 50% value for cut-off, 
at the training sample (Table 81). 
 
Table 81 - Logistic regression classifier accuracy using two different cut-offs for posterior probability: classical 
(50%) and obtained by ROC analysis (37.88%). 
Model AUC (p) 
Cut-off 
(%) 
 
% 
Correct 
K P 
K 
between 
McNemar 
(p) 
 Sens Spec +LR 
LF 0.748 
(0.012) 
50.00%  73.61% 0.456 < 0.001 1.000 
(< 0.001) 
< 0.001  94.12% 67.27% 2.88 
LROC 37.88%  73.61% 0.456 < 0.001 < 0.001  94.12% 67.27% 2.88 
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3.3 Decision trees 
As before, four algorithms were applied for growing decision trees: CART, CHAID, Exhaustive 
CHAID and QUEST. However, CHAID and exhaustive CHAID algorithms were unable to grow a 
tree, perhaps due to sample size, and CART and QUEST algorithms lead to the same solution, 
presented in Figure 52, identifying only chromatic contrast in the Tritan axis, at meridian 
135º, as a classifier of diabetic retinopathy. 
 
Figure 52 – Decision tree for classification of diabetic retinopathy. 
 
 
The obtained model exhibited good accuracy, and an excellent positive likelihood ratio, as 
observed in Table 82. 
 
Table 82 - Decision tree classifier accuracy. 
Model AUC (p)  % Correct K p McNemar (p)  Sens. Spec. +LR 
T 
0.797 
(0.003) 
 90.28% 0.713 < 0.001 0.453  70.59% 88.89% 18.41 
 
 
4. Model Comparison 
Despite the used methodology for evaluation of diabetes classification, where obtained 
classifiers were applied to a test sample, at this moment it still is not possible to use the 
same methodology for evaluation of the diabetic retinopathy classifiers that were 
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developed, since only five cases remain, all with diabetic retinopathy. Hence, further work 
must be done, and at the moment, classifiers performance will be evaluated only in the 
training sample. 
  
All the models were applied to the same 35 cases, and the value of 50% probability of 
belonging to the group with diabetic retinopathy was used as cut-off. The model with 
highest sensitivity is the one obtained with logistic regression, which only uses chromatic 
contrast sensitivity on the Tritan axis for classification, and may be used as screening in a 
regular visit to the ophthalmologist.  
On the other hand, the model obtained with discriminant analysis is the one with highest 
specificity, also using contrast sensitivity at the Tritan axis (meridian 135º), but also needs 
OCT acquisition and laboratory tests, namely values of visual scan in inner nasal region and 
haemoglobin, for classification. It also includes the duration of disease as a marker of 
diabetic retinopathy, which is an abstract parameter, difficult to measure with precision, 
since diabetes is a silent disease until diagnosed. 
The model obtained with a decision tree algorithm is the one with worse sensitivity, and 
intermediate specificity, and is not much different from the logistic regression model, since it 
only uses chromatic sensitivity at the Tritan axis for classification. The decision tree 
algorithm uses the 135º meridian for classification, while the logistic model needs 
computation of the area of the polygon generated by the measures on the four meridians 
and origin, which is a simple process. 
Models present moderate agreement, pair by pair, since Kappa coefficient between the 
discriminant model and the logistic model is 0.512 (p = 0.001); between the discriminant 
model and the decision tree model, the Kappa coefficient is 0.588 (p < 0.001) and between 
the logistic and decision tree models, kappa is 0.468 (p = 0.001). 
Hence, the most complex model (the discriminant one) presents the higher accuracy, given 
by the area under the ROC curve for probabilities of presence of diabetic retinopathy, with 
statistical significant difference both to the logistic regression model (p = 0,002) and to the 
decision tree model (p = 0.044). These p-values were not corrected for multiple 
comparisons, thus by the Bonferroni rule, which is rather conservative, but may be applied 
here, the only difference that survives to multiple comparisons is the difference between the 
accuracy of the discriminant analysis model and the logistic regression model (Table 83). 
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Table 83 - Comparison of diabetic retinopathy classifiers on the training sample. 
Model AUC (p) AUC between  
% 
Correct 
k p 
McNemar 
(p) 
 Sens Spec +LR 
D 
0.931 
(< 0.001) 
vs L: p = 0.002 
vs T: p = 0.044 
 88.57% 0.770 < 0.001 0.625  82.35% 94.44% 14.82 
L 
0.748 
(0.012) 
vs T: 0.530  73.61% 0.456 < 0.001 0.039  94.12% 67.27% 2.88 
T 
0.797 
(0.003) 
  90.28% 0.713 < 0.001 0.453  70.59% 88.89% 19.41 
 
In fact, the expected values for population, with 95% confidence, and considering a 
prevalence of 34.6% on diabetic retinopathy among diabetics (not only type 2), getting the 
predictive values presented in Table 84. 
 
Table 84 - Expected values of sensitivity, specificity, positive likelihood ratio and predictive values. 
Model  
Sensivity 
(95% CI) 
Specificity 
(95% CI) 
+LR 
(95% CI) 
PPV 
(95% CI) 
NPV 
(95% CI) 
D  
82.35% 
(56.6% - 96.2%) 
94.44% 
(72.7% - 99.9%) 
14.82 
(2.2 - 100.9) 
88,7% 
(56,0% - 99,5%) 
91,0% 
(71,6% - 98,8%) 
L  
94.12% 
(71.3% - 99.9%) 
67.27% 
(53.3% - 79.3%) 
2.88 
(1.9 - 4.3) 
60,3% 
(43,2% - 75,8%) 
95,6% 
(82,1% - 99,7%) 
T  
66.67% 
(41.0% - 86.7%) 
96.61% 
(88.3% - 99.6%) 
19.67 
(4.8 - 79.8) 
91,1% 
(69,0% - 99,2%) 
86,1% 
(73,7% - 94,1%) 
 
As the clinical importance of positive predictive value, in practice, is higher than sensitivity, 
and no statistical significant differences are found between the discriminant model and the 
decision tree model (adjusted p-value by the Bonferroni correction is 0.132), data presented 
on Table 84 and projected on Figure 53, suggest the use of the decision tree classifier, which 
is also a simpler method. However, models should be evaluated in a test sample before we 
decide for a definitive model. 
 
Figure 53 – Predictive values and 95% confidence interval relative to the three classifiers developed, assuming a 
prevalence of 34.6%..  
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 C H A P T E R  7  
 
D I S C U S S I O N  
 
 
In order to identify possible type 2 diabetes markers that indicate the presence of diabetes, 
or the presence of non-proliferative diabetic retinopathy, we had several dilemmas to 
handle. 
 
Perhaps the greatest dilemma was due to the fact of having age mismatch between original 
groups, when classifying type 2 diabetes, and the fact of having correlated data for the two 
eyes, whatever classification we were performing.  
 
For age mismatch between controls and type 2 diabetics, the simplest solution was to enter 
age in the multivariate models in order to ascertain if that was a differentiation parameter. 
Naturally, vision is affected by the aging process, but we did not find any correlation 
between age and any of the clinical or demographic measures (Figure 30) or between age 
and blood test or eye related measures, whichever the group considered. 
 
For duplicate data for the eyes, other considerations were made. In fact, OCT data were 
collected on both eyes, but visual psychophysical tests were performed only in the dominant 
eye. The simplest way to carry the analysis would be to discard collected data from the non-
dominant eye, but then we could be wasting important information.  
Armstrong
32
 published, in 2013, guidelines about how to handle both eye data. The majority 
of studies that in literature that he revised considered, most of the times, only the right eye, 
or the dominant eye, in spite both eyes data were available. In cases where both eye 
information was collected and used, most of the studies in the three journals he revised 
(OVO, OVS, CBO) considered both eye but uncorrected for correlation between eyes. 
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As no association was found, by Armstrong, between the methods to select the eye for 
analysis and journals, it seems reasonably to say that there were no previous defined 
guidelines to handle this situation. Nevertheless, there seems to be present some 
heterogeneity between methodologies, within and between journals. A meta-analysis is a 
procedure that integrates quantitative findings from separate but similar studies and 
provides a numerical estimate of the overall effect of interest
90
. However, with only three 
journals revised it seems unreasonable to perform a meta-analysis
91,92
. Nevertheless, we 
may use a descriptive meta-analysis, that is, we may plot available data and observe 
variability without determining the usual Cochran’s Q or I
2
 statistics used to evaluate 
heterogeneity
93
. 
 
When only one eye data was collected, the proportion of expected dominant eyes used, 
under the random effects model, lies between 10.49% and 23.78%, with 95% confidence 
interval, being the right eye the one most used, as observed in Table 85 and Figure 54. 
 
Table 85 - Data information from one eye – only one eye data collected. 
Criteria 
Sample 
size 
Right Eye Random Eye Dominant Eye 
(one eye data) 
Proportion 
(%) 
95% CI 
Proportion 
(%) 
95% CI 
Proportion 
(%) 
95% CI 
Journal 
OVO 51 47.06 32.93 - 61.54 5.88 1.23 - 16.24 9.80 3,26 - 21,41 
OVS 62 30.65 19.56 - 43.65 17.74 9.20 - 29.53 19.36 10,42 - 31,37 
CBO 35 25.71 12.49 - 43.26 14.29 4.81 - 30.26 20.00 8,44 - 36,938 
Total Effects 
(Random) 
148 34.92 23.46 - 47.33 12.97 6.43 - 21.38 16.60 10.49 - 23.78 
 
Figure 54 – Expected proportion of papers using right, random or dominant eye for analysis, in OVO, OVS, CBO 
and global measure of the total expected proportion. 
 
When both eye data were collected, there was also much heterogeneity, as observed in 
Table 86 and Figure 55.  
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Table 86 - Data information from both eyes – two eye data collected. 
Criteria 
Sample 
size 
One eye only 
Both Corrected for 
Correlation 
Both Uncorrected for 
Correlation 
(one eye data) 
Proportion 
(%) 
95% CI 
Proportion 
(%) 
95% CI 
Proportion 
(%) 
95% CI 
Journal 
OVO 19 15.79 3.38 - 39.58 10.53 1.30 - 33.14 31.58 12.57 - 56.55 
OVS 32 28.13 13.75 - 46.75 15.63 5.28 - 32.79 34.38 18.57 - 53.19 
CBO 31 19.36 7.45 - 37.47 9.68 2.04 - 25.75 38.71 21.85 - 57.81 
Total Effects 
(Random) 
82 22.74 14.51 - 32.20 13.37 7.02 - 21.38 35.85 26.05 - 46.29 
 
 
 Figure 55 – Expected proportion of papers using Right, random or dominant eye for analysis, in OVO, OVS, CBO 
and global measure of the total expected proportion, when data from both eyes were available. 
 
 
To join this, there were no criteria defined, in these journals, about when to use one or both 
eye information. This is why Armstrong’s guidelines
32
 are so important. Nonetheless, he 
does not refer guidelines for studies where we have data from one eye in some variables, 
and data from both eyes in other variables. Furthermore, no guidelines are defined about 
the use of both eyes information for classification problems, or for analysis of correlation 
when data are not Gaussian.  
In fact, Armstrong
32
 suggests the use of the intra-class correlation coefficient or the 
concordance correlation coefficient to evaluate correlation among measurements. However, 
in a certain way, both are based on the normal distribution assumptions, since the intra-class 
correlation coefficient is determined using mean or variance between measurements, and 
concordance correlation coefficient is based upon Pearson’s correlation coefficient. Hence, 
we propose a pseudo-concordance correlation coefficient, based on Spearman’s Rank order 
correlation, which have showed to be close to the other measures in the evaluation of 
correlation and concordance between eyes. 
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Armstrong
32
 also suggests the use of Bland and Altman plots to measure agreement. Once 
again, this graphical procedure is based on the mean and standard deviation (SD), and its 
frontier lines are defined at the mean + 1.96 SD of the differences, that is, by default, it 
assumes that data are normally distributed, which is often not the case. The Youden plot, 
which is centred on the median of each one of the measures, is an alternative procedure for 
graphical evaluation of correlation and concordance between measurements, without 
normality assumptions. However, as it also gives also a quantification of the random error 
between measurements, it may be used to access differences between groups and, by doing 
so we may access a global measure of precision between eye measurements in group 
observations, and a measure of precision of instrument measurement between eyes. 
 
We decided to use only one eye in the study, as concordance between eyes was observed to 
be present, and there were no statistical significant differences between eyes in the majority 
of analyzed variables. In fact, differences were found only on the temporal quadrant of the 
RNFL (p < 0.001), and on the nasal-superior (p < 0.001) and nasal-inferior quadrants (p = 
0.002), where no statistical differences in the random error between eyes were found. 
However, we found that the random error, which is not controlled as systematic error may 
be, presents statistical differences between controls and type 2 diabetics in the 
measurements made for the left and the right eyes, at the inner-superior and inner-inferior 
quadrants of volume scan density acquired by Spectralis OCT. At the end, there were no 
statistical significant differences between the eyes in these quadrants, thus random error 
was ignored. Likewise, as the methodology should be the same in all the study and as 
concordance was highly significant, being the object of study individuals and not eyes, we 
decided to use only one eye information.  
 
As Armstrong
32
 presented, the variability for the chosen eye for analysis is large. However, 
we had some directives to choose the eye, since data available for the visual psychophysical 
tests were for the dominant eye. Maybe in future studies the design should consider 
collecting data in visual psychophysical tests for both eyes in order to evaluate correlation, 
concordance and random error in visual psychophysical tests. Therefore, we used only the 
dominant eye data, even when we had both data available. 
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Another dilemma we had to handle was that we had as many variables as cases, but a data 
reduction based upon simple statistic methods was performed. These methods involved two 
group comparisons and posterior ROC analysis, which enabled us to discard useless 
variables, as they did not have any group separating property.  
Hence, we identified a smallest subgroup of variables which allowed differentiation between 
controls and type 2 diabetics, as presented on chapter 1 of part II of the results, and a 
subgroup of variables which could separate subjects with diabetic retinopathy from others 
without diabetic retinopathy, within the type 2 diabetes group. Here, a question arises: why 
did we use two statistical classifiers and not just one which would discriminate between 
three groups, that is, between controls, type 2 diabetics without diabetic retinopathy and 
those who have diabetic retinopathy? The reduction of variables could be performed by 
similar methods, using univariate tests for independent samples that allow comparison 
between three groups, such as ANOVA or Kruskal-Wallis test as the first criteria for 
discarding some variables, and ROC analysis could be applied in order to discriminate 
between each pair of groups. Statistical classification could be performed using the same or 
similar methods since there are classification functions which permit discrimination between 
three groups. Discriminant function analysis maybe used for more than three groups, logistic 
regression should be replaced for ordinal regression, and decision tree algorithms can 
handle more than two groups. However, we could not use some variables that were 
measured only in the type 2 diabetic group, such as duration of the disease. This could be set 
to zero years, in controls, but we were biasing results. On the other hand, ETDRS grading for 
diabetic retinopathy was performed only in the diabetic group. Using binary variables for 
groups, we also have similar group dimension for the training sample (47 controls and 49 
type 2 diabetics; 20 type 2 diabetics without and 20 with diabetic retinopathy), instead of 
having one variable with different distribution along groups. This fact is an asset, especially 
when discriminant analysis assumption fails, as the F distribution is very robust to the 
violation of multivariate normal distribution when groups have similar dimensions. However, 
it is not to reject the hypothesis of, when all data are available, developing a classification 
function that empowers classification into one of the three groups, simultaneously, or even 
into four groups if the sample will include cases with proliferative diabetic retinopathy, since 
we expect to have between 200 and 300 controls and a similar number of type 2 diabetics at 
the end of the inclusion process. At that time, data reduction will also be needed, since we 
may also use multimodal imaging results obtained for brain, heart and liver. Hence, this is an 
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ongoing process and these are the preliminary results in classification of type 2 diabetes or 
non-proliferative diabetic retinopathy using only blood sample and eye data. 
Some analyses were performed in smaller subgroups, adding blood pressure plus systolic 
and diastolic volume obtained by heart imaging, which were found to be related with the 
presence of non-proliferative diabetic retinopathy. However, few cases had data inserted 
onto the database on these parameters and, therefore, multivariate tests could not include 
these variables since sample size would be inadequate for classification methods. Further 
work will be done when heart, brain and liver imaging data is processed and ready to be 
analyzed. 
Considering classification results, they will be separated now into two different sections. Let 
us focus on type 2 diabetes classification. 
 
According to sociodemographic parameters (Table 10 and Figure 26), we found that type 2 
diabetics were significantly older (p < 0.001), presented significantly higher body mass index 
(p < 0.001), being heavier and smaller in height than controls, showed a tendency for 
differences for the abdominal perimeter, higher for this group (p = 0.053), as well as higher 
systolic blood pressure (p < 0..001) although no differences were found in diastolic blood 
pressure or pulse. Notice that the percentage of subjects medicated for blood pressure in 
this group was significantly higher than in the control group (p < 0.001), as well as the 
prevalence of family history of diabetes (p < 0.001). 
 
Comparison between groups for blood glucose and glycosylated haemoglobin were 
obviously statistical significant (Table 11) and were not used as possible classifiers, since this 
were the parameters used as gold standard to confirm the presence of type 2 diabetics. 
Considering all the other variables measured in blood samples, and presented on Tables 12 
to 18, we were able to identify that type 2 diabetics had statistical significantly differences 
values for ALT (p = 0.029), alkaline phosphatase (p = 0.004), gamma GT (p = 0.020), total 
cholesterol (p = 0.001), cholesterol HDL (p < 0.001) and LDL (p=0.003), atherogenic index (p = 
0.028), triglycerides (p < 0.001), apolipoprotein A1 (p < 0.001), leucocytes (p = 0.024), 
haemoglobin (p = 0.004), haematocrit (p = 0.006) and erythrocyte coefficient of variation (p 
= 0.043), C-peptide (p = 0.002), and the descriptive statistics allowed us to trace a 
preliminary profile of type 2 diabetics under treatment, since all of them had previously 
been diagnosed at least one year before: they showed some potentially liver damage, higher 
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risk of cardiovascular disease reflected by higher levels on triglycerides and atherogenic 
index, in spite of better control of cholesterol values (although they presented lower values 
either of LDL cholesterol or of HDL cholesterol), more prone to have lower values of 
haemoglobin, indicating lower oxygenation levels in this group, and lower values of 
haematocrit with higher values of erythrocyte coefficient of variation and, therefore, lower 
blood viscosity, perhaps due to the fact that the majority of type 2 diabetics are medicated 
for hypertension. As expected, type 2 diabetes subjects presented lower values of C-peptide, 
as it reflects the amount of insulin present in blood. 
In fact, type 2 diabetics presented higher levels of ALT, an indicator of liver damage or injury, 
and higher levels of the enzymes alkaline phosphatase and gamma GT, related to all forms of 
liver disease. The maximum value for controls is within the normal range of alkaline 
phosphatase levels, but for type 2 diabetics it exceeded the normal maximum value (Table 
13), and for those patients it may be an indicator of biliary obstruction. Gamma GT values in 
the blood are an indicator of the liver and biliary systems. 
Parameters concerning cholesterol are significantly lower in the diabetic group, either the 
total cholesterol or the LDL and HDL cholesterol (Table 14). LDL cholesterol can build-up a 
lining over the walls of the arteries and increase the risk of heart disease, and should be 
below 129 mg/dL; HDL cholesterol protects against heart disease, by eliminating LDL 
cholesterol, and should be above 60 mg/dL. As apolipoprotein A1 is the principal protein 
component of the HDL cholesterol, it is also present in lower values on type 2 diabetics, 
although no statistical significant differences were found for apolipoprotein B100, present in 
LDL cholesterol. Total cholesterol is a measure of HDL, LDL and other lipid components. Type 
2 diabetics show lower levels of mean and median cholesterol (respectively 175.24 and 
161.00 mg/dL) than controls (200.78 and 197.00 mg/dL) but the range of values in type 2 
diabetics (86.00 to 398.00 mg/dL) is much higher than in controls (117.00 to 292.00 mg/dL). 
Overall, desirable values should be under 200 mg/dL, but not too low, since cholesterol is 
necessary to build and maintain membranes, as it modulates membrane fluidity over the 
range of physiological temperatures. On the other hand, type 2 diabetics have higher risk of 
coronary or other cardiovascular disease, as they have higher values of triglycerides (mean 
138.45; median 146.00) than controls (mean 117.72; median 94.00). Abnormal values (above 
150 mg/dL), are present in both groups, as well for the atherogenic index, a parameter that 
reflects the ratio between triglycerides and HDL cholesterol as it is computed as log	
	 ⁄ . In fact, type 2 diabetics present higher levels of triglycerides 
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and lower levels of HDL cholesterol, which is reflected on this ratio as that group has a 
higher risk of cardiovascular diseases.  
Type 2 diabetics also presented higher values of leucocytes (p = 0.024) and lower values of 
haematocrit (the percentage of haemoglobin in total blood volume composed by red cells) 
and, consequently, lower values of haemoglobin which are related to a good oxidation as it 
is a transporter of oxygen in the organism. 
As the extra-cellular and citoplasmatic life of insulin is very short, C-peptide is a marker for 
insulin values since it is connected to insulin forming pro-insulin and is released in blood in 
the same proportion as insulin. Moreover, C-peptide has a higher life-time than insulin thus, 
it was already expected that type 2 diabetics had lower values of C-peptide (Table 18), 
although this had to be confirmed. 
Concerning ophthalmological tests, a type 2 diabetic is expected to present lower best 
corrected visual acuity (p = 0.001) than controls, similar volume scan density (Table 19), and 
differences on the temporal (p = 0.041) and temporal-inferior (p = 0.047) quadrants of the 
retinal nerve fibre layer thickness (Table 20), with higher thickness of the temporal quadrant 
but lower thickness at the inferior region of the temporal quadrant. This group of subjects 
has worst performance of the speed test (Table 21), whichever the meridian used, 
performed worse in the achromatic vision discrimination test (Table 22) along meridian 90º 
(p = 0.005), and also worst on chromatic contrast sensitivity test on the Protan axis, along 
the meridian 0º (p = 0.043), on the Deutan axis, either globally (p = 0.013) or along meridians 
0º and 45º (respectively p < 0.001 and p = 0.042),  as well as on the Tritan axis, whichever 
the meridian used or even the global measure, as observed in Tables 23 to 25. 
 
When we performed a univariate classification on the above identified variables which had 
differences between the two subgroups, by a ROC analysis, we confirmed that, in fact, most 
of those parameters could be used as classifiers of type 2 diabetes since they presented 
good accuracy on prediction of type 2 diabetes, measured by the area under the ROC curve, 
as well as the variable positive predictive value (Tables 26 to 35). However, we did not 
posteriorly consider some of the variables (as weight and height, as they are included in the 
body mass index), and abdominal perimeter, pulse and systolic or diastolic blood pressure 
due to the lack of information in several cases. 
Then, a more refined profile of a type 2 diabetic older than 40 may be traced as a subject 
whom will probably show one or more of the following conditions: 
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- Body Mass Index > 26.95 kg/m
2
; 
- ALT > 26.50 units per litre of serum; 
- Alkaline Phosphatase > 64.50 units per litre of serum; 
- Gamma GT > 24.50 units per litre of serum; 
- Atherogenic Index > 3.35; 
- Total Cholesterol < 182.50 mg/dL; 
- Cholesterol LDL > 114.50 mg/dL; 
- Cholesterol HDL < 45.50 mg/dL; 
- Triglycerides > 119.00 mg/dL; 
- Apolipoprotein A1 < 132.50 mg/dL; 
- Leucocytes  > 6.55 ml/mm
3
; 
- Haemoglobin < 12.65 g/100mL; 
- Haematocrit < 38.25%; 
- C-Peptide < 1.35 ng/mL; 
- BCVA  < 0.90; 
- RNFL on Temporal quadrant  > 67.50 µm; 
- Speed test 
- Meridian 0º > 1.59; 
- Meridian 45º > 2.17; 
- Meridian 90º > 0.86; 
- Meridian 135º > 1.62; 
- Global area > 2.86; 
- Achromatic test 
- Meridian 90º > 2.32; 
- Chromatic test 
- Protan 
- Meridian 0º > 2.47 x 10
-3
 (º/s); 
- Deutan  
- Meridian 0º > 3.40 x 10
-3
 (candelas/m
2
); 
- Meridian 0º > 8.34 x 10
-3
 (candelas/m
2
); 
- Tritan test 
- Meridian 0º > 67.20 x 10
-3
 (ratio to maximum); 
- Meridian 45º > 59.99 x 10
-3
 (ratio to maximum); 
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- Meridian 90º > 77.13 x 10
-3
 (ratio to maximum); 
- Meridian 135º > 109.11 x 10
-3
 (ratio to maximum); 
- Global area > 6.16 x 10
-3
 (ratio to maximum). 
 
These variables identified as univariate classifiers of diabetes were tested under multivariate 
techniques in order to evaluate their independent prediction of type 2 diabetes using 
discriminant analysis, logistic regression and decision trees algorithms. 
 
Although classical assumptions of discriminant analysis were violated, the model could be 
developed and identified hypertension measured by blood pressure controlled by 
medication, body mass index, cholesterol HDL, triglycerides, C-peptide, retinal nerve fibre 
layer thickness in the temporal quadrant and chromatic contrast sensitivity for the Tritan 
axis along meridian 135º as classifiers of diabetes (Table 36), being the accuracy of 
predictions given by the area under the ROC curve for posterior probabilities of 0.985 (p < 
0.001), at the training sample (Table 37). This model has high sensitivity (92.31%) and 
specificity (92.31%) if we consider the cut-off of 50% regarding posterior probability, and 
97.44% if we consider the 61.04% cut-off, obtained by ROC analysis, for that probability), 
and its positive likelihood ratio is, respectively, 12.00 and 36.00. This model is very robust, 
but has few applications for screening of diabetes, since it needs parameters of blood tests, 
OCT and psychophysical tests. 
A subject will be classified, according to this model, as a type 2 diabetic if | ≥ 50%, 
given by 
 
| = .!"#$%&'()& .!"#*$%&'(+&,-.!"#$%&'()& , where.
/ = 0"-.12.34
 = 0"5.62.44  and   
 78 = −3.233 + 1.548 × AB + 3.274 × A	DE135º − 0.039 × HℎJ −  
 −0.998 × HK	 + 0.034 × LM7NK + 0.008 × A	
	 +  
 +0.090 × OPQ          
 
The variable HTA is set to 1 if the subject is medicated for hypertension, and 0 if not. All the 
other variables are numerical. 
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A simpler way to classify a subject as type 2 diabetic is if 78 > 0.122, and determinate 
posterior probability later. 
 
The model obtained by regression analysis (Tables 38, 39 and 41), using binary variables 
according to the cut-offs obtained by ROC analysis and previously presented, also identify 
hypertension, body mass index (> 26.95 kg/m
2
) and thickness of the RNFL on the temporal 
quadrant (> 67.50 µm), but uses values of apolipoprotein A1 (< 132.50 mg/dL) and 
achromatic contrast sensitivity along the 90º meridian (> 2.32) as predictors of diabetes, 
with an accuracy of predictions based on the posterior probability of 0.952 (p < 0.001), 
which presents a sensibility of 86.05% and a specificity of 93.18%, with a positive likelihood 
ratio of 12.62. The gain in PLR, compared to the PLR obtained by discriminant analysis do not 
justifies the use of this model, as it loses sensitivity. 
The logistic regression classifier is defined as  ≥ 50%, where  
  = ST%%.UVWXV.YZY×[\]XY.ZWZ×]^_`abZUº)XY.cW%×defXV.UU&×]ghia]%XV.%%Y×jklm(nobi)-ST%%.UVWXV.YZY×[\]XY.ZWZ×]^_`ab(ZUº)XY.cW%×defXV.UU&×]ghia]%XV.%%Y×jklm(nobi) 
 
Each one of the variables assumes the value of 1 or 0 according to the dichotomization 
obtained by ROC analysis and presented before. 
 
Applying decision tree algorithms, we obtained four models that do not differ in accuracy 
(Table 42; DeLong test minimum p-value, not adjusted for multiple comparisons, is 0.052). 
Models were evaluated by the application of ROC analysis to the probability of being 
diabetic. Although models obtained by the application of CHAID or Exhaustive CHAID 
algorithms are the ones with higher sensitivity (respectively 94.29% and 91.43%), the models 
obtained with CART and QUEST algorithms are the ones with higher positive likelihood ratio 
(respectively 4.59 and 3.86). 
Decision tree models are simpler to apply in a routine ophthalmological exam, since they 
only use sociodemographic variables such as age (CART algorithm) or age and BMI (QUEST 
algorithm) or blood pressure controlled by medication (CHAID and Exhaustive CHAID 
algorithms), and values obtained in the speed test and Chromatic contrast over the Tritan 
axis or in meridian 45º (CART and QUEST algorithms) or in meridian 135º (CHAID and 
Exhaustive CHAID algorithms). CART algorithm considers haemoglobin but in the last node, 
so tree may be pruned in order to consider only non-invasive exams. 
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Comparing the performance of these models on the training sample, the one with highest 
positive likelihood ratio, as well as area under the ROC curve, is the one obtained with 
discriminant analysis, and the one with highest sensitivity is the one obtained with the 
CHAID algorithm on decision tree analysis, as summarized below (Table 87): 
 
Table 87 - Accuracy of developed models measured in the training sample. 
Model AUC (p) 
Cut-off 
Function 
(Prob) 
 
% 
Correct 
k p 
 
McNemar 
(p) 
 Sens. Spec. +LR 
DF 
0.985 
(< 0.001) 
0.122 
(50.00%) 
 92.31% 0.846 < 0.001 
 
1.000  92.31% 92.31% 12.00 
DROC 
0.264 
(61.04%) 
 94.87% 0.897 < 0.001 
 
0.625  92.31% 97.44% 36.00 
L 
0.942 
(< 0.001) 
50.00%  89.66% 0.793 < 0.001 
 
0.508  83.87% 90.48% 8.81 
T1 
0.882 
(< 0.001) 
50.00%  82.29% 0.629 < 0.001 
 
0.332  82.86% 81.97% 4.59 
T2 
0.800 
(0.048) 
50.00%  80.43% 0.615 < 0.001 
 
< 0.001  94.29% 71.93% 3.36 
T3 
0.789 
(< 0.001) 
50.00%  79.35% 0.591 < 0.001 
 
0.004  91.43% 72.93% 3.26 
T4 
0.860 
(< 0.001) 
50.00%  81.25% 0.619 < 0.001 
 
0.031  88.57% 77.05% 3.86 
 
In fact, we find statistical significant difference between the area under the ROC curve 
obtained by discriminant model and decision trees based on CHAID, Exhaustive CHAID and 
QUEST algorithms (respectively p = 0.002, p = 0.001 and p = 0.012 by the DeLong test). The 
logistic regression model presents also better accuracy than trees obtained with CHAID and 
Exhaustive CHAID algorithms (respectively p = 0.027, p = 0.018). These p-values were not 
adjusted for multiple comparisons, thus, a simple but rather conservative procedure would 
be considering the Bonferroni correction, that is, those p-values should be multiplied by 15 
(H2) and the resulting p-values adjusted (K̂) would be given by K̂ = N	Eq1; K − sDtu. In 
this case, we can assume that the discriminant model accuracy is higher and statistical 
significant different from decision tree models obtained by CHAID and Exhaustive CHAID 
algorithms (respectively p = 0.030 and p = 0.015), and no other statistical significant 
differences are found between the other models. 
Notice that all models, with the exception of T2, T3 and T4 present similar false positive and 
false negative rates, according to the McNemar test. 
 
When we apply these models to new cases, that is, to the test sample, results are surprising 
since the worse models in the training sample became the best models on the test sample.  
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Note that (Table 87) the discriminant and logistic classifiers are the ones with highest area 
under the ROC curve (respectively 0.937 and 0.935, both with p values under 0.001), but 
both present lower limit of the 95% confidence interval for specificity below 50%, and the 
first one has also a lower limit on the 95% confidence interval for positive likelihood ratio 
below 1, meaning that in the extreme ranges it may be as probable to have a true positive 
classification as a false positive one.  Moreover, decision tree T1 and T4 classifiers also 
present lower limits on 95% confidence interval above 50%, and are the ones with lower 
accuracy. Then, the chosen classifier for diabetes is the one obtained with the CHAID or with 
the exhaustive CHAID decision tree algorithms, which performance is equal when applied on 
the test sample, since they present good accuracy (AUC = 0.894, p < 0.001), both with 
expected sensitivity and specificity on population above 50% (respectively 87.88% ∈71.80%; 96.60%  and 83.33% ∈ 51.60%; 97.90%  with  95% confidence), and an 
expected positive likelihood ratio between 1.50 and 18.80, which means that is 1.5 times to 
about 19 times more probable to have a true positive classification than a false positive 
classification. 
 
In clinical practice, and for screening purposes, we are interested in evaluating positive (PPV) 
and negative predictive values (NPV) in order to determine the posterior probability for a 
given subject to be a type 2 diabetic, when it is classified as that (PPV) or to be healthy in 
respect to type 2 diabetes when is classified as normal (NPV). As this values depend on 
disease prevalence, and diabetes prevalence is becoming higher every year, due to several 
factors such as the aging of populations, pair wise with the reduction of physical activity and 
the increase of obesity, among others, the values presented in Figure 55 are based on the 
estimates of diabetes prevalence from the year of 2012, and predictive values need to be 
updated as new data on prevalence becomes available. 
The model presented may be written as the following, classifying a subject as diabetic 
whenever ≥ 50%, for any subject without diagnosed hypertension, since all subjects 
undergoing treatment for hypertension have higher risk of also have type 2 diabetes, with a 
probability of 82.61%: 
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xDt	NDt	JE	N		DE	135º	Jz	I	HIJND		A	DE	D8	  
⇒
|}
~
} 134.33 @ 105 ⇒  87.50%
 134.33 @ 105 ⇒   7.69%
EEJE ⇒   22.45%
 
This is a simple and non-invasive method to detect type 2 diabetes, that may be used in 
ophthalmological visits. If there is a suspicion of the presence of type 2 diabetes, then it 
should be confirmed with standard diagnostic tests, which are the gold standard. 
 
However, if prevalence continues to grow, in Portugal, at the same rate as it grew between 
the years of 2009 and 2012 (1.2%), in a few years (Figure 56) the positive predictive value of 
this classifier will be above 50%, with similar negative predictive values. If, as expected, type 
2 diabetes prevalence grows faster than 1.2% every three years, then rapidly we may get 
higher positive predictive values for this classifier, without losing its negative predictive 
value. 
 
Figure 56 – 12 years prevision for predictive values of T2 classifier. 
 
 
Concerning diabetic retinopathy, we were not able to apply exactly the same methodology 
used for the development of type 2 diabetes classifier, since we were not able to have, at 
this moment, a test sample with a reasonable number of cases to evaluate developed 
models based on the training sample. This will be done afterwards, and probably we will 
have enough data to test developed models within a few months. 
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The development of diabetic retinopathy classifiers using the training sample was obtained 
using the same methodology as before. Hence, we begun to compare the same variables as 
before, as well as family history of diabetes, duration of the disease, and compared groups 
according to ETDRS grading which was performed on 40 type 2 diabetics (20 with and 20 
without diabetic retinopathy), and dichotomized as DR present or absent. Groups were 
matched for age and gender, as well as daily habits (tobacco and alcohol use, and regular 
exercise practice) and family history of diabetes. Likewise, no statistical significant 
differences were found in the percentage of cases with need for control of blood pressure 
with medication, height, weight, body mass index and bio impedance, pulse, systolic or 
diastolic blood pressure. However, subjects with diabetic retinopathy had type 2 diabetes for 
a longer duration than subjects without diabetic retinopathy (from 2 to 12 years longer), as 
presented in Tables 48 and 49. 
 
Concerning blood tests (Tables 50 to 57), we did not find statistical significant differences for 
glucose levels (p = 0.622) or HbA1C levels (p = 0.967), but we were able to differentiate 
groups based upon creatinine (p < 0.001), erythrocytes (p = 0.023), haemoglobin and 
haematocrit (respectively 0.010 and 0.014). We may say that a type 2 diabetic with non-
proliferative diabetic retinopathy has usually previous history of diabetes on family, higher 
levels of creatinine and less oxidation as he present lower values of haemoglobin and 
haematocrit. 
Measures obtained for the dominant eye (Tables 58 to 64) are statistically different for the 
inner-nasal quadrant of volume scan density from OCT (p = 0.026), where subjects with 
diabetic retinopathy present higher volume scan density, without statistical significant 
differences regarding the retinal nerve fibre layer thickness. Speed, achromatic vision and 
chromatic vision for the Protan axis were also similar between groups. Yet, for the Deutan 
axis, over the 0º meridian (p = 0.041), and for the Tritan axis, over meridians 0º (P = 0.003) 
and 135º (p = 0.002), as well on the global measure for Tritan (p = 0.017) which was 
obtained by the 5-sided polygon generated by the median values of meridians and the 
origin, where type 2 diabetics without diabetic retinopathy showed to have changed 
chromatic discrimination. 
 
Using Receiver Operating Characteristic curve analysis (Tables 65 to 75), we were able to 
reduce the set of variables, since we found that the only variables with significant area under 
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the ROC curve were the duration of the disease (AUC = 0.748; p = 0.007), erythrocytes (AUC 
= 0.710; p = 0.023), haemoglobin (AUC = 0.746; p = 0.008) and haematocrit (AUC = 0.728; p = 
0.014), volume scan density on inner-nasal quadrant (AUC = 0.705; p = 0.027), discrimination 
for the Deutan axis over the 0º meridian (AUC = 0.701; p = 0.042), and for the Tritan axis 
over the 0º meridian (AUC = 0.776; p = 0.004), and the 135º meridian (AUC = 0.792; p = 
0.003), as well as for the global area (AUC = 0.735; p = 0.017), which allowed us to identify 
the following cut-offs: 
- duration of the disease >  18.50 years; 
- erythrocytes  <  4.23x10
6
/mm
3
; 
- haemoglobin <  13.20 g/100mL; 
- haematocrit < 36.25%; 
- volume scan (OCT) on Inner-Nasal quadrant  > 355.50 µm; 
- chromatic test 
- Deutan  
- meridian 0º > 4.46 x 10
-3
 (candelas/m
2
); 
- Tritan test 
- meridian 0º > 63.25 x 10
-3
 (ratio to maximum); 
- meridian 135º > 174.81 x 10
-3
 (ratio to maximum); 
- global area > 5.94 x 10
-3
 (ratio to maximum); 
 
As on the development of type 2 diabetes classification models, the variables identified as 
univariate discriminators of the presence of diabetic retinopathy were tested using 
discriminant analysis, logistic regression and decision trees algorithms. 
 
Normal distribution for variables on each group failed mainly on eye measurements, and 
especially in the group without diabetic retinopathy but, as in the case of the development 
of a diabetes classifier, we proceeded with the application of discriminant analysis since 
groups had exactly the same dimension and the F statistic is very robust to normality 
deviations in these situations. On the other hand, we confirmed the homogeneity of 
covariance matrices since we obtained a p-value of 0.942 at the Box M test. 
 
We obtained a classifier for the presence of diabetic retinopathy defined as: 
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 *L#SS	SS , ≥ 50%, where 
 L#SS|	SS   .!"#$%&'()j	i`oon& .!"#*$%&'()j	on& ,-.!"#$%&'()j	ioon&   
 
Where ./ = 0"-.12.34 = 0"5.62.44  and 
 78 = −1.672 + 5.215 × A	DE!º + 0.109 × tD	JE −  
 −0.590 × DNJ
J	E + 0.021 × xS  
 
Or, simply ascertain whether 78 > 0.002	or not. 
 
The model obtained by regression analysis, using binary variables according to the cut-offs 
obtained by ROC analysis and presented above and in Tables 78 to 80, identifies only the 
global area of chromatic discrimination on the Tritan axis as separating subjects with 
diabetic retinopathy present from those where it is absent, and the classifier is defined as L#SS ≥ 50%, where 
 
L#SS  = ST&.YUYX&.ZZ×+_`ab\-ST&.YUYX&.ZZ×+_`ab\ 
(HℎJNA = 1		zHℎJNA ≥ 5.94 × 105; Jℎ	, HℎJNA = 0	 
 
Considering decision tree algorithms, CHAID and Exhaustive CHAID were not able to grow 
the tree, and CART and QUEST algorithms lead to the same solution, which is 
 xDt	NDt	JE	N		DE	135º	Jz	ℎ	HℎJND		A	DE	D8	  
≥ 174.81 × 105 	⇒ () = 85.71%< 174.81 × 105 	⇒ () = 23.81% 
 
Comparing the obtained models at the training sample, we may observe that the all the 
three classifiers (discriminant, logistic and decision tree classifiers) are centered on 
chromatic discrimination over the Tritan axis, either on the global area or along meridian 
135º. However, the discriminant model is more complex and also identifies volume scan 
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measured on the inner nasal quadrant, haemoglobin and duration of the disease as markers 
of diabetic retinopathy.   
In fact, as observed on Table 83, the discriminant model has significantly higher accuracy 
measured by the area under the ROC curve determined for posterior probabilities than the 
logistic model (non-adjusted DeLong test p = 0.002) and also than the decision tree model 
(non-adjusted DeLong test p = 0.044). However, we should consider that difference only 
exists between the logistic regression classifier and the discriminant classifier due to multiple 
comparisons performed. Moreover, positive likelihood ratios of the discriminant model 
(14.82) and of the decision tree model (19.41) are much higher than the one obtained for 
logistic regression model (2.88), in spite of this model is the one with higher sensitivity 
(87.88% ∈ 71.80%; 96.60% and 83.33% ∈ 51.60%; 97.90% with  95% confidence. 
All these three models should be evaluated on a set of new cases, and will be, in a near 
future, but at the moment we can only compare their performance in the training sample.  
With this data, and considering a prevalence of 34.6% for diabetic retinopathy within 
diabetics, the decision tree and discriminant models present good positive predictive values, 
as observed on Table 84 and Figure 49, with a lower bound on the 95% confidence interval 
above 50%, which does not happen with the logistic regression model. Note that the disease 
prevalence used was determined among all diabetics, and not only for type 2 diabetics. 
However, the estimates refer that diabetic retinopathy will affect 50% of diabetics and, if 
that really happens on type 2 diabetics, then the decision tree model is expected to have a 
positive predictive value of 95.16%, which means that in every 100 subjects with values for 
chromatic vision over the Tritan axis along meridian 135º of 0.17481 or higher, 95 will be, in 
fact, type 2 diabetics. With the actual values of prevalence, this is real for 91 in every 100 
subjects. 
The logistic model as high negative predictive value 95.6% ∈ 82.1%; 99.70% with 95% 
confidence, thus, as it is a simple model based also on chromatic discrimination over the 
Tritan axis, it may be applied to all cases that turned out to be classified as negative on the 
decision tree model, improving classification. 
This may be a simple and non-invasive test to perform and that enables the standardization 
of different criteria for diabetic retinopathy classification. However, as it was previously 
referred, this model must be evaluated first on a test sample of adequate dimension. 
 
 
 C H A P T E R  8  
 
C O N C L U S I O N S  
 
 
Correlation between eye measurements obtained by Optical Coherence Tomography is 
moderate to strong. In fact, concerning the volume scan density, the minimal correlation 
coefficient found was of 0.777 for the Inner Inferior quadrant, and concerning the retinal 
nerve fibre layer thickness, the minimal correlation coefficient obtained was of 0.674 in the 
nasal quadrant. 
 
Whenever we had data not adjusted to normal distribution, we may use a pseudo-
concordance correlation coefficient to evaluate concordance between eyes, as it uses non-
parametric assumptions, and it is a closer measure to the intra-class correlation coefficient 
than the classical concordance correlation coefficient which is computed using Pearson’s 
correlation though, based on parametric assumptions. 
 
 
Besides being correlated, the two eyes also show great concordance. Hence, only one eye is 
sufficient for analysis. 
 
 
In spite of hypertension is evaluated through the register of medication taken for blood 
pressure control, we found that type 2 diabetics have higher values of systolic blood 
pressure than controls, but no difference was found in the diastolic blood pressure. 
 
Subjects with type 2 diabetics have higher risk concerning liver and biliary system damage, 
evaluated by levels of ALT, alkaline phosphatase and gamma GT in the blood, higher risk of 
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cardiovascular disease reflected by higher levels for triglycerides and atherogenic index. 
Furthermore, they have less oxygenation due to lower levels of haemoglobin, haematocrit 
and higher coefficient of variation on erythrocytes.  
Oddly, type 2 diabetics present lower levels of total cholesterol, cholesterol LDL and 
apolipoprotein A1, but also lower levels of cholesterol HDL. However, when we analyse 
these variables in a multivariate context, interacting with other parameters, they became 
risk factors for type 2 diabetes. 
 
Concerning vision, type 2 diabetics are expected to have a lower best corrected visual acuity, 
higher thickness of the retinal nerve fibre layer in the temporal quadrant, less perception of 
motion, less perception of colour (achromatic vision) along meridian 90º, and 
monochromatic vision along meridian 0º, with higher probability of having damages in all 
the photo pigment cones (Protan, Deutan and Tritan). Concerning the 135º meridian, vision 
is compromised since the vision is mostly dichromatic due to Tritan axis, and for the 45º 
meridian vision is usually atypical due to Deutan and Tritan axes. 
 
 
The development of a simple global measure for speed, achromatic and chromatic vision 
tests, dependant of the four measures obtained in each one of the meridians, for each test, 
revealed to be useful, allowing discrimination of type 2 diabetes with the speed test where 
type 2 diabetics shown to be slower at movement detection, and on the Tritan axis of the 
chromatic test, where type 2 diabetics presented more difficulties. The algorithm for 
computing the area of the 5-side polygon is simple, and may be easily implemented. 
 
 
Although discriminant analysis assumptions were violated, the model for type 2 diabetes 
classification is very robust either in the training sample or the test sample. 
It identifies Hypertension, Body Mass Index, Cholesterol HDL, Triglycerides, C-Peptide, 
thickness in the temporal quadrant of the retinal nerve fibre layer of the dominant eye and 
chromatic contrast sensitivity at meridian 135º as markers of type 2 diabetes, which allows 
to define a profile for this subjects as individuals who need medication for controlling blood 
pressure, higher Body Mass Index, lower values of Cholesterol HDL and higher values of 
Triglycerides (indicating lower metabolic control on lipids and thus higher risk of 
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cardiovascular diseases), lower values on C-peptide (indicating lower values of insulin 
present on blood and of insulin production by the pancreas), and with a higher thickness of 
the retinal nerve fibre layer which may induce a lack of perception of light and thus may be 
related with the tritanope defect on meridian 135º. 
 
The three logistic regression models lead to the same solution, whichever the method used. 
It identifies three of the previous variables as type 2 diabetic markers: Hypertension, Body 
Mass Index and thickness of the retinal nerve fibre layer of the dominant eye, in the 
temporal quadrant. Cholesterol HDL and Triglycerides, identified with the discriminant 
analysis model, were replaced by Apolipoprotein A1 (which has a specific role on the lipid 
metabolism) at the logistic regression model, having the role of increasing the risk of the 
presence of type 2 diabetes. Tritanope defect is replaced by the total loss on chromatic 
vision along meridian 90º Nevertheless, the profile of a type II diabetic given by this model is 
similar to the previous one, where diagnosed hypertension under medication and body mass 
index are considered as risk factors for type 2 diabetes. 
 
Decision tree models are similar two by two; CART and QUEST algorithms base their primary 
decision on age, perhaps due to the fact of patients in the sample are older. On the other 
hand, models based on the CHAID algorithm have as first decision criteria the fact that 
subjects have their blood pressure controlled by medication, as discriminant and logistic 
regression models. All the models present good accuracy on the training sample, and share 
common criteria for splitting nodes based upon chromatic vision at Tritan axis. 
 
The CART algorithm identifies the global measure for speed discrimination, chromatic vision 
on meridian 45º and values of haemoglobin as markers of type 2 diabetes. The profile for 
these subjects will be defined as a subject that is younger than 51.5 years and has a global 
value on speed of, at least, 3.75, or for older subjects with at least 51.5 years, presenting 
minimum values of 59.99x10
-3
 for the 45º meridian of the Tritan axis on chromatic vision. 
The accuracy of the classification for older subjects may be improved whenever subjects 
present haemoglobin values below 14.95 g/100mL, whatever the gender. 
The QUEST algorithm also bases its classification of older subjects, with at least 51.5 years, 
on values measured for the 45º meridian of the Tritan axis, with the same cut-off, which was 
the one identified with univariate ROC analysis, but for younger subjects bases its 
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classification is based up on the Body Mass Index. Considering that a subject with less than 
51.5 years and a Body Mass Index of, at least, 32.55 kg/m
2
, there is 80% probability of being 
a type 2 diabetic. 
For CHAID and Exhaustive CHAID algorithms, chromatic sensitivity over the meridian 135º of 
the Tritan axis is the criteria to classify subjects without diagnosed hypertension, when its 
value is, at least 134.33x10
-3
, defining the probability for the presence of type 2 diabetes as 
87.50%. If the subject has diagnosed hypertension and is being treated for this medical 
condition, then the probability that he or she also is, as well, type 2 diabetic, is 82.61%. 
 
In spite of the violation of the assumptions for discriminant analysis, the models behaves 
quite well when applied to the test sample, showing higher concordance with the true result 
than the logistic regression model, which does not have so many requirements, but uses less 
information since it is based on dichotomized variables and not on quantitative ones. 
Notwithstanding, the decision tree model, namely the CHAID algorithm, has the better 
performance when applied to the test sample. 
 
The posterior probability for the presence of type 2 diabetes on non-hypertensive subjects, 
or undiagnosed hypertensive subjects is 22.45%, similar to the type 2 diabetes prevalence 
for the Portuguese population for the age group over 60 years old. 
 
The loss of the chromatic vision for the Tritan axis is a crucial marker for type 2 diabetes. 
 
The classifier for type 2 diabetes based upon decision tree algorithm has a high positive 
predictive value, adjusted for actual prevalence values of this disease for the Portuguese 
population, especially concerning the age group from 60 to 75 years of age, particularly for 
males but also for females, or for obese subjects, with at least 30 kg/m
2
 of the Body Mass 
Index. 
 
 
The duration of diabetes is a known factor contributing for the development of diabetic 
retinopathy that was identified, once more, as a marker for the progression of this disease 
and, though, visual impairment. 
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Values of erythrocytes, haemoglobin and haematocrit may also be considered as possible 
markers of the presence of diabetic retinopathy.  
In what concerns the eye, we found that volume scan density at the inner-nasal quadrant 
and chromatic vision on the Deutan (meridian 0º) and Tritan (meridian 0º, meridian 135º 
and global value of Tritan) axes may, negatively, discriminate the presence of diabetic 
retinopathy. 
 
The model obtained with discriminant analysis, although failing the multivariate normality 
assumption, gives an accurate profile for patients with diabetic retinopathy based on higher 
duration of the disease, lower values on haemoglobin, and worse values of volume scan 
density at the inner-nasal quadrant and Tritanope presence at least over the meridian 135º. 
 
The model obtained with logistic regression analysis only considers the overall measure for 
the Tritan axis as a classifier for the presence of diabetic retinopathy, although the adequate 
accuracy demonstrated. 
 
Considering the decision tree model based on CHAID or Exhaustive CHAID algorithms, we are 
able to classify the presence of diabetic retinopathy based upon values of chromatic colour 
discrimination over the Tritan axis, on meridian 0º. 
 
The model presenting higher positive predictive value, at least when applied to the training 
sample, was developed with decision tree algorithms. 
 
 
The loss of the chromatic vision for the Tritan axis is a crucial marker for non-proliferative 
diabetic retinopathy in type 2 diabetes. 
 
 
For the developed models, the ones that always performed better were the models based 
upon decision tree algorithms, without assumptions on data distribution. The logistic 
regression models do not have, also, distribution assumptions, but were the ones with worse 
performance, although its performance is adequate. The use of binary variables brings loss 
of information with impact on the accuracy of these models. Discriminant analysis models 
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are robust to the violation of assumptions on data distribution, and return classifiers with 
good accuracy on previsions, but also more complex than decision tree models. 
 
We may present a classifier for type 2 diabetes subjects already tested on new cases, and 
based upon measures obtained for the dominant eye of subjects aged between 40 and 75 
years old (to use in subjects not undergoing hypertension therapy): 
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The eye plays, though, an important role in the diagnostic of type 2 diabetes, giving 
important clues for diagnosing this systemic disease on subjects older than 40 years old. 
 
 
A classifier for non-proliferative diabetic retinopathy which needs to be evaluated on new 
set of cases, also based on measures obtained for the dominant eye of subjects aged 
between 40 and 75 years old: 
  	
  	
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The Tritan axis is the most important marker identified. It enables classification of type 2 
diabetes (meridian 45º) in subjects not undergoing treatment for hypertension, and also 
classification of non-proliferative diabetic retinopathy (meridian 135º) in type 2 diabetics. 
The identified marker is specific for subjects aged between 40 and 75 years, without 
neuropsychiatric, renal, heart, ocular or any other severe disease unrelated to the aging 
process. 
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A final model for screening each of the referred conditions may be proposed (Figure 57), in 
spite of the need for future confirmation (on an independent test sample) concerning the 
diabetic retinopathy classifier. Hence, Tritanope vision represents an augmented risk for 
both clinical classification frameworks. 
 
Figure 57 – Final classification model for type 2 diabetes and non-proliferative diabetic retinopathy in subjects 
aged between 40 and 75 years old 
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 C H A P T E R  9  
 
F I N A L  C O N S I D E R A T I O N S  
 
 
1. Study Limitations 
 
Although they have already been mentioned in the discussion chapter, we leave here a 
summary of some limitations found during the analysis, as we intend to pursue the study 
and they will be the object of further work. 
 
At the moment, not all of the cases have been included in the study, and type 2 diabetics 
and control groups were not matched for age. However, age was considered in all the 
multiple variable analyses for classification, thus so models were adjusted for age 
differences. 
Furthermore, there were still few data available for analysis regarding multimodal imaging 
related to heart, liver and brain, hence these variables were not considered in analysis, as 
well as medical procedures such as blood pressure or abdominal perimeter measurements, 
which may be related to type II diabetes.  
 
We should be able to evaluate the impact of gestational diabetes on type II diabetic females, 
which prevalence is known to be increasing from 3.4% in 2005 to 4.8% in 2012, representing 
an enhanced risk of the developing type 2 diabetes in the future years. However, we were 
not able to develop a classifier for women using this variable, since parity was not evaluated, 
nor the number of pregnancies and number of pregnancies with gestational diabetes. 
 
Random error between left and right eye was significantly different for the inner superior 
and inner inferior quadrants. We decided to use only one eye in the study, since 
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concordance between eyes was high, in spite of some differences found in the Temporal, 
Nasal-Inferior and Nasal-Superior quadrants of the RNFL, as suggested by Armstrong
[32]
. We 
hope that, until the end of the study inclusion process, the random error found between 
groups in measurements performed on volume scan density in both eyes becomes identical, 
since the only way to improve random error is to increase the sample size.  
 
When we presented classifiers for non-proliferative diabetic retinopathy, we were not able 
to evaluate the developed models into an independent test sample, since few data are still 
available. We consider these classifiers as preliminary classifiers, which will need to be 
tested in a sample of new cases. On the other hand, there were no cases in the sample with 
proliferative diabetic retinopathy thus we were not able to study this condition. 
 
Overall, there are still many parameters with missing data in the database, not because they 
have not been measured, but because we are still waiting to be recorded in the database. 
This fact reduced the sample size of the data for training and for test samples in about 20% 
and we have collected only about less than 50% of the final sample size. 
 
 
2. Further work 
 
At the end of the study, we will have available 400 to 600 subjects, half on each group 
(controls and type 2 diabetics). 
 
We intend to study with more detail the correlation between eyes, and especially the 
random error of measurements. With the increase of the sample size, it is expected that the 
errors in measurements between eyes may decrease due to the reduction of the random 
error, since systematic error should be controlled. However, it is of great interest, especially 
for methodology, that we compare random errors in measurements between groups, since 
it can be used as an assessment of the precision of the measurements. The random error 
comparison since it may be, by itself, a discrimination parameter between groups. 
 
With the complete sample, we will be able to have all the data from all the tests performed 
and cross-correlation between organ dependent measures may be assessed. It is our 
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intention to use half of the final large sample as a training sample, and that developed 
models may be evaluated on new subjects. By then, we will be able to study the impact of 
diabetes not only on diabetic retinopathy, but also in liver and heart injury, as well as in 
brain. 
 
Concerning statistical methods, all the classifiers presented may be used then, with few 
adaptations, for three group classification, that is, for discrimination between controls, type 
2 diabetics without diabetic retinopathy and type 2 diabetics with diabetic retinopathy 
patients, or for discrimination between grading levels of diabetic retinopathy. However, ROC 
analysis is still used for discrimination between groups. Some work is already undergoing in 
order to obtain these curves for three group discrimination, using volume formulas instead 
or areas under the curve. In fact, their construction is somewhat similar to a three group 
discrimination function, where one function discriminates between one group and the other 
two, and the second function discriminates between the last two groups. This will always be 
an univariate procedure and it is being developed, but the intention is to integrate it with 
the multi-ROC procedures that are beginning to appear. In fact, multi-ROC procedures are in 
a development phase, although some have been recently published, using integration of 
linear combinations in a reduced space of the area under the ROC curve. It would be very 
interesting to develop ROC functions for three group discrimination, with cut-off definition 
for each group, and to integrate this in a multi-ROC procedure. 
On the other hand, not related to statistical methods but with the clinical practice, if we 
become able to discriminate between this diabetic retinopathy grading, then we may 
propose a method for its classification based upon more objective measurements in order to 
standardize diabetic retinopathy grading and easily obtain an objective quantification of that 
grading. 
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